Column1; baid;acvalue;aid;sid;cid;geneid;pmid;aidtype;aidmdate;hasdrc;rnai;activity;protacxn;acname;acqualifier;aidsrcname;aidname;cmpdname;targetname;targeturl;ecs;repacxn;taxid;cellids;targettaxid;anatomyid;anatomy;Smiles
0;363133957;;1417077;404710804;124088406;27346;301446970;Literature-derived;20200619;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-ditolylguanidine from human sigma2 receptor expressed in HEKT cells at 10 uM after 90 mins by microbeta scintillation counting method;4-[4-(Hydroxymethyl)cycloheptyl]phenol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC(CCC(C1)C2=CC=C(C=C2)O)CO
1;363297552;;1481558;381871479;137654906;27346;283023970;Literature-derived;20200622;0;0;Unspecified;Q5BJF2;;;ChEMBL;Antagonist activity at sigma2 receptor (unknown origin) at 25 uM relative to control;(2S)-3-amino-N-hydroxy-2-[[(1S)-5-[2-[4-[[2-(hydroxymethyl)imidazol-1-yl]methyl]phenyl]ethynyl]-2,3-dihydro-1H-inden-1-yl]amino]-3-methylbutanamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)([C@@H](C(=O)NO)N[C@H]1CCC2=C1C=CC(=C2)C#CC3=CC=C(C=C3)CN4C=CN=C4CO)N
2;363475882;26;1353759;103520867;16202156;27346;294388910;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma-2 receptor (unknown origin);N-[4-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)butyl]-2-(2-(18F)fluoranylethoxy)-5-iodo-3-methoxybenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC[C@H]1C2=C(C=CC(=C2)C)OC[C@@]1(C)N
3;363475883;904;1353759;104242051;197060;27346;294388910;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma-2 receptor (unknown origin);Ibogaine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@]12COC3=C([C@@H]1CCN2)C(=CC(=C3)OC)OC
4;363475884;1033;1353759;103252283;11165837;27346;294388910;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma-2 receptor (unknown origin);N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-methoxy-5-methylbenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC[C@H]1C2=C(CC[C@@]1(C)N)C=CC(=C2)OC
5;363475885;32;1353759;404657930;98049507;27346;294388910;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma-2 receptor (unknown origin);3-ethyl-N-[(1S,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]-2-oxobenzimidazole-1-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)N1CC[C@@H]2[C@]1(COC3=C2C=CC(=C3)O)C
6;363475886;34;1353759;103237360;10474335;27346;294388910;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma-2 receptor (unknown origin);1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC[C@H]1C2=C(C=CC(=C2)OC)OC[C@@]1(C)N
7;363475887;519;1353759;404659709;145954849;27346;294388910;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma-2 receptor (unknown origin);[(1R,5R)-9-(6-aminohexyl)-9-azabicyclo[3.3.1]nonan-3-yl] N-(2-methoxy-5-methylphenyl)carbamate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC[C@H]1C2=C(C=C(C=C2)O)OC[C@@]1(C)N
8;363475888;126;1353759;242100117;17758676;27346;294388910;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma-2 receptor (unknown origin);1-cyclohexyl-4-[3-(9H-carbazol-9-yl)propyl]piperazine hydrochloride;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NC=C(C=N1)C2=CC=C(C=C2)C(C3=CC=CC=C3F)C(=O)NO
9;363475889;12;1353759;103252427;9829526;27346;294388910;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma-2 receptor (unknown origin);Siramesine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC=C(C(=C1)C(C2=CC=C(C=C2)C3=NC=C(C=N3)C(F)(F)F)C(=O)NO)F
10;363523782;12;1375799;404686172;126720252;27346;297679670;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from human sigma2 receptor expressed in HEK293T cell membranes after 90 mins by scintillation counting method;4-[4-[1-[4-[1-(6-Aminohexyl)triazol-4-yl]butyl]piperidin-4-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1CC2=CC=CC=C2C3(O1)CCC(CC3)NCC4=CC=CC=C4
11;363666201;113;1415966;404714757;11531451;27346;301088340;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);4,5,6,7-tetrahydro-4-(2-(morpholin-4-yl)ethyl)-1-phenyl-1H-indazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=C(C=C1)OCCN2CCN(CC2)C(=O)C3=CC4=CC=CC=C4N3
12;363700358;50119;1409615;103169732;2719;27346;323538590;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from the Sigma2 receptor;Chloroquine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN(CCC1(CC(C1)NC(=O)C2=CC3=CC=CC=C3C=C2)O)[C@H]4CCC5=C(C4)SC(=N5)N
13;363700359;2512;1409615;103605085;26987;27346;323538590;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from the Sigma2 receptor;Clemastine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN[C@H]1CCC2=C(C1)SC(=N2)N
14;363700360;10;1409615;103566848;3652;27346;323538590;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from the Sigma2 receptor;Hydroxychloroquine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C2=CC=CC=C2N=C3C1=CC=CC3=O
15;363700361;2512;1409615;103237360;10474335;27346;323538590;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from the Sigma2 receptor;1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2(CCC1NCC3=CC=CC=C3)C4=CC=CC=C4CCO2
16;363700362;95;1409615;103224052;2247;27346;323538590;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from the Sigma2 receptor;Astemizole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CC1=CC=CC=C1)C2CCC3(CC2)C4=CC=CC=C4CC(O3)OC
17;363700363;955;1409615;103224052;2247;27346;323538590;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from the Sigma2 receptor;Astemizole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1CC2=CC=CC=C2C3(O1)CCC(CC3)NCC4CCCCC4
18;363700364;79433;1409615;381854209;9817231;27346;323538590;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from the Sigma2 receptor;3-(4-methylphenyl)-5-(1-propyl-3,6-dihydro-2H-pyridin-5-yl)-1,2-oxazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CC1CCCCC1)C2CCC3(CC2)C4=CC=CC=C4CC(O3)OC
19;363862569;761;1467942;381843647;137636134;27346;291725280;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma 2 receptor (unknown origin) after 120 mins by liquid scintillation counting method;N-[2-(4-benzylpiperidin-1-yl)ethyl]-4-nitro-3-(trifluoromethyl)aniline;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2(CCC1NCC3=CC=CC=C3)C4=CC=CC=C4CCO2
20;363862570;223;1467942;381853196;137642542;27346;291725280;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma 2 receptor (unknown origin) after 120 mins by liquid scintillation counting method;N-[3-(4-benzylpiperidin-1-yl)propyl]-4-nitro-3-(trifluoromethyl)aniline;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1C2=CC=CC=C2C3(O1)CCC(CC3)NCC4=CC=CC=C4
21;363862571;162;1467942;381880791;137657904;27346;291725280;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma 2 receptor (unknown origin) after 120 mins by liquid scintillation counting method;N-[3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)propyl]-4-nitro-3-(trifluoromethyl)aniline;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CC1=CC=CC=C1)C2CCC3(CC2)C4=CC=CC=C4CC(O3)OC
22;363862572;23;1467942;381857034;137645149;27346;291725280;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma 2 receptor (unknown origin) after 120 mins by liquid scintillation counting method;N-[4-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)butyl]-4-nitro-3-(trifluoromethyl)aniline;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1CC2=CC=CC=C2C3(O1)CCC(CC3)NCC4CCCCC4
23;363862573;255;1467942;381887677;137662176;27346;291725280;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma 2 receptor (unknown origin) after 120 mins by liquid scintillation counting method;N-[5-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)pentyl]-4-nitro-3-(trifluoromethyl)aniline;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1C2=CC=CC=C2C3(O1)CCC(CC3)NCC4=CC=CC=C4
24;363862574;24;1467942;381868923;137653169;27346;291725280;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma 2 receptor (unknown origin) after 120 mins by liquid scintillation counting method;N-[5-(4-benzylpiperidin-1-yl)pentyl]-4-nitro-3-(trifluoromethyl)aniline;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN[C@H]1CCC2=C(C1)SC(=N2)N
25;363862575;84;1467942;381837951;137632351;27346;291725280;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma 2 receptor (unknown origin) after 120 mins by liquid scintillation counting method;N-[4-(4-benzylpiperidin-1-yl)butyl]-4-nitro-3-(trifluoromethyl)aniline;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN(CCC1(CC(C1)NC(=O)C2=CC3=CC=CC=C3C=C2)O)[C@H]4CCC5=C(C4)SC(=N5)N
26;363862576;16;1467942;103167216;3559;27346;291725280;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma 2 receptor (unknown origin) after 120 mins by liquid scintillation counting method;Haloperidol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC=C(C=C1)C(=O)O
27;363862577;238;1467942;381865400;137650821;27346;291725280;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma 2 receptor (unknown origin) after 120 mins by liquid scintillation counting method;N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-4-nitro-3-(trifluoromethyl)aniline;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC(=CC=C1CO[N+](=O)[O-])C(=O)O
28;363896653;231;1456744;103394707;9885114;27346;284899500;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma2 receptor (unknown origin);7-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-4H-1,4-benzoxazin-3-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC(=CC=C1CO)C(=O)O
29;363896654;20;1456744;103357668;11301655;27346;284899500;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Inhibition of sigma2 receptor (unknown origin);2-[[4-(3,4-dimethylphenyl)piperazin-1-yl]methyl]-1H-benzimidazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1CC2=CC=CC=C2)C(=O)C3=CC=C(C=C3)C(F)(F)F
30;363957985;2;1500194;160676443;65659;27346;287562630;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;Eprobemide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC(=CC(=C1)C(F)(F)F)C2=CC=C(O2)CNCC3=CN=CC=C3
31;363957986;12;1500194;404665930;41306434;27346;287562630;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-cyanobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1[C@@H](CCC1=O)C2=CN=CC=C2
32;363957987;2;1500194;404665537;41307231;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-bromo-2-fluorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCCCC1=CC(=C(C(=C1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O
33;363957988;321;1500194;404688747;31588412;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-3-dimethylaminobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@H]2[C@@H]([C@H]2[C@@]([C@H]1F)(C(=O)O)N)C(=O)O
34;363958214;17;1500194;404652648;118607439;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;4-[benzyl(methyl)amino]-N-(4-chlorophenyl)butanamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1CC[C@H]([C@@H](C1)OC(=O)O[C@@H](C)OC(=O)[C@H]2[C@H]3[C@@H]2[C@@]([C@H](C3)F)(C(=O)O)N)C(C)C
35;363958215;34;1500194;404659742;18118650;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-3-chlorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1C(CN1C(=O)C2=NC3=C(N2C4=CC(=C(C=C4)Cl)Cl)N=CC=C3)(F)F
36;363958216;12;1500194;404661803;41306333;27346;287562630;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-2-chlorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C(=C(C(=C1OC)OC)OC)OC)C(=O)CCCCCCN2CCC3=CC(=C(C=C3C2)OC)OC
37;363958217;4;1500194;404663993;60701380;27346;287562630;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-[benzyl(methyl)amino]propyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C(=C(C(=C1OC)OC)OC)OC)C(=O)CCCCN2CCC3=CC(=C(C=C3C2)OC)OC
38;363958218;2;1500194;242416088;1081502;27346;287562630;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;4-chloro-N-(2-pyrrolidin-1-ylethyl)benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC12C3=CC=CC=C3CO2)CCCCC4=CN(C5=CC=CC=C54)C6=CC=C(C=C6)F
39;363958219;48;1500194;404656724;118607347;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;Benzamide derivative 8;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C(=C(C(=C1OC)OC)OC)OC)C(=O)CCCCCN2CCC3=CC(=C(C=C3C2)OC)OC
40;363958220;11;1500194;404657249;145953153;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[2-[benzyl(methyl)amino]ethyl]-2,3-dichlorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=C(C=C1)OC)C(=O)NCCCCN2CCC3=CC(=C(C=C3C2)OC)OC
41;363958221;2;1500194;103292864;4235;27346;287562630;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;Moclobemide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C(=C(C(=C1OC)OC)OC)OC)C(=O)CCCN2CCC3=CC(=C(C=C3C2)OC)OC
42;363958222;47;1500194;404652522;51111240;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-fluorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=NC(=N1)CN2CCCC2)C3=CC=C(C=C3)C4=CC=CC=C4
43;363958223;95;1500194;404655149;29048070;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N'-benzyl-N-[(4-chlorophenyl)methyl]-N'-methylpropane-1,3-diamine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=NC(=N1)CN2CCCC2)C3=CC=C(C=C3)C4CCCCC4
44;363958224;2;1500194;404671993;118607455;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[4-(benzylmethylamino)butyl]-4-chlorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=NC(=N1)CN2CCCC2)C3=CC(=C(C=C3)C4=CC(=C(C=C4)Cl)Cl)Cl
45;363958225;16;1500194;404652243;52750322;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-propylbenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=NC(=N1)CN2CCCC2)C3=CC=C(C=C3)OC4=CC=CC=C4
46;363958226;12;1500194;404661697;18118651;27346;287562630;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-methoxybenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1C2=CC=C(C=C2)C3=C4C=CC(=CC4=CC(=C3)C(=O)O)C5=CC=C(C=C5)C(F)(F)F)C=O
47;363958227;12;1500194;404652614;18118654;27346;287562630;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-3-methoxybenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCN1C2=C3C=C(NC3=NC=C2CN(C1=O)C4=C(C(=CC(=C4F)OC)OC)F)CN5CCOCC5
48;363958228;2;1500194;404656733;110440208;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-tertbutylbenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CC3=CC=CC=C3CNC(=O)C4=CC=C(C=C4)F)O
49;363958229;49;1500194;404664142;118607453;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-butylbenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CC3=CC=CC=C3CNC(=O)C4=CC=CC(=C4)C#N)OC
50;363958230;31;1500194;404653612;41306445;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-2,3-dichlorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CC3=CC=CC=C3CNC(=O)C4=CC=C(C=C4)C#N)OC
51;363958490;2;1500194;404658724;17644936;27346;287562630;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;4-chloro-N-[3-(4-methylpiperazin-1-yl)propyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CC3=CC=CC=C3CNC(=O)C4=CC=C(C=C4)Br)O
52;363958491;98;1500194;404662101;110445832;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-trifluoromethylbenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CC3=CC=CC=C3CNC(=O)C4=CC(=C(C=C4)I)OC)O
53;363958492;2;1500194;404662955;10356384;27346;287562630;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;4-chloro-N-[2-(4-methylpiperazin-1-yl)ethyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CC2=CC(=C(C=C21)O)O)CC3=CC=CC=C3CNC(=O)C4=CC=CC(=C4)C#N
54;363958493;35;1500194;404662401;145956728;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;4-chloro-N-[3-(1,3-dihydroisoindol-2-yl)propyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CC3=CC=CC=C3CNC(=O)C4=CC5=CC=CC=C5C=C4)O
55;363958494;59;1500194;404667049;118607364;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-3,4-dichlorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CC3=CC=CC=C3CNC(=O)C4=CC=C(C=C4)Cl)O
56;363958495;12;1500194;404651607;40624141;27346;287562630;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-2-bromobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CC3=CC=CC=C3CNC(=O)C4=CC=C(C=C4)C5=CC=CC=C5)O
57;363958496;14;1500194;404658224;118607309;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-(2-(benzyl(methyl)amino)ethyl)-4-nitrobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CC2=CC(=C(C=C21)O)O)CC3=CC=CC=C3CNC(=O)C4=CC=C(C=C4)C#N
58;363958497;16;1500194;404658374;9049339;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-[benzyl(methyl)amino]propyl]-4-bromobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CC3=CC=CC=C3CNC(=O)C4=CC=C(C=C4)I)O
59;363958498;2;1500194;404663989;52149645;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-[benzyl(methyl)amino]propyl]-4-chlorobenzenesulfonamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=CC(=C1OC)C(=O)NCC2=CC=CC=C2CN3CCC4=CC(=C(C=C4C3)O)OC
60;363958499;19;1500194;404654122;41306362;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;Benzamide derivative 11;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CC3=CC=CC=C3CNC(=O)C4=CC=C(C=C4)C#N)O
61;363958500;17;1500194;404651932;118607283;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-(2-(benzyl(methyl)amino)ethyl)-4-cyanobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C=NC=C1[C@](COC2=C(C=C(C=C2)C#N)C3=CC=C(C=C3)OC(F)(F)F)(C4=CC=C(C=C4)C#N)O
62;363958501;36;1500194;404652702;27148262;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-nitrobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C=NC=C1[C@](COC2=C(C=C(C=C2)C#N)C3=CC=C(C=C3)OC(F)(F)F)(C4=CC=C(C=C4)C#N)O
63;363958502;2;1500194;404661725;118607351;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-(N-methyl-2-phenylethylamino)propyl]-4-chlorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCS(=O)(=O)C1=NC=C2C(=C1)C=C(N2)C[C@](CC(C)(C)C3=C(C=C(C=C3)F)C(=O)N)(C(F)(F)F)O
64;363958503;2;1500194;404653386;3126148;27346;287562630;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;4-chloro-N-[3-(pyrrolidin-1-yl)propyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC(=O)N[C@H]1CC[C@H](C1)C(=O)N(C)C2=CC=C(C=C2)C3=NC4=CC=CC=C4O3
65;363958504;85;1500194;404689082;60346448;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[2-[benzyl(methyl)amino]ethyl]-4-chlorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](C(=O)NC1(CC1)C2=CC=CC=N2)NC(=O)C3=CN=C4N3[C@](C(=O)N4C5=CC(=C(C(=C5)Cl)F)Cl)(C)CC6=CC=C(C=C6)C#N
66;363958505;35;1500194;404656716;41306385;27346;287562630;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from S2R in human Jurkat cell membranes after 1 hr in presence of (+)-pentazocine by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-3-bromobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)N1CCC(CC1)C2=C(C=C(C=C2)C(=O)N=C(N)N)C(F)(F)F
67;364897142;;1512501;440168398;153287572;27346;316202300;Literature-derived;20210302;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells at 10 uM after 90 mins by microbeta scintillation counting method relative to control;(3S,4S)-4-ethyl-3,6-dimethyl-2,4-dihydrochromen-3-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1[C@H]2C3(CCS(=O)(=O)CC3)C4=C(N2S(=O)(=O)C5=CC=C(C=C5)F)C=CC(=C4)C(=O)NCC6=C(C=C(C=N6)C(F)(F)F)Cl
68;364897143;;1512501;440123917;155519891;27346;316202300;Literature-derived;20210302;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells at 10 uM after 90 mins by microbeta scintillation counting method relative to control;(3aS,9bS)-7,9-dimethoxy-3a-methyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC(=O)N(C[C@H](C)N1CCC(CC1)CC2=CC=CC=C2)C3=CC=CC=C3
69;364897144;;1512501;440148836;155536080;27346;316202300;Literature-derived;20210302;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells at 10 uM after 90 mins by microbeta scintillation counting method relative to control;(1S,2R)-1-ethyl-7-methoxy-2-methyl-3,4-dihydro-1H-naphthalen-2-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC(=O)N(CC(C)N1CCC(CC1)CC2=CC=CC=C2)C3=CC=CC=C3
70;364897145;;1512501;440146114;153287550;27346;316202300;Literature-derived;20210302;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells at 10 uM after 90 mins by microbeta scintillation counting method relative to control;1-[(3aS,9bS)-7-hydroxy-3a-methyl-1,2,4,9b-tetrahydrochromeno[3,4-b]pyrrol-3-yl]ethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC(=O)N(CC(C)N1CCC(CC1)CC2=CC=CC=C2)C3=CC=C(C=C3)F
71;364897146;;1512501;440134957;155526977;27346;316202300;Literature-derived;20210302;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells at 10 uM after 90 mins by microbeta scintillation counting method relative to control;(3S,4S)-4-ethyl-6-methoxy-3-methyl-2,4-dihydrochromen-3-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=NC=C(C=C5)F
72;364897147;;1512501;440215686;147652368;27346;316202300;Literature-derived;20210302;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells at 10 uM after 90 mins by microbeta scintillation counting method relative to control;(3S,4S)-3-amino-4-ethyl-3-methyl-2,4-dihydrochromen-7-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C=CN=C1CN2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
73;364906759;;1514809;440112865;86302836;27346;304638020;Literature-derived;20210302;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]DTG from human sigma receptor at 10 uM after 120 mins by scintillation counting method relative to control;2-(2-fluorophenyl)-N-hydroxy-2-[4-(2-methylpyrimidin-5-yl)phenyl]acetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=NC=C(C=C1)CN2C[C@H]3[C@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
74;364906761;;1514809;440130958;81689842;27346;304638020;Literature-derived;20210302;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]DTG from human sigma receptor at 10 uM after 120 mins by scintillation counting method relative to control;2-(2-fluorophenyl)-N-hydroxy-2-[4-[5-(trifluoromethyl)pyrimidin-2-yl]phenyl]acetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=NC=C(C=C1)CN2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=CC(=CC=C5)F
75;365267097;10;1512457;440133221;153287553;27346;316202300;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3a-methyl-5-phenyl-2,3,4,9b-tetrahydro-1H-pyrrolo[2,3-c]quinoline;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1N2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=NC=C(C=C5)F
76;365267098;63096;1512457;440140551;147653864;27346;316202300;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-6-bromo-3a-methyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@H]2[C@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=CC=CC=N5
77;365267099;15849;1512457;440134043;153287566;27346;316202300;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3,3a-dimethyl-5-phenyl-1,2,4,9b-tetrahydropyrrolo[2,3-c]quinoline;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1N2C[C@H]3[C@H](C2)OCC4=C(N=NN34)C5=NC=C(C=C5)F
78;365267100;199526;1512457;440154067;153061504;27346;316202300;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(1S,2S)-1-ethyl-2-methyl-1,3-dihydrobenzo[f]chromen-2-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=NC=C(C=C1)CN2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
79;365267101;31623;1512457;440221484;146709966;27346;316202300;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3S,4S)-4-ethyl-3-methyl-2,4-dihydrobenzo[h]chromen-3-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CN=C(C=C3)C(F)(F)F)OCC4=C(N=NN24)C5=CC=CC=C5F
80;365267102;100;1512457;440134957;155526977;27346;316202300;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3S,4S)-4-ethyl-6-methoxy-3-methyl-2,4-dihydrochromen-3-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=CN=CC=C5
81;365267103;100;1512457;440148836;155536080;27346;316202300;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(1S,2R)-1-ethyl-7-methoxy-2-methyl-3,4-dihydro-1H-naphthalen-2-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=NC=CC=N5
82;365267104;31623;1512457;440152149;153287567;27346;316202300;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3a,8-dimethyl-5-(4-methylphenyl)-2,3,4,9b-tetrahydro-1H-pyrrolo[2,3-c]quinoline;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=CC=CC=N5
83;365267105;100;1512457;440146114;153287550;27346;316202300;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;1-[(3aS,9bS)-7-hydroxy-3a-methyl-1,2,4,9b-tetrahydrochromeno[3,4-b]pyrrol-3-yl]ethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1N2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
84;365267106;12589;1512457;440110637;153287542;27346;316202300;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3a-methyl-6-phenyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1CN2C[C@H]3[C@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
85;365267107;10;1512457;440171121;147636204;27346;316202300;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3a-methyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrol-7-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CN=CC=C3)OCC4=C(N=NN24)C5=CC=CC=C5F
86;365267287;31623;1512457;440171256;148302367;27346;316202300;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3S,4S)-4-ethyl-3-methyl-6-phenyl-2,4-dihydrochromen-3-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=C(C=CC=N5)F
87;365267288;398107;1512457;440204965;153287535;27346;316202300;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3,3a-dimethyl-1,2,4,9b-tetrahydrochromeno[3,4-b]pyrrol-7-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=C(C=NC=C5)F
88;365267289;31623;1512457;440149911;153287541;27346;316202300;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3,3a-dimethyl-6-phenyl-1,2,4,9b-tetrahydrochromeno[3,4-b]pyrrole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1CN2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
89;365267290;100;1512457;440168398;153287572;27346;316202300;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3S,4S)-4-ethyl-3,6-dimethyl-2,4-dihydrochromen-3-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@H]2[C@H](CN1CC3=CC=CC=C3)OCC4=C(N=NN24)C5=CC=CC=C5F
90;365267291;1;1512457;440228796;149396365;27346;316202300;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3a-methyl-7-phenylmethoxy-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=CC=C3)OCC4=C(N=NN24)C5=CC=CC=C5F
91;365267292;7943;1512457;440227019;153287557;27346;316202300;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-8-bromo-5-(4-bromophenyl)-3a-methyl-2,3,4,9b-tetrahydro-1H-pyrrolo[2,3-c]quinoline;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=CC=C3)OCC4=C(N=NN24)C5=CC(=CC=C5)F
92;365267293;100;1512457;440123917;155519891;27346;316202300;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-7,9-dimethoxy-3a-methyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@H]2[C@H](CN1CC3=CC=CC=C3)OCC4=C(N=NN24)C5=CC(=CC=C5)F
93;365267294;125893;1512457;440132439;153287537;27346;316202300;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;1-[(3aS,9bS)-3a-methyl-5-phenyl-1,2,4,9b-tetrahydropyrrolo[2,3-c]quinolin-3-yl]ethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCC(CC1)C2=C3CO[C@@H]4CN(C[C@H]4N3N=N2)CC5=CC=C(C=C5)F
94;365267295;316228;1512457;440198304;155557042;27346;316202300;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-8-methoxy-3a-methyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1C2=C3CO[C@@H]4CN(C[C@H]4N3N=N2)CC5=CC=C(C=C5)F
95;365267296;63096;1512457;440214664;153287574;27346;316202300;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3S,4S)-4-ethyl-3-methyl-1-phenyl-2,4-dihydroquinolin-3-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1N2C[C@H]3[C@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
96;365267297;7943;1512457;440226874;153287539;27346;316202300;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3a-methyl-8-phenyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1N2C=C(N=N2)CC3=CC=CC=C3)CC4=CC=CC=C4
97;365267298;125893;1512457;440117345;153287551;27346;316202300;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;1-[(3aS,9bS)-3a-methyl-6-phenyl-1,2,4,9b-tetrahydrochromeno[3,4-b]pyrrol-3-yl]ethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1CN2CC[C@]34[C@@H]5C6=C(C[C@]3([C@H]2CC7=C4C(=C(C=C7)O)O5)O)C8=CC=CC=C8N6
98;365267299;31623;1512457;440131968;153287568;27346;316202300;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3a,7,9-trimethyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](C(=O)NCC(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCO)NC(=O)[C@H](CC2=CC=C(C=C2)O)N
99;365267300;100;1512457;440215686;147652368;27346;316202300;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma2 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3S,4S)-3-amino-4-ethyl-3-methyl-2,4-dihydrochromen-7-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN([C@@H]1CCCC[C@H]1N2CCCC2)C(=O)CC3=CC(=C(C=C3)Cl)Cl
100;365439310;;1587565;131285359;54582640;27346;309390140;Literature-derived;20210302;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes at 1 uM after 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method relative to control;N-benzyl-3-methoxyspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCOC(=O)CC1=CC(=C(C=C1)OCC(=O)N2CCN(CC2)C3=CC=CC=C3)OCC
101;365492888;;1607500;440152736;27842480;27346;323426850;Literature-derived;20210302;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-DTG from sigma 2 receptor (unknown origin) at 10 uM measured after 90 mins by microbeta counting analysis relative to control;(1H-Indol-2-yl)(4-(2-(4-methoxyphenoxy)ethyl)piperazin-1-yl)methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC(=C(C=C1)C2C3=C(CCN2)C4=C(N3)C=CC(=C4)F)O
102;365492889;;1607500;163332281;53475319;27346;323426850;Literature-derived;20210302;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-DTG from sigma 2 receptor (unknown origin) at 10 uM measured after 90 mins by microbeta counting analysis relative to control;N-((1R,3R)-3-(2-(((S)-2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)(propyl)amino)ethyl)-3-hydroxycyclobutyl)-2-naphthamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC(=C(C=C1C2C3=C(CCN2)C4=C(N3)C=CC(=C4)Cl)OC)OC.Cl
103;365492890;;1607500;103245538;119570;27346;323426850;Literature-derived;20210302;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-DTG from sigma 2 receptor (unknown origin) at 10 uM measured after 90 mins by microbeta counting analysis relative to control;Pramipexole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC(=C(C=C1)C2C3=C(CCN2)C4=C(N3)C=CC(=C4)Cl)O
104;366234075;;1519582;194137287;6817;27346;317066390;Literature-derived;20220318;0;0;Inactive;Q5BJF2;;;ChEMBL;Displacement of [3H]-CTG from human recombinant sigma2 receptor expressed in HEKT cells incubated for 90 mins by microbeta scintillation counting method;Pyocyanin;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1C(CN(C1=O)CC2=CC=CO2)C(=O)NC3=CC=C(C=C3)C4=NC(=NO4)C5=CC=C(C=C5)Cl
105;366387399;13;1571154;440200842;155558029;27346;305687600;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from human sigma 2 receptor;(1R,2R,3S,4R,5S)-1-methyl-4-[6-(2-phenylethylamino)-2-(2-phenylethynyl)purin-9-yl]bicyclo[3.1.0]hexane-2,3-diol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1(F)F)C2=NC3=CC=CC=C3C4=C2C=CN4CC5=CC(=CC=C5)Cl
106;366390099;155;1571905;103472624;44405080;27346;306053310;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma receptor 2 (unknown origin);(2R,3S,4R,5S)-4-[2-chloro-6-(cyclopentylamino)purin-9-yl]-2,3-dihydroxy-N-methylbicyclo[3.1.0]hexane-1-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](C(=O)NC1(CC1)C2=CC=CC=N2)NC(=O)C3=CN=C4N3[C@](C(=O)N4C5=CC(=C(C(=C5)Cl)F)Cl)(C)CC6=CC=C(C=C6)C#N
107;366390100;753;1571905;440112114;155512086;27346;306053310;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma receptor 2 (unknown origin);(1R,2R,3S,4R,5S)-4-[6-[di(cyclobutyl)methylamino]purin-9-yl]-1-(hydroxymethyl)bicyclo[3.1.0]hexane-2,3-diol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NOC(=N1)[C@H]2C[C@H](CN(C2)C(=O)N3CCS(=O)(=O)C3)C4=CC=C(C=C4)C(F)(F)F
108;366390101;662;1571905;440114236;155513505;27346;306053310;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma receptor 2 (unknown origin);(2S,3S,4R,5R)-2-(chloromethyl)-5-[6-[di(cyclobutyl)methylamino]purin-9-yl]oxolane-3,4-diol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](C1=C(C=NC2=CC(=NN21)Cl)NC3=CC=C(C=C3)[C@@H](C(F)(F)F)N(C)C(=O)C4CCS(=O)(=O)CC4)OC
109;366390102;432;1571905;440183509;15599151;27346;306053310;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma receptor 2 (unknown origin);(2R,3R,4S,5S)-2-[6-[[(1R,2S,4S)-2-bicyclo[2.2.1]heptanyl]amino]purin-9-yl]-5-(chloromethyl)oxolane-3,4-diol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C(=NN1CC2=CC=C(C=C2)C(C)(C)C)C(F)(F)F)NC(=O)C3=CC(=NC4=C3C=CC(=C4)F)C(=O)N
110;366390103;255;1571905;440185901;155552117;27346;306053310;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma receptor 2 (unknown origin);(1S,2R,3S,4R,5S)-4-(6-amino-2-chloropurin-9-yl)-1-(chloromethyl)bicyclo[3.1.0]hexane-2,3-diol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1C2CN(C2)C(=O)C3=CC4=C(C=C3)N(C=C4)C5=CC=C(C=C5)F)C6=NC=CC=N6
111;366390104;349;1571905;440165136;155543832;27346;306053310;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma receptor 2 (unknown origin);(1S,2R,3S,4R,5S)-4-[2-chloro-6-[di(cyclobutyl)methylamino]purin-9-yl]-1-(chloromethyl)bicyclo[3.1.0]hexane-2,3-diol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1(C2=CC=CC=C2[N+](=C1/C=C/C=C/C=C\3/C(C4=CC=CC=C4N3CCCCCC(=O)NCCCCCCN5C=C(C6=CC=CC=C65)CCCCN7CCC8(CC7)C9=CC=CC=C9CO8)(C)C)C)C.[I-]
112;366390105;435;1571905;103566156;10403711;27346;306053310;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma receptor 2 (unknown origin);(2S,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-N-cyclopropyl-3,4-dihydroxytetrahydrofuran-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC(CCC1NS(=O)(=O)C(F)(F)F)(C2=C(C=CC(=C2)F)F)S(=O)(=O)C3=CC=C(C=C3)Cl
113;366390106;172;1571905;440146698;155534733;27346;306053310;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma receptor 2 (unknown origin);methyl 1-[(1S,2R,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-bicyclo[3.1.0]hexanyl]-1,2,4-triazole-3-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(C1)C(=O)C2=CC(=C3C=CC=CN3C2=O)CN4CCC(CC4)(C#N)C5=CC=CC=N5
114;366390107;583;1571905;440221656;155566272;27346;306053310;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma receptor 2 (unknown origin);(1S,2R,3S,4R,5S)-4-[2-chloro-6-[di(cyclobutyl)methylamino]purin-9-yl]-1-[(2-fluorophenyl)sulfanylmethyl]bicyclo[3.1.0]hexane-2,3-diol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C(=NN1C2=C(C=C(C=N2)C3CC3)F)OC(C)C)OC4=C(C=CC=C4F)F
115;366390108;796;1571905;103720039;97627;27346;306053310;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma receptor 2 (unknown origin);9-Riburonosyladenine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NC(=NC=C1)NC2=CC(=CC(=C2)C3=CN=C(S3)[C@]4(CC[C@@H](C(C4)(C)C)C(=O)O)O)C
116;366390109;642;1571905;440112216;155512151;27346;306053310;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma receptor 2 (unknown origin);(2R,3R,4S,5S)-2-[6-[di(cyclobutyl)methylamino]purin-9-yl]-5-(ethylsulfanylmethyl)oxolane-3,4-diol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](C1=CC=CC(=C1)C#N)N2C=C(C=C(C2=N)C(=O)N)Cl
117;366390110;201;1571905;163338250;70676458;27346;306053310;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma receptor 2 (unknown origin);(1R,2R,3S,4R,5S)-4-[2-chloro-6-(dicyclopentylmethylamino)purin-9-yl]bicyclo[3.1.0]hexane-2,3-diol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=CC(=N1)C(F)(F)F)C2=CN=C(N=C2)N3CCC4=C3C(=CC(=C4)S(=O)(=O)NC5=C(C=C(C=C5F)Cl)F)N6CCCC6=O
118;366390111;202;1571905;440214440;155563428;27346;306053310;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma receptor 2 (unknown origin);ethyl (1S,2R,3S,4R,5S)-4-[2-chloro-6-[di(cyclobutyl)methylamino]purin-9-yl]-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=CC(=N1)C(=O)NCC2=CC=C(C=C2)C(=O)O)C3=CC4=C(C=C3)NC=C4
119;366390112;209;1571905;440149666;155536619;27346;306053310;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma receptor 2 (unknown origin);1-[(1S,2R,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-bicyclo[3.1.0]hexanyl]-1,2,4-triazole-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CC1=CC=CC=C1)CC2=CSC3=C2C(=O)NC(=N3)C(=O)NCC4=CC(=CC=C4)OC
120;366390113;117;1571905;440197289;155556618;27346;306053310;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma receptor 2 (unknown origin);(1S,2R,3S,4R,5S)-1-(chloromethyl)-4-[6-[di(cyclobutyl)methylamino]purin-9-yl]bicyclo[3.1.0]hexane-2,3-diol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)CC(=O)N1CCC2=C(C1)C(=NC(=N2)C3=CC=C(C=C3)Br)N(C)CC4=CC=CC=C4
121;366422571;46;1587573;440130608;155524132;27346;309390140;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)-N-methylspiro[cyclohexane-4,1'-isochromene]-1-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=CC(=C1)N2C=CN3C2=CC(=N3)C4=CN=CC=C4)NC(=O)C5=CC(=CC=C5)S(F)(F)(F)(F)F
122;366422572;94;1587573;440139150;155529711;27346;309390140;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)-1-methoxy-N-methylspiro[1H-2-benzofuran-3,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN([C@@H]1CCC2=C(C3=CC=CC=C3N2C1)CC(=O)O)S(=O)(=O)C4=CC=C(C=C4)F
123;366422573;16;1587573;440218571;155524132;27346;309390140;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)-N-methylspiro[cyclohexane-4,1'-isochromene]-1-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC(=O)N[C@@H]1CC[C@@H](C1)C(=O)N(C)C2=CC=C(C=C2)C3=NC4=CC=CC=C4O3
124;366422574;;1587573;440149758;155534365;27346;309390140;Confirmatory;20220830;0;0;Inconclusive;Q5BJF2;Ki;;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-benzylspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C(C=C1)CC[C@H](C2=CC(=CC=C2)OCCN3CCOCC3)OC(=O)[C@@H]4CCCCN4C(=O)[C@@H](C5CCCCC5)C6=CC(=C(C(=C6)OC)OC)OC)OC
125;366422575;46;1587573;440205546;155547337;27346;309390140;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)-3-ethoxyspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC2=C(C=C1)[C@@H](C[C@@H](O2)C3=CC(=C(C=C3)OC)OC)NC(=O)C4(CC4)C5=CC6=C(C=C5)OC(O6)(F)F
126;366422576;;1587573;131281397;54583594;27346;309390140;Confirmatory;20220830;0;0;Inconclusive;Q5BJF2;Ki;;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-benzyl-3-methoxy-N-methylspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C(=NN1CC2=CC=C(C=C2)C#N)C(F)(F)F)NC(=O)C3=CC(=NC4=C3C=CC(=C4)F)C(=O)N
127;366422577;16;1587573;440173979;155547337;27346;309390140;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)-3-ethoxyspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C1=CC=C(C=C1)C(=O)NC2=CN3C=C(C=CC3=N2)C4=CC=NC=C4)C(=O)N5CCN(CC5)C
128;366422578;227;1587573;131277323;54582640;27346;309390140;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-benzyl-3-methoxyspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@]1(C(=O)N(C2=NC=C(N21)C(=O)NC3(CC3)C4=NC(=NO4)C5CCC5)C6=CC(=CC(=C6)Cl)Cl)CC7=CC=C(C=C7)C#N
129;366422579;8;1587573;440148670;155535978;27346;309390140;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)spiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC=C2C(=C1)C(=O)NC(S2)C3=CC=CC=N3
130;366422833;13;1587573;440203023;155553997;27346;309390140;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)-3-methoxy-N-methylspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC[C@H](C(=O)O)NC1=C(C(=NC2=C1C=CN=C2)C3=CC=C(C=C3)C4=CC=CC(=C4F)C)C#N
131;366422834;7;1587573;440202935;155558857;27346;309390140;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)spiro[cyclohexane-4,1'-isochromene]-1-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](C(=O)NC1=NC(=CS1)C2=CC=CC(=C2)C3=NN(C=C3)C)NC(=O)C4=CN(C=N4)C5(CC5)C#N
132;366422835;;1587573;440210455;155518065;27346;309390140;Confirmatory;20220830;0;0;Inconclusive;Q5BJF2;Ki;;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)-3-methoxyspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)CC#CC1=CC(=C(C=C1)OCCCC2=C(N=C(S2)N3CCC4=C(C3)C(=CC=C4)C(=O)NC5=NC6=CC=CC=C6S5)C(=O)O)F
133;366422836;;1587573;440190734;155553997;27346;309390140;Confirmatory;20220830;0;0;Inconclusive;Q5BJF2;Ki;;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)-3-methoxy-N-methylspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1CN(C[C@@H](O1)C)C2=NC=NC(=C2)C3=NNC4=C3C=C(C=C4)OC5(CC5)C
134;366422837;12;1587573;440143746;155532745;27346;309390140;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)-N-methylspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN([C@H](C2=C1N=CC=C2)C3=CC=C(C=C3)F)C(=O)NC4=CN=C(N=C4)OC5=CC=C(C=C5)F
135;366422838;93;1587573;440118523;155516317;27346;309390140;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)-3-ethoxy-N-methylspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)N1CCC(CC1)C2=C(C=C(C=C2)C(=O)NC3=NCCN3)C(F)(F)F
136;366422839;;1587573;440146142;155534365;27346;309390140;Confirmatory;20220830;0;0;Inconclusive;Q5BJF2;Ki;;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-benzylspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1[C@@H]2C3(CCS(=O)(=O)CC3)C4=C(N2S(=O)(=O)C5=CC=C(C=C5)F)C=CC(=C4)C(=O)NCC6=C(C=C(C=N6)C(F)(F)F)Cl
137;366422840;76;1587573;440146692;155529711;27346;309390140;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)-1-methoxy-N-methylspiro[1H-2-benzofuran-3,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCNCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl
138;366422841;33;1587573;440192600;155535978;27346;309390140;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)spiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl
139;366422842;55;1587573;440205309;155532745;27346;309390140;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)-N-methylspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C=CC(=O)NC1=CC2=C(C=C1)NC(=O)N2C3CCN(CC3)CC4=CC=C(C=C4)C5=C(C=C6C(=N5)C=CNC6=O)C7=CC=CC=C7
140;366422843;;1587573;440112135;155512102;27346;309390140;Confirmatory;20220830;0;0;Inconclusive;Q5BJF2;Ki;;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-benzyl-1-methoxyspiro[1H-2-benzofuran-3,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2=C(C=CC(=C2)NC3=C(C=C(C=C3)F)F)C(=O)C4=C1C=CC(=C4)OC[C@@H](CO)O
141;366422844;;1587573;131279338;54583594;27346;309390140;Confirmatory;20220830;0;0;Inconclusive;Q5BJF2;Ki;;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-benzyl-3-methoxy-N-methylspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COCCOC1=NC(=NC2=C1CN(CC2)C(=O)C3=C4C=CC=CN4C=N3)C5=CN=C(C=C5)Cl
142;366422845;14;1587573;440134266;155516317;27346;309390140;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)-3-ethoxy-N-methylspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(SC(=N1)CC2=CC(=CC=C2)C(F)(F)F)C3=CN=C(C=C3)C(=O)N
143;366422846;2;1587573;103186197;7333;27346;309390140;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;1,3-Di-o-tolylguanidine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCC(CC6)OC)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C
144;366423118;;1587573;440121123;155518065;27346;309390140;Confirmatory;20220830;0;0;Inconclusive;Q5BJF2;Ki;;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)-3-methoxyspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)C1=C(C2=CC(=C(N=C2N(C1=O)C)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl)NC(=O)C
145;366423119;39;1587573;440157739;155515524;27346;309390140;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)-1-methoxyspiro[1H-2-benzofuran-3,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C2=CC=CC=C2OC[C@@H](C1=O)N3CCC4=CN(N=C4C3=O)CC5=CC=CC=C5
146;366423120;67;1587573;440219682;155558857;27346;309390140;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)spiro[cyclohexane-4,1'-isochromene]-1-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC=C(C(=C1)F)S(=O)(=O)NNC(=O)C2=CC(=CC(=C2)C3=CC=CC=N3)F
147;366423121;11;1587573;440117325;155515524;27346;309390140;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-(cyclohexylmethyl)-1-methoxyspiro[1H-2-benzofuran-3,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC=C(C=C1)CC(=O)NC2=CC(=C(C=C2)OC3=CC(=CC=C3)Cl)S(=O)(=O)N
148;366423122;;1587573;440134905;155512102;27346;309390140;Confirmatory;20220830;0;0;Inconclusive;Q5BJF2;Ki;;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in human RT4 cell membranes incubated for 120 mins in the presence of sigma1 receptor ligand (+)-pentazocine by scintillation counting method;N-benzyl-1-methoxyspiro[1H-2-benzofuran-3,4'-cyclohexane]-1'-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1C2=NC(=CS2)C3=CC4=CC=CC=C4O3)CC5=NC6C(N5)C=CC=N6
149;366431580;251;1592019;136926064;3050372;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;1-(3-Phenoxypropyl)-4-phenylpiperazine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1C(CN1C(=O)C2=CC=C(C=C2)F)(COC3=CC=C(C=C3)Br)C(=O)O
150;366431581;2138;1592019;312351721;118709751;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[3-(2-fluorophenyl)sulfanylpropyl]-8-azabicyclo[3.2.1]octan-3-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCCN(CCCC)C(=O)CN1C[C@H]([C@@H]([C@H]1CC(C)(C)CCC)C(=O)O)C2=CC3=C(C(=C2)OC)OCO3
151;366431582;22;1592019;312351721;118709751;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[3-(2-fluorophenyl)sulfanylpropyl]-8-azabicyclo[3.2.1]octan-3-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC(C1=CC(=NC2=C1C(=C(S2)C(=O)N)N)N3CCC(CC3)S(=O)(=O)C)(F)F
152;366431583;5888;1592019;136931562;57345618;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Chlorophenyl)-4-[3-(4-fluorophenoxy)propyl]-1,4-diazepane;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)[C@H]1CCN(C1)C2=CC(=NC3=CC=NN32)C4=CC=CC=C4
153;366431584;59;1592019;136931562;57345618;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Chlorophenyl)-4-[3-(4-fluorophenoxy)propyl]-1,4-diazepane;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CN=C(C=C1N2C3=CC=CC=C3N(C2=O)CC(=O)N)C4=C(C=CC(=C4)Cl)F
154;366431585;3981;1592019;440157814;155540848;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Fluorophenyl)-4-(4-pyrimidin-2-yl-1,4-diazepan-1-yl)butan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C=C(C2=C(C=CN=C21)OC3=C(C=C(C=C3F)NC4=CC(=NC(=N4)N)Cl)F)Cl
155;366431586;44;1592019;440157814;155540848;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Fluorophenyl)-4-(4-pyrimidin-2-yl-1,4-diazepan-1-yl)butan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1CN(C[C@@H](O1)C)C2=NC=NC(=C2)C3=NN(C4=C3C=C(C=C4)OC5(CC5)C)C
156;366431587;8;1592019;440216108;155564110;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;4-[4-(5-Chloropyridin-2-yl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC(=O)N(C1)C2=CC(=CC3=C2N(CC3)C4=NC=C(C=N4)N)S(=O)(=O)NC5=C(C=C(C=C5F)Cl)F
157;366431588;7943;1592019;440216108;155564110;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;4-[4-(5-Chloropyridin-2-yl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCOC1=C(C=CC(=C1)N2C3CN(CC2COC3)C(=O)[C@H]4C[C@@H](CN4C5=CC=C(C=C5)Cl)O)Cl
158;366431589;2512;1592019;440122051;155518665;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;(NZ)-N-[4-[4-(5-chloropyridin-2-yl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butylidene]hydroxylamine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CNC(=O)C1=CC(=CC2=C1O[C@@H]([C@H]2C3=CC=CC=C3)CF)C(=O)NC4[C@H]5[C@@H]4COC5
159;366431590;27;1592019;440122051;155518665;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;(NZ)-N-[4-[4-(5-chloropyridin-2-yl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butylidene]hydroxylamine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)C(=O)C1=C(C2=C(S1)N=C(C=C2C(F)(F)F)N3CCC(CC3)S(=O)(=O)C)N
160;366431591;515;1592019;136942320;57401819;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Chlorophenyl)-4-[4-(4-fluorophenyl)butyl]piperazine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F
161;366431592;2512;1592019;440196484;155556295;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;(NZ)-N-[1-(4-fluorophenyl)-4-(4-pyrimidin-2-yl-1,4-diazepan-1-yl)butylidene]hydroxylamine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC2=C(C=C1)[C@H](C[C@H](O2)C3=CC(=C(C=C3)OC)OC)NC(=O)C4(CC4)C5=CC6=C(C=C5)OC(O6)(F)F
162;366431593;26;1592019;440196484;155556295;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;(NZ)-N-[1-(4-fluorophenyl)-4-(4-pyrimidin-2-yl-1,4-diazepan-1-yl)butylidene]hydroxylamine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](C2CNC(=O)C3=CC4=NNN=C4C=C3)CN1C(=O)OCC5=CC(=CC(=C5)C(F)(F)F)C(F)(F)F
163;366431751;131;1592019;440209083;155561279;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;(NZ)-N-[1-(4-fluorophenyl)-4-(4-pyridin-2-yl-1,4-diazepan-1-yl)butylidene]hydroxylamine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1(C2=CC=CC=C2Cl)C(=O)NC3=CC(=C(C=C3)OC4=CC(=CC=C4)Cl)S(=O)(=O)N
164;366431752;56;1592019;103624002;11653679;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;4-[4-(4-Chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C=NC=C1[C@@](COC2=C(C=C(C=C2)C#N)C3=CC=C(C=C3)OC(F)(F)F)(C4=CC=C(C=C4)C#N)O
165;366431753;5129;1592019;103624002;11653679;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;4-[4-(4-Chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC(=O)N1CCCC1CNC2CCC(CC2)(C3=C(C=CC(=C3)F)F)S(=O)(=O)C4=CC=C(C=C4)Cl
166;366431754;8511;1592019;136921693;57345619;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Chlorophenyl)-4-[4-(4-fluorophenyl)butyl]-1,4-diazepane;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)C(=O)CN1C=C(C=N1)C2=NC(=NO2)C3(CC3)C4=CC=C(C=C4)C5=CN=C(N=C5)N
167;366431755;85;1592019;136921693;57345619;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Chlorophenyl)-4-[4-(4-fluorophenyl)butyl]-1,4-diazepane;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)C1=C2C=CC=C(C2=NC=C1)S(=O)(=O)NC3=CC=CC=C3C#CC4=CN=C(C=C4OC)C(=O)O
168;366431756;3311;1592019;136932521;57396571;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Chlorophenyl)-4-(3-phenoxypropyl)piperazine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C=NC=C1[C@](COC2=C(C=C(C=C2)C#N)C3=CC=C(C=C3)OC(F)(F)F)(C4=CC=C(C=C4)C#N)O
169;366431757;33;1592019;136932521;57396571;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Chlorophenyl)-4-(3-phenoxypropyl)piperazine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](C1=CC=CC=C1)OC2=C(C(=CC(=C2)C(=O)NC3CCC(CC3)O)F)NC(=O)C
170;366431758;5012;1592019;103359590;15443;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;Azaperone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H](CN([C@H]1C(=O)N2CC3COCC(C2)N3CC4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl)O
171;366431759;52;1592019;103359590;15443;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;Azaperone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2CN([C@H]1CN2C3=NN=C(S3)NC(=O)CC4=CC=CC=C4)C5=NN=CC=C5
172;366431760;63096;1592019;242648185;90644067;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Chlorophenyl)-4-[3-(4-fluorophenyl)sulfinylpropyl]piperazine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C2C=C(C=CC2=NN1)C3C(=C(NC(=C3C#N)C)C)C#N
173;366431761;6;1592019;242648185;90644067;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Chlorophenyl)-4-[3-(4-fluorophenyl)sulfinylpropyl]piperazine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=CC(=N1)C)C[C@H]2CCCN(C2)CC3=CN=C(S3)NC(=O)C
174;366431762;4266;1592019;440137851;155528865;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;1-(5-Chloropyridin-2-yl)-4-[4-(4-fluorophenyl)butyl]piperazine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCOC1=CC=C(C=C1)[C@H]2[C@@H]([C@H](CN2CC(=O)NC3=C(C=CC=C3CC)CC)C4=CC5=C(C=C4)OCO5)C(=O)O
175;366431763;43;1592019;440137851;155528865;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;1-(5-Chloropyridin-2-yl)-4-[4-(4-fluorophenyl)butyl]piperazine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC(=O)N[C@H]1CC[C@H](C1)C(=O)N(C)C2=CC=C(C=C2)C3=NC4=CC=CC=C4O3
176;366431764;8511;1592019;440214480;155563452;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;4-[4-(5-Chloropyridin-2-yl)piperazin-1-yl]-1-(4-fluorophenyl)butan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=CC(=C(C=C3)CCC(=O)O)F)C)OC4CCS(=O)(=O)CC4
177;366431765;84;1592019;440214480;155563452;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;4-[4-(5-Chloropyridin-2-yl)piperazin-1-yl]-1-(4-fluorophenyl)butan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1N2C3=C(C=C(C=C3)C(F)(F)F)N=C2C4=CN=CC=C4
178;366431766;3236;1592019;440173663;155547197;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Fluorophenyl)-4-(4-pyridin-2-yl-1,4-diazepan-1-yl)butan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C(=NN1C2=NC=C(C=C2)C3CC3)OC(C)C)OC4=CC=C(C=C4)F
179;366431767;32;1592019;440173663;155547197;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Fluorophenyl)-4-(4-pyridin-2-yl-1,4-diazepan-1-yl)butan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NC(=NC=C1C2=C3C=NNC3=CC(=C2)C(F)(F)F)N4CC[C@H](C4)O
180;366431768;1995;1592019;312351718;13091356;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[3-(4-fluorophenoxy)propyl]-8-azabicyclo[3.2.1]octan-3-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC=CC=C1OC2=C(C3=CC=CC=C3C(=C2)N4C(=O)C=C(NC4=O)C(F)(F)F)Cl
181;366431769;18;1592019;312351718;13091356;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[3-(4-fluorophenoxy)propyl]-8-azabicyclo[3.2.1]octan-3-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=CC2=C1N=C(C=C2O[C@@H]3C[C@H]4C(=O)N[C@@]5(CC5/C=C\CCCCC[C@@H](C(=O)N4C3)NC(=O)OC6CCCC6)C(=O)O)C7=CSC(=N7)NC(=O)C(C)C)OC
182;366431770;2951;1592019;312351719;13091359;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[3-(4-fluorophenyl)sulfanylpropyl]-8-azabicyclo[3.2.1]octan-3-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC[C@@H](C(=O)O)NC1=C(C(=NC2=C1C=CN=C2)C3=CC=C(C=C3)C4=CC=CC(=C4F)C)C#N
183;366431771;29;1592019;312351719;13091359;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[3-(4-fluorophenyl)sulfanylpropyl]-8-azabicyclo[3.2.1]octan-3-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C=CC(=N1)C2=CC(=CC=C2)C3=CSC(=N3)NC(=O)[C@H](COC)NC(=O)C4=CN(C=C4)S(=O)(=O)C
184;366432048;2512;1592019;312351717;76518514;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[4-(4-fluorophenyl)butyl]-8-azabicyclo[3.2.1]octan-3-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C([C@H](NC(=O)N1C2=CC=CC(=C2)C(F)(F)F)C3=CN=C(C=C3)C#N)C(=O)C
185;366432049;27;1592019;312351717;76518514;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[4-(4-fluorophenyl)butyl]-8-azabicyclo[3.2.1]octan-3-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCNC(=O)C1=CC2=C(C=CN=C2N1C)N3CCOC[C@@H]3C
186;366432050;2239;1592019;440190959;155554079;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;1-(5-Chloropyridin-2-yl)-4-[3-(4-fluorophenyl)sulfanylpropyl]-1,4-diazepane;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(CC1)CCCNC(=O)C2=CC=C(C=C2)CNC(=O)C3=C(N(N=C3)C4=CC=CC=C4)N
187;366432051;22;1592019;440190959;155554079;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;1-(5-Chloropyridin-2-yl)-4-[3-(4-fluorophenyl)sulfanylpropyl]-1,4-diazepane;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC=C(C=C1)S(=O)(=O)NNC(=O)C2=C(C=CC(=C2)C3=CN=NC=C3)F
188;366432052;512;1592019;136932520;3069135;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;Piperazine, 1-(3-(4-fluorophenoxy)propyl)-4-phenyl-;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC[C@@]([C@@H](C1)NC2=CC=C(C=C2)F)(C(F)(F)F)O
189;366432053;8128;1592019;312351720;118709750;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[3-(3-fluorophenyl)sulfanylpropyl]-8-azabicyclo[3.2.1]octan-3-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC/C=C\C2C[C@]2(NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](CC1)NC(=O)OC4CCCC4)OC5=CC=NC=C5)C(=O)O
190;366432054;81;1592019;312351720;118709750;27346;307371350;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[3-(3-fluorophenyl)sulfanylpropyl]-8-azabicyclo[3.2.1]octan-3-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)[C@@H]1CCN(C1)C2=CC(=NC3=CC=NN32)C4=CC=CC=C4
191;366439138;100;1594276;440203843;155559223;27346;309043830;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;[2-Phenyl-5-[2-[4-(trifluoromethyl)phenyl]ethylamino]-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1[C@H]2C3(CCS(=O)(=O)CC3)C4=C(N2S(=O)(=O)C5=CC=C(C=C5)F)C=CC(=C4)C(=O)NCC6=C(C=C(C=N6)C(F)(F)F)Cl
192;366439139;12589;1594276;440191481;155554287;27346;309043830;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;[5-(Benzylamino)-2-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)C1=NC=NC(=C1Cl)C2=CC3=C(C=C2)N=C(N3)NC4=NC=CC(=C4)CN5CCN(CC5)C(=O)CC(F)(F)F
193;366439140;3162;1594276;440209565;155561471;27346;309043830;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;[5-[2-(1,3-Benzodioxol-5-yl)ethylamino]-2-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CN=C(C=C1N2C3=C(C=NC=C3)N(C2=O)CC(=O)N)C4=C(C=CC(=C4)Cl)F
194;366439141;100;1594276;440121446;146597626;27346;309043830;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;[2-(4-Fluorophenyl)-5-[(4-fluorophenyl)methylamino]-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=C(C2=C1C=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)C5CCNCC5)C(=O)O
195;366439142;100;1594276;440121446;146597626;27346;309043830;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;[2-(4-Fluorophenyl)-5-[(4-fluorophenyl)methylamino]-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)C1=C(C2=CC(=C(N=C2N(C1=O)C)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl)NS(=O)(=O)C
196;366439143;25119;1594276;440188048;146641795;27346;309043830;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;[5-[2-(4-Hydroxyphenyl)ethylamino]-1-propyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NOC(=N1)[C@H]2C[C@H](CN(C2)C(=O)N3CCS(=O)(=O)C3)C4=CC=C(C=C4)C(F)(F)F
197;366439144;100;1594276;440180841;155550094;27346;309043830;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;4-[5-(2-Phenylethylamino)-3-(piperidine-1-carbonyl)-4,5,6,7-tetrahydroindazol-2-yl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=CC(=N1)C)C[C@H]2CCCN(C2)CC3=CSC(=N3)NC(=O)C
198;366439145;1;1594276;440198087;146641558;27346;309043830;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;[5-[2-(4-Fluorophenyl)ethylamino]-1-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C1=NC(=NC=C1)CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)C4)S(=O)(=O)C
199;366439146;25119;1594276;440145184;146597630;27346;309043830;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;[2-(4-Fluorophenyl)-5-(2-pyridin-4-ylethylamino)-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](C1=CC=CC=N1)NC(=O)NC2=NC(=C3C=NNC3=C2)CO
200;366439221;100;1594276;440151802;146641788;27346;309043830;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;[5-[2-(3-Hydroxyphenyl)ethylamino]-1-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC2CCCCC2)NC(=O)C3=CC=C(C=C3)CNC(=O)C4=CN=C5N4C=CC=C5
201;366439222;100;1594276;440153424;146597677;27346;309043830;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;[1-Benzyl-5-(2-pyridin-4-ylethylamino)-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC2=C(C(=NC=C2C3=CC=CO3)N[C@@H]4CCN(C[C@H]4C(=O)NC5CCCCC5)C)NC1=O
202;366439223;50119;1594276;440225425;146641568;27346;309043830;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;[5-(Benzylamino)-1-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(CC1)C2=NC(=NC=C2)NCCC3=CC=CC=C3
203;366439224;100;1594276;440137804;146641556;27346;309043830;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;[1-Phenyl-5-[2-[4-(trifluoromethyl)phenyl]ethylamino]-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=CC=C1NC2=NC(=NC=C2OC)C3=NN(C4=CC=CC=C43)CC5=C(C=C(C=C5F)OCCCO)F
204;366439225;63096;1594276;440181218;146597639;27346;309043830;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;N,N-dimethyl-1-propyl-5-[2-[4-(trifluoromethyl)phenyl]ethylamino]-4,5,6,7-tetrahydroindazole-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1=CC2=CC(=CC=C2)OC3=NC=C(C=C3)C(F)(F)F)C(=O)NC4=NN=CC=C4
205;366439226;100;1594276;440129673;146597628;27346;309043830;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;5-[(4-fluorophenyl)methylsulfanyl]-N,N-dimethyl-1-propyl-4,5,6,7-tetrahydroindazole-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)C[C@@H](C(=O)N[C@@H](CCCNC(=NC)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)NNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)NC(=O)[C@@H](CC3=CC=NC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)O)N
206;366439227;100;1594276;440221974;146641564;27346;309043830;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;[5-[(4-Fluorophenyl)methylamino]-1-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=CC(=C1)CNC(=O)C2=NC3=C(C(=CS3)COCC4=CC=C(C=C4)C(=O)O)C(=O)N2
207;366439228;15849;1594276;440132889;155525645;27346;309043830;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;[5-[(4-Fluorophenyl)methylamino]-2-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC(=C(C=C1C#N)Cl)NC2=CC3=C(C=C2)NC(=O)N3
208;366439229;199526;1594276;440134995;45160790;27346;309043830;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;5-((4-Fluorobenzyl)amino)-N,N-dimethyl-1-propyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NC2=CC(=C(C=C2C(=N1)N[C@@H](C)C3=CC(=CS3)C4=CC=CC=C4CNC)OC)OC
209;366439230;100;1594276;440169877;146597666;27346;309043830;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;5-[(4-fluorobenzoyl)amino]-N,N-dimethyl-1-propyl-4,5,6,7-tetrahydroindazole-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC=C(C=C1)C2=C(C=C(C=C2)C(=O)NC3=NC=C(C=C3)N4C(=CC(=N4)C5=CN=CC=C5)C(F)(F)F)F
210;366439231;100;1594276;440151474;146641787;27346;309043830;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;[1-Benzyl-5-[(4-fluorophenyl)methylamino]-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN([C@@H](C2=C1N=CC=C2)C3=CC=C(C=C3)F)C(=O)NC4=CC=C(C=C4)OC5=CC=C(C=C5)F
211;366439232;31623;1594276;440187843;155552895;27346;309043830;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;[5-[2-(1,3-Benzodioxol-5-yl)ethylamino]-1-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC/C(=N\O)/C(=C/C1=CC(=C(C=C1)F)C)/C
212;366439233;25119;1594276;440192923;155554849;27346;309043830;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;[2-(4-Hydroxyphenyl)-5-(2-phenylethylamino)-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](C(F)(F)F)N(CC1=CC=C(C=C1)F)C(=O)CN2C(=O)[C@]3(CCC4=C3C=CC(=C4)NC(=O)NC)OC2=O
213;366439234;39811;1594276;440203452;146597651;27346;309043830;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;5-[2-(1,3-benzodioxol-5-yl)ethylamino]-N,N-dimethyl-1-propyl-4,5,6,7-tetrahydroindazole-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NC2=C(C(=N1)C3CCN(CC3)C(=O)C4=C(C=C(C=C4)OC(F)(F)F)N)N=CC(=C2)N5CCN(CC5)C
214;366439235;100;1594276;440147746;146597638;27346;309043830;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;5-[(4-fluorophenyl)sulfonylamino]-N,N-dimethyl-1-propyl-4,5,6,7-tetrahydroindazole-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)([C@@H](CN1CC2=CC(=C(C=C2C1=O)N3CCOCC3)NC(=O)C4=C5N=CC=CN5N=C4)F)O
215;366439308;100;1594276;440112262;146597678;27346;309043830;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) after 120 mins in presence of sigma1 antagonist (+)-SKF10047 by microbeta scintillation counting method;5-[(4-fluorophenyl)methoxy]-N,N-dimethyl-1-propyl-4,5,6,7-tetrahydroindazole-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C([C@@H](NC(=O)N1C2=CC=CC(=C2)C(F)(F)F)C3=CN=C(C=C3)C#N)C(=O)C
216;366442078;761;1596349;440116746;155515129;27346;310426180;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) incubated for 120 mins by scintillation counting method;3-[4-(Azepan-1-yl)butyl]-5-chloro-1,3-benzothiazol-2-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CNC(=O)C1=CC(=CC2=C1O[C@H]([C@@H]2C3=CC=CC=C3)CF)C(=O)NC4[C@H]5[C@@H]4COC5
217;366442079;11;1596349;440131518;155524744;27346;310426180;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) incubated for 120 mins by scintillation counting method;2-[4-(Azepan-1-yl)butylsulfanyl]-5-chloro-1,3-benzoxazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1(CN2C(=C(C(=N2)C3=NC=C(C=C3)F)C4=CC=NC5=NN(C=C45)C)CO1)C
218;366442080;79;1596349;440203830;155559218;27346;310426180;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) incubated for 120 mins by scintillation counting method;2-[3-(Azepan-1-yl)propylsulfanyl]-5-chloro-1,3-benzothiazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)N1CCC(CC1)C2=C(C=C(C=C2)C(=O)N=C(N)N)C(F)(F)F
219;366442081;6516;1596349;440195228;155555743;27346;310426180;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) incubated for 120 mins by scintillation counting method;3-[2-(Azepan-1-yl)ethyl]-5-chloro-1,3-benzoxazol-2-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CN(C=N1)C2=C(C=C(C=C2)C3=CN(N=N3)C4CCC5=C(C=CC=C5F)N(C4=O)CC(F)(F)F)OC
220;366442082;176;1596349;103167216;3559;27346;310426180;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) incubated for 120 mins by scintillation counting method;Haloperidol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=CC(=C1)N2C(=NC(=N2)CC3=CC(=CC(=C3)F)C(F)(F)F)C)C(=O)N
221;366442083;1673;1596349;440136740;155528147;27346;310426180;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) incubated for 120 mins by scintillation counting method;3-[2-(Azepan-1-yl)ethyl]-5-chloro-1,3-benzothiazol-2-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC=C2C(=C1)C(=O)N=C(S2)C3=CC=CC=N3
222;366442084;688;1596349;440219961;155565622;27346;310426180;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) incubated for 120 mins by scintillation counting method;3-[3-(Azepan-1-yl)propyl]-5-chloro-1,3-benzothiazol-2-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1C[C@H]([C@@H]([C@H]1CN2C(=O)C3=CC=CC=C3N=N2)C(=O)O)C(=O)C4=CC=C(C=C4)OCCC5CCOCC5
223;366442085;10;1596349;440227018;155568367;27346;310426180;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) incubated for 120 mins by scintillation counting method;2-[2-(Azepan-1-yl)ethylsulfanyl]-5-chloro-1,3-benzothiazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CS(=O)(=O)C1=NC=CC(=C1)[C@H](CCNS(=O)(=O)C)NC(=O)C2=CN=CC3=C2C=NN3C4=CC=C(C=C4)F
224;366442086;218;1596349;440130311;155523942;27346;310426180;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) incubated for 120 mins by scintillation counting method;2-[4-(Azepan-1-yl)butylsulfanyl]-5-chloro-1,3-benzothiazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1C[C@@H]([C@H]([C@@H]1CN2C(=O)C3=CC=CC=C3N=N2)C(=O)O)C(=O)C4=CC=C(C=C4)OCCC5CCOCC5
225;366442087;87;1596349;440162521;155542765;27346;310426180;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) incubated for 120 mins by scintillation counting method;2-[2-(Azepan-1-yl)ethylsulfanyl]-5-chloro-1,3-benzoxazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC=CC=C1C(=O)NC2=NN(C3=C2C=C(C=C3)C4C(=C(NC(=C4C#N)C)C)C#N)C
226;366442088;16;1596349;440123949;155519913;27346;310426180;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) incubated for 120 mins by scintillation counting method;2-[3-(Azepan-1-yl)propylsulfanyl]-5-chloro-1,3-benzoxazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1CCN(CC1)C2=NC(=NC=C2)NCC3=CN(C=N3)C
227;366442261;641;1596349;440147793;155535411;27346;310426180;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) incubated for 120 mins by scintillation counting method;3-[3-(Azepan-1-yl)propyl]-5-chloro-1,3-benzoxazol-2-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCOC1=C2C=CC=NC2=C(C=C1)S(=O)(=O)NC3=C(C=C(C=C3)Cl)C#CC4=CN=C(C=C4OC)C(=O)O
228;366442262;38;1596349;440226445;155568142;27346;310426180;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma2 receptor (unknown origin) incubated for 120 mins by scintillation counting method;3-[4-(Azepan-1-yl)butyl]-5-chloro-1,3-benzoxazol-2-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)NC1=CC=C(C=C1)C2=CC(=NC3=CC(=NN23)C(=O)NCCCN4C=CN=C4)C5=CC=CC=C5
229;366461782;198;1606850;440212108;155562467;27346;322715690;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma 2 receptor (unknown origin) measured after 90 mins by microbeta counting analysis;(1R,2R,3S,4R,5S)-4-[6-[2-(4-hydroxy-3-methoxyphenyl)ethylamino]-2-(2-phenylethynyl)purin-9-yl]bicyclo[3.1.0]hexane-2,3-diol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCS(=O)(=O)C1=NC=C2C(=C1)C=C(N2)C[C@](CC(C)(C)C3=C(C=C(C=C3)F)C(=O)N)(C(F)(F)F)O
230;366462847;;1607455;103245538;119570;27346;323426850;Confirmatory;20220830;0;0;Inactive;Q5BJF2;Ki;;ChEMBL;Displacement of [3H]-DTG from sigma 2 receptor (unknown origin) measured after 90 mins by microbeta counting analysis;Pramipexole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NN(C=C1)C2=C(C=C(C=C2)C3=CN(N=N3)C4CCC5=CC=CC=C5N(C4=O)CC(F)(F)F)OC
231;366462848;275;1607455;440152736;27842480;27346;323426850;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma 2 receptor (unknown origin) measured after 90 mins by microbeta counting analysis;(1H-Indol-2-yl)(4-(2-(4-methoxyphenoxy)ethyl)piperazin-1-yl)methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1CNC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=C(C=C(C=C3)N4CCN(CC4)CC5=C(C=C(C=C5)C(F)(F)F)C6=CC=C(C=C6)Cl)OC7=CN=C8C(=C7)C=CN8)[N+](=O)[O-]
232;366463200;;1607455;163332281;53475319;27346;323426850;Confirmatory;20220830;0;0;Inactive;Q5BJF2;Ki;;ChEMBL;Displacement of [3H]-DTG from sigma 2 receptor (unknown origin) measured after 90 mins by microbeta counting analysis;N-((1R,3R)-3-(2-(((S)-2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)(propyl)amino)ethyl)-3-hydroxycyclobutyl)-2-naphthamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C(=NN1CC2=CC=C(C=C2)C(C)(C)C)C(F)(F)F)NC(=O)C3=CC(=NC4=C3C=CC(=C4)F)C(=O)N
233;366515340;284;1626254;103186197;7333;27346;273093760;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);1,3-Di-o-tolylguanidine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=CC(=C(C=C3)C(=O)O)F)C)OC4CCS(=O)(=O)CC4
234;367407736;100;1651998;442056651;25235287;27346;322278830;Confirmatory;20210802;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Binding affinity to sigma2 receptor (unknown origin);8-bromo-4,5,5-trimethyl-6H-benzo[c][2,7]naphthyridine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC2=C(C=C1)C=C(C=C2)OCC3(CN(C3)C(=O)C4=CC=C(C=C4)F)C(=O)O
235;367415238;;1655667;103187512;7470;27346;324354010;Literature-derived;20210802;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) at 10 uM incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method relative to control;4-Methylbenzoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C1=CN=CC(=C1)C2=NC3=C(N2C4CC4)C=C(C=C3)F)O
236;367415239;;1655667;442051161;9855737;27346;324354010;Literature-derived;20210802;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) at 10 uM incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method relative to control;4-[(nitrooxy)methyl]Benzoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC=C(C=C1)CNC2=NC(=NC(=N2)N)C3=CC=CC(=C3)CO
237;367415240;;1655667;442050748;76360;27346;324354010;Literature-derived;20210802;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) at 10 uM incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method relative to control;4-(Hydroxymethyl)benzoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCS(=O)(=O)C1=NC=C2C(=C1)C=C(N2)C[C@@](CC(C)(C)C3=C(C=C(C=C3)F)C(=O)N)(C(F)(F)F)O
238;367478488;16;1655661;103167216;3559;27346;324354010;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;Haloperidol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](C1=CC(=NC=C1)NC2=NC3=C(N2)C=C(C=C3)C4=CC(=NC=N4)N(C)C)N5CCN(CC5)C(=O)CC(F)(F)F
239;367478489;2673;1655661;442058659;156018155;27346;324354010;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;[4-[2-(4-Benzylpiperidin-1-yl)ethylcarbamoyl]phenyl]methyl nitrate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](C1=C(C=NC2=CC(=NN21)Cl)NC3=CC=C(C=C3)[C@H](C(F)(F)F)N(C)C(=O)C4CCS(=O)(=O)CC4)OC
240;367478490;7;1655661;442047708;156010417;27346;324354010;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;[4-[5-(4-Benzylpiperidin-1-yl)pentylcarbamoyl]phenyl]methyl nitrate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)N=CC4=C3N(C(=N4)COC)[C@H](C)C5=CC=CC=C5)OC[C@H]6CCNC6
241;367478491;1465;1655661;103178693;441278;27346;324354010;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;Pentazocine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(C[C@H]1C(=O)NC2=NC3=C(S2)CN(CC3)C(=O)CN=[N+]=[N-])C#N
242;367478492;32;1655661;442047169;156010039;27346;324354010;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;[3-[2-[(1-Benzylpiperidin-4-yl)amino]-2-oxoethyl]phenyl]methyl nitrate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC=C(C=C1)C2=CC(=NC3=CC(=NN23)C(=O)NCCCN4C=CN=C4)C5=CC=CC=C5
243;367478493;89;1655661;442050412;156012425;27346;324354010;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;[4-[4-(4-Benzylpiperidin-1-yl)butylcarbamoyl]phenyl]methyl nitrate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CNCCC1C2=CC=C(C=C2)C3=C4C=CC(=CC4=CC(=C3)C(=O)O)C5=CC=C(C=C5)C(F)(F)F
244;367478494;27;1655661;442062061;156020556;27346;324354010;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;[4-[(1-Benzylpiperidin-4-yl)carbamoyl]phenyl]methyl nitrate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CNC2=NC=CC(=C12)OC3=C(C=C(C=C3F)NC4=CC(=NC(=N4)N)Cl)F
245;367478495;75;1655661;442062263;156020695;27346;324354010;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;[3-[4-(4-Benzylpiperidin-1-yl)butylcarbamoyl]phenyl]methyl nitrate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1OC2=C(C=C(C(=C2)NC3=CC4=C(C=C3)NC(=O)CC4)Cl)[N+](=O)[O-]
246;367478496;100;1655661;442050748;76360;27346;324354010;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;4-(Hydroxymethyl)benzoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C2C=C(C=CC2=NN1)[C@@H]3C(=C(NC(=C3C#N)C4=CC=C(C=C4)Cl)C)C#N
247;367478497;33;1655661;442062611;156020944;27346;324354010;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;[3-[2-(4-Benzylpiperidin-1-yl)ethylcarbamoyl]phenyl]methyl nitrate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](C1=C(C=NC2=CC(=NN21)Cl)NC3=CC=C(C=C3)[C@@H](C(F)(F)F)N(C)C(=O)C4CCS(=O)(=O)CC4)OC
248;367478818;93;1655661;442064033;156021903;27346;324354010;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;[3-[3-(4-Benzylpiperidin-1-yl)propylcarbamoyl]phenyl]methyl nitrate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)N1CCC(CC1)[C@](C2=CC=CC=C2)(C3=CC4=C(C=C3)N=C(C(=C4Cl)CC5=CC=C(C=C5)N6C=CC=N6)OC)O
249;367478819;23;1655661;442059958;156019080;27346;324354010;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;[4-[3-(4-Benzylpiperidin-1-yl)propylcarbamoyl]phenyl]methyl nitrate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN([C@@H]1CCC2=C(C3=C(N2C1)C=CC(=C3)S(=O)(=O)C)CC(=O)O)S(=O)(=O)C4=CC=C(C=C4)F
250;367478820;18;1655661;160693271;54726191;27346;324354010;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;Dolutegravir;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1(C#N)C2=CC=CC=N2)CC3=C4C=CC=CN4C(=O)C(=C3)C(=O)O
251;367478821;127;1655661;442054786;156015448;27346;324354010;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;N-[4-(4-benzylpiperidin-1-yl)butyl]-4-methylbenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](C1=CC=C(C=C1)F)N(CC2=CC(=CC=C2)C(=O)O)C(=O)C3=CC4=CC=CC=C4N=C3
252;367478822;100;1655661;103187512;7470;27346;324354010;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;4-Methylbenzoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(CC1)C2=CC3=C(C(=NC=N3)C4CCN(CC4)C(=O)C5=C(C=C(C=C5)OC(F)(F)F)N)N=C2
253;367478823;100;1655661;442051161;9855737;27346;324354010;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;4-[(nitrooxy)methyl]Benzoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=C(C=C1)C2=CN=C(S2)[C@]3(CC[C@@H](C(C3)(C)C)C(=O)O)O)NC4=CC=CC(=N4)C(F)(F)F
254;367478824;26;1655661;442048230;156010802;27346;324354010;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;N-[4-(4-benzylpiperidin-1-yl)butyl]-4-(hydroxymethyl)benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NC2=CC(=C(C=C2C(=N1)N[C@H](C)C3=CC(=CS3)C4=CC=CC=C4CNC)OC)OC
255;367478825;142;1655661;442048600;156011077;27346;324354010;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;[3-[5-(4-Benzylpiperidin-1-yl)pentylcarbamoyl]phenyl]methyl nitrate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C2=CC=CC=C2N=C1C3=CSC(=N3)C4CCN(CC4)CC5=NC6C(N5)C=CC=N6
256;367478826;2514;1655661;442062571;156020917;27346;324354010;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;[4-[2-[(1-Benzylpiperidin-4-yl)amino]-2-oxoethyl]phenyl] nitrate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NC=CC(=N1)COC(=O)N2C[C@@H]3[C@H](C2)C3CNC(=O)C4=CC5=NNN=C5C=C4
257;367478827;19;1655661;442061448;156020125;27346;324354010;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor (unknown origin) incubated for 1 hr in presence of (+)SKF10047 by liquid scintillation counting method;[3-[(1-Benzylpiperidin-4-yl)carbamoyl]phenyl]methyl nitrate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=CC(=C1)N[C@@H]2CCCC[C@@]2(C(F)(F)F)O)F
258;367478929;62;1655950;442061455;156020131;27346;324354210;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-ditolylguanidine from human Sigma 2 receptor by radioligand displacement assay;"4-Benzyl-1-[(2,2-dimethyl-1,3-dioxolan-4-yl)methyl]piperidine;oxalic acid";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC1=CC=CC=C1C(=O)NC2=NNC3=C(C(=C(C=C32)C4C(=C(N(C(=C4C#N)C)C)C)C#N)F)C
259;367478930;12;1655950;442059881;156019016;27346;324354210;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-ditolylguanidine from human Sigma 2 receptor by radioligand displacement assay;"4-Benzyl-1-(1,3-dithiolan-4-ylmethyl)piperidine;oxalic acid";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)C[C@@H](C(=O)N[C@@H](CCCNC(=NC)N)C(=O)NCC(=O)N)NC(=O)NNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)NC(=O)[C@@H](CC2=CN=CC=C2)NC(=O)[C@@H](CC3=CC=C(C=C3)O)N
260;367478931;81;1655950;442052548;156013934;27346;324354210;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-ditolylguanidine from human Sigma 2 receptor by radioligand displacement assay;"4-Benzyl-1-(1,4-dithiaspiro[4.6]undecan-3-ylmethyl)piperidine;oxalic acid";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C(C=C1)CC[C@H](C2=CC(=CC=C2)OCCN3CCOCC3)OC(=O)[C@H]4CCCCN4C(=O)[C@H](C5CCCCC5)C6=CC(=C(C(=C6)OC)OC)OC)OC
261;367478932;65;1655950;442055022;156015602;27346;324354210;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-ditolylguanidine from human Sigma 2 receptor by radioligand displacement assay;"4-benzyl-1-[[(3R,4'S)-spiro[1,2-dihydroindene-3,2'-1,3-dithiolane]-4'-yl]methyl]piperidine;oxalic acid";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CN=C(N=C1NC2=C(C=NC=C2)OC)C3=NN(C4=CC=CC=C43)CC5=C(C=C(C=C5F)OCCO)F
262;367478933;85;1655950;442058955;156018373;27346;324354210;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-ditolylguanidine from human Sigma 2 receptor by radioligand displacement assay;"4-benzyl-1-[[(2S,4R)-2-methyl-2-phenyl-1,3-dithiolan-4-yl]methyl]piperidine;oxalic acid";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCOC(=O)C1=CC2=C(N1)C=CC(=C2)C3=CC(=NN3C)C(=O)NCC4=CC=C(C=C4)C(=O)O
263;367478934;93;1655950;442062690;156020999;27346;324354210;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-ditolylguanidine from human Sigma 2 receptor by radioligand displacement assay;"4-benzyl-1-[[(2R,4R)-spiro[1,3-dithiolane-2,4'-2,3-dihydro-1H-naphthalene]-4-yl]methyl]piperidine;oxalic acid";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1CN(C[C@@H](C1(F)F)C)C2=NC=C(C(=N2)NC3=CC4=C(C=C3)N(C(=O)N4CCC(C)(C)O)C)Cl
264;367478935;158;1655950;442051444;156013137;27346;324354210;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-ditolylguanidine from human Sigma 2 receptor by radioligand displacement assay;"4-benzyl-1-[[(2S,4S)-spiro[1,3-dithiolane-2,5'-6,7,8,9-tetrahydrobenzo[7]annulene]-4-yl]methyl]piperidine;oxalic acid";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C2=CC=CC=C2OC[C@@H](C1=O)N3CCC4=C(N(N=C4C3=O)CC5=CC=CC=C5)Br
265;367478936;71;1655950;442053121;156014333;27346;324354210;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-ditolylguanidine from human Sigma 2 receptor by radioligand displacement assay;"4-Benzyl-1-(spiro[1,3-dithiolane-2,9'-fluorene]-4-ylmethyl)piperidine;oxalic acid";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](C1=CC=C(C=C1)F)N(CC2=CC(=C(C=C2)Cl)C(=O)O)C(=O)C3=CC4=CC=CC=C4N=C3
266;367478937;182;1655950;442054092;156014992;27346;324354210;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-ditolylguanidine from human Sigma 2 receptor by radioligand displacement assay;"1-Benzyl-4-[(2,2-dimethyl-1,3-dioxolan-4-yl)methyl]piperazine;oxalic acid";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1C(CN1C(=O)NC2=NN=CC=C2)C/C=C/C3=CN=CC(=N3)OC4=NC=C(C=C4)C(F)(F)F
267;367479343;59;1655950;442061282;156020008;27346;324354210;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-ditolylguanidine from human Sigma 2 receptor by radioligand displacement assay;"4-Benzyl-1-[(2,2-dimethyl-1,3-dithiolan-4-yl)methyl]piperidine;oxalic acid";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@](C1CC1)(C2=CC=C(C=C2)C3=CN=C(N=C3)N)C4=NOC(=N4)C5=CN(N=C5)CC(=O)N(C)C
268;367479344;107;1655950;442055165;156015695;27346;324354210;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-ditolylguanidine from human Sigma 2 receptor by radioligand displacement assay;"4-benzyl-1-[[(2S,4R)-spiro[1,3-dithiolane-2,5'-6,7,8,9-tetrahydrobenzo[7]annulene]-4-yl]methyl]piperidine;oxalic acid";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC[C@H](CC(=O)O)N1C(=O)C2=C(C=CC=N2)N(C1=O)CC3=CN(C4=CC(=CC(=C43)C)C)C
269;367479345;3;1655950;442056085;156016311;27346;324354210;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-ditolylguanidine from human Sigma 2 receptor by radioligand displacement assay;"4-Benzyl-1-(1,4-dithiaspiro[4.4]nonan-3-ylmethyl)piperidine;oxalic acid";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](C1=CC=CC(=C1)C#N)N2C=C(C=C(C2=N)C(=O)N)Cl
270;367479346;9;1655950;442050493;156012478;27346;324354210;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-ditolylguanidine from human Sigma 2 receptor by radioligand displacement assay;"1-Benzyl-4-(1,3-dithiolan-4-ylmethyl)piperazine;oxalic acid";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1C2=NOC(=N2)[C@H]3C[C@H](CN(C3)C(=O)N4CCS(=O)(=O)CC4)C5=CC=C(C=C5)OC(F)(F)F
271;367479347;33;1655950;442046446;156009509;27346;324354210;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-ditolylguanidine from human Sigma 2 receptor by radioligand displacement assay;"1-Benzyl-4-[(2,2-dimethyl-1,3-dithiolan-4-yl)methyl]piperazine;oxalic acid";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CNC(=O)C1=CC(=CN(C1=O)CC2=CC=CC=C2)C(=O)NC3CC3
272;367479348;63;1655950;442052131;156013628;27346;324354210;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-ditolylguanidine from human Sigma 2 receptor by radioligand displacement assay;"4-benzyl-1-[[(2S,4S)-2-methyl-2-phenyl-1,3-dithiolan-4-yl]methyl]piperidine;oxalic acid";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC2=C(C(=NC=C2C3=CC=CO3)N[C@H]4CCN(C[C@@H]4C(=O)NC5CCCCC5)C)NC1=O
273;367479349;3;1655950;442048237;156010809;27346;324354210;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-ditolylguanidine from human Sigma 2 receptor by radioligand displacement assay;"4-benzyl-1-[[(3R,4'R)-spiro[1,2-dihydroindene-3,2'-1,3-dithiolane]-4'-yl]methyl]piperidine;oxalic acid";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1CC(C)(C)CCC)C(=O)O)C2=CC3=C(C(=C2)OC)OCO3
274;367479350;87;1655950;442058583;156018103;27346;324354210;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-ditolylguanidine from human Sigma 2 receptor by radioligand displacement assay;"4-benzyl-1-[[(2S,4R)-spiro[1,3-dithiolane-2,4'-2,3-dihydro-1H-naphthalene]-4-yl]methyl]piperidine;oxalic acid";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(N2C(=N1)C(=CC=N2)N3CCOCC3)C4=CN=C(C=C4)CCOC
275;367490243;2952;1661756;442062794;1178663;27346;328320230;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-DTG from recombinant sigma 2 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;3-[[benzyl(methyl)amino]methyl]-2-methyl-7-(trifluoromethyl)-1H-quinolin-4-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;521.0;;;;CC/C(=N\O)/C(=C/C1=CC=C(C=C1)F)/C
276;367490244;10;1661756;442050343;156012377;27346;328320230;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Kd;>;ChEMBL;Displacement of [3H](+)-DTG from recombinant sigma 2 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;(E)-1-(4-bromophenyl)-N-[1-[3-(trifluoromethyl)phenyl]pyrazolidin-3-yl]methanimine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;521.0;;;;CC1=CC(=C(C=C1NC(=O)C2=CC(=CC(=C2)C#N)S(F)(F)(F)(F)F)N3C=CN4C3=CC(=N4)C5=CN=CC=C5)C
277;367490245;2373;1661756;442054780;56918678;27346;328320230;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-DTG from recombinant sigma 2 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;2-[3-Methyl-4-[[methyl-[(2-phenyl-1,3-thiazol-4-yl)methyl]amino]methyl]pyrazol-1-yl]ethanol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;521.0;;;;CCNC(=O)C1=CC2=C(C=CN=C2N1)N3CCOC[C@@H]3C
278;367490246;;1661756;442059284;562719;27346;328320230;Confirmatory;20220830;0;0;Inconclusive;Q5BJF2;Ki;;ChEMBL;Displacement of [3H](+)-DTG from recombinant sigma 2 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;(4-Benzyl-piperazin-1-yl)-(4-trifluoromethyl-phenyl)-methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;521.0;;;;C[C@@H](C(=O)NC1(CC1)C2=CC=CC=N2)NC(=O)C3=CN=C4N3[C@](C(=O)N4C5=CC(=C(C(=C5)Cl)F)Cl)(C)CC6=CC=C(C=C6)C#N
279;367490247;10;1661756;442051758;91814689;27346;328320230;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Kd;>;ChEMBL;Displacement of [3H](+)-DTG from recombinant sigma 2 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;(3-(3,4-dihydroisoquinolin-2(1H)-yl)pyrrolidin-1-yl)(1H-indol-3-yl)methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;521.0;;;;C1CCC(CC1)CCCNC(=O)C2=CC=C(C=C2)CNC(=O)C3=C(N(N=C3)C4=CC=CC=C4)C(F)(F)F
280;367490248;10;1661756;442057734;42953357;27346;328320230;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Kd;>;ChEMBL;Displacement of [3H](+)-DTG from recombinant sigma 2 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;N-[2-(dimethylamino)-1-phenylethyl]-1-(4-fluorophenyl)-5-methylpyrazole-4-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;521.0;;;;C[C@H](C1=CC=CC=C1)NC(=O)NC2=NC(=C3C=NNC3=C2)CO
281;367490249;985;1661756;442061510;45881521;27346;328320230;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-DTG from recombinant sigma 2 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;N-[[5-chloro-1-(2-chlorophenyl)-3-methylpyrazol-4-yl]methyl]-1-(3,5-difluorophenyl)methanamine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;521.0;;;;C1=CC=C(C=C1)CNC2=NC(=NC(=N2)N)C3=CC=CC=C3CO
282;367490250;10;1661756;442054140;156015029;27346;328320230;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Kd;>;ChEMBL;Displacement of [3H](+)-DTG from recombinant sigma 2 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;2-Amino-1-(4-imidazo[1,2-b]pyridazin-6-ylpiperazin-1-yl)-3-phenylpropan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;521.0;;;;CC(C)(C)C1=CC(=CC(=C1)C2=CN3C=C(N=C3C=C2)NC(=O)C4=CC=C(C=C4)C(C)(C)C(=O)N5CCN(CC5)C)C(C)(C)C
283;367490545;25;1661756;442055669;75448340;27346;328320230;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-DTG from recombinant sigma 2 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;3-[[[1-(3-Chloro-4-fluorophenyl)pyrrolidin-3-yl]amino]methyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;521.0;;;;C1CC(C1)(C2=CC=C(C=C2)C3=C(N4C(=N3)C=CC(=N4)C(=O)N)C5=CC=CC=C5)N
284;367490546;949;1661756;442057743;4095865;27346;328320230;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-DTG from recombinant sigma 2 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;N-(3,5-difluorophenyl)-3-[(4-fluorophenyl)methyl]-1,3-diazinane-1-carbothioamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;521.0;;;;C1CN(C[C@@H]1C(=O)NC2=NC3=C(S2)CN(CC3)C(=O)CN=[N+]=[N-])C#N
285;367490547;;1661756;442053890;16044337;27346;328320230;Confirmatory;20220830;0;0;Inconclusive;Q5BJF2;Ki;;ChEMBL;Displacement of [3H](+)-DTG from recombinant sigma 2 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;N-(3-pyridylmethyl){5-[3-(trifluoromethyl)phenyl]-2-furyl}methanamine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;521.0;;;;CC1=CN(C(=O)C2=CC(=NN12)CN3C(=CC(=N3)C(F)F)Cl)[C@@H](C)CC#N
286;367490548;10;1661756;442055929;56705499;27346;328320230;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Kd;>;ChEMBL;Displacement of [3H](+)-DTG from recombinant sigma 2 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;N-[3-(1H-indol-3-yl)-1-methylpropyl]-1-isobutyrylpiperidin-4-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;521.0;;;;[2H]C([2H])([2H])C1(CN2C(=C(C(=N2)C3=NC=C(C=C3)F)C4=C5C=NNC5=NC=C4)CO1)C([2H])([2H])[2H]
287;367490549;15;1661756;442063392;156021463;27346;328320230;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-DTG from recombinant sigma 2 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;4-[[1-[5-(Trifluoromethyl)pyridin-2-yl]piperidin-4-yl]amino]oxan-3-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;521.0;;;;CC1=CC2=C(C=C1)NC(=CC2=O)CNCCCOC3=CC=CC=C3
288;371811282;;1682275;103707730;854019;27346;331200800;Literature-derived;20220318;0;0;Unspecified;Q5BJF2;;;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) at 10 uM relative to control;Cotinine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CS(=O)(=O)C1=NC=CC(=C1)C2(CC2)NC(=O)C3=CN=CC4=C3C=NN4C5=CC=C(C=C5)F
289;371834551;1;1690207;123099027;49832807;27346;320709170;Confirmatory;20220318;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Binding affinity to Sigma 2 receptor (unknown origin);(+/-)-3-(4-Phenylbutyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-1,7-diol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCOCCN1C=C(C=CC1=O)C(=O)NC2=NC=C(C=C2)N3C(=CC(=N3)C4=CN=CC=C4)C(F)(F)F
290;371841051;;1692678;103460177;644019;27346;328045020;Literature-derived;20220318;0;0;Unspecified;Q5BJF2;;;ChEMBL;Inhibition of sigma2 receptor (unknown origin) at 10 uM relative to control;Cannabidiol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](C(F)(F)F)N(CC1=CC=C(C=C1)F)C(=O)CN2C(=O)[C@]3(CCC4=C3C=C(C=C4)NC(=O)NC)OC2=O
291;371959291;;1703698;103348150;9815616;27346;326981100;Literature-derived;20220318;0;0;Inactive;Q5BJF2;;;ChEMBL;Binding affinity to sigma2 receptor (unknown origin) 10 umol/L by radioligand binding assay;(1s,2s,3s,5r,6s)-2-Amino-3-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1C2=CC=CC=C2)C3=CN=C4N3C=CN=C4N5CCOCC5
292;371959292;;1703698;461556274;72550767;27346;326981100;Literature-derived;20220318;0;0;Inactive;Q5BJF2;;;ChEMBL;Binding affinity to sigma2 receptor (unknown origin) 10 umol/L by radioligand binding assay;(1S,2S,3S,5R,6S)-2-amino-3-fluoro-6-[(1S)-1-[(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexyl]oxycarbonyloxyethoxy]carbonylbicyclo[3.1.0]hexane-2-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CN(C(=O)C2=CC(=NN12)CN3C(=CC(=N3)C(F)F)Cl)[C@H](C)CC#N
293;371962352;10;1704795;461540998;135339817;27346;328778050;Confirmatory;20220318;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);7-[3-[4-(6-Fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propoxy]-2-methyl-3,4-dihydroisoquinolin-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC12C3=CC=CC=C3CO2)CCCCC4=CN(C5=CC=CC=C54)C6=CC=C(C=C6)F
294;372015144;;1725046;461547259;162665987;27346;330621630;Literature-derived;20220318;0;0;Unspecified;Q5BJF2;;;ChEMBL;Inhibition of sigma2 receptor (unknown origin) relative to control;[3-(3,4-Dichlorophenyl)imidazo[4,5-b]pyridin-2-yl]-(3,3-difluoroazetidin-1-yl)methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC(=CC(=C1OCC[18F])C(=O)NCCCCN2CCC3=CC(=C(C=C3C2)OC)OC)I
295;372020861;;1727497;461523312;162649201;27346;330496070;Literature-derived;20220318;0;0;Active;Q5BJF2;;;ChEMBL;Antagonist activity at sigma 2 receptor in human MCF7 cells assessed as reduction in intracellular calcium release at 30 uM incubated for 3 hrs by Fluo-3 AM dye based confocal laser scanning microscopy;7-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-1-(2,3,4,5-tetramethoxy-6-methylphenyl)heptan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4CCCCC4
296;372020862;;1727497;461517295;162644944;27346;330496070;Literature-derived;20220318;0;0;Active;Q5BJF2;;;ChEMBL;Antagonist activity at sigma 2 receptor in human MCF7 cells assessed as reduction in intracellular calcium release at 30 uM incubated for 3 hrs by Fluo-3 AM dye based confocal laser scanning microscopy;5-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-1-(2,3,4,5-tetramethoxy-6-methylphenyl)pentan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)OC)OC
297;372021048;;1727496;103252427;9829526;27346;330496070;Literature-derived;20220318;0;0;Active;Q5BJF2;;;ChEMBL;Agonist activity at sigma 2 receptor in human MCF7 cells assessed as stimulation of intracellular calcium release at 10 uM incubated for 3 hrs by Fluo-3 AM dye based confocal laser scanning microscopy;Siramesine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)OC)OC
298;372021258;;1727497;461521791;162648136;27346;330496070;Literature-derived;20220318;0;0;Active;Q5BJF2;;;ChEMBL;Antagonist activity at sigma 2 receptor in human MCF7 cells assessed as reduction in intracellular calcium release at 30 uM incubated for 3 hrs by Fluo-3 AM dye based confocal laser scanning microscopy;6-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-1-(2,3,4,5-tetramethoxy-6-methylphenyl)hexan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)OC)OC
299;372021259;;1727497;103252283;11165837;27346;330496070;Literature-derived;20220318;0;0;Active;Q5BJF2;;;ChEMBL;Antagonist activity at sigma 2 receptor in human MCF7 cells assessed as reduction in intracellular calcium release at 30 uM incubated for 3 hrs by Fluo-3 AM dye based confocal laser scanning microscopy;N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-methoxy-5-methylbenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)OC)OC
300;372021260;;1727497;461516649;162644480;27346;330496070;Literature-derived;20220318;0;0;Active;Q5BJF2;;;ChEMBL;Antagonist activity at sigma 2 receptor in human MCF7 cells assessed as reduction in intracellular calcium release at 30 uM incubated for 3 hrs by Fluo-3 AM dye based confocal laser scanning microscopy;4-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-1-(2,3,4,5-tetramethoxy-6-methylphenyl)butan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=CC(=C(C=C3C2)OC)OC
301;372075071;;1744237;461516368;162644304;27346;333727820;Literature-derived;20220318;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane at 1000 nM incubated for 1 hr by liquid scintillation counting method relative to control;1-Methyl-5-(4-phenylphenyl)-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=CC(=C(C=C3C2)OC)OC
302;372075072;;1744237;461562037;154929720;27346;333727820;Literature-derived;20220318;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane at 1000 nM incubated for 1 hr by liquid scintillation counting method relative to control;5-(4-Cyclohexylphenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=CC(=C(C=C3C2)OC)OC
303;372075073;;1744237;461557885;154929649;27346;333727820;Literature-derived;20220318;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane at 1000 nM incubated for 1 hr by liquid scintillation counting method relative to control;5-[3-Chloro-4-(3,4-dichlorophenyl)phenyl]-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1(C2=CC=CC=C2[N+](=C1/C=C/C=C/C=C/3\C(C4=CC=CC=C4N3CCCCCC(=O)NC5=CC6=C(C=C5)C=CN6CCCCN7CCC8(CC7)C9=CC=CC=C9CO8)(C)C)C)C.[I-]
304;372075570;;1744237;461548331;154929623;27346;333727820;Literature-derived;20220318;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane at 1000 nM incubated for 1 hr by liquid scintillation counting method relative to control;1-Methyl-5-(4-phenoxyphenyl)-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1(SCC(S1)CN2CCC(CC2)CC3=CC=CC=C3)C.C(=O)(C(=O)O)O
305;372129010;10;1685178;461519667;146641305;27346;336039610;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;<;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);4-[2-[(1-Oxo-2,3,4,5,8,9,10,11-octahydro-[1,4]diazepino[1,2-b]indazol-10-yl)amino]ethyl]benzonitrile;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)OC)OC
306;372129011;10;1685178;461528964;146641578;27346;336039610;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;<;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);N-(3-methoxyphenyl)-1-propyl-5-(2-pyridin-4-ylethylamino)-4,5,6,7-tetrahydroindazole-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)OC)OC
307;372129012;10;1685178;461557110;146641758;27346;336039610;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);[5-[2-(4-fluorophenyl)ethyl]-1-propyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)OC)OC
308;372129013;10;1685178;461531598;146641800;27346;336039610;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;<;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);4-[2-[[1-Phenyl-3-(piperidine-1-carbonyl)-4,5,6,7-tetrahydroindazol-5-yl]amino]ethyl]benzonitrile;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4CCCCC4
309;372129014;10;1685178;461525069;146641812;27346;336039610;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;<;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);[5-[2-(1H-imidazol-2-yl)ethylamino]-1-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4CCCCC4
310;372129015;10;1685178;461545142;146641256;27346;336039610;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;<;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);piperidin-1-yl-[1-propyl-5-[2-[3-(trifluoromethyl)phenyl]ethyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-3-yl]methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)COC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O
311;372129016;10;1685178;461562241;146641781;27346;336039610;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);9-[2-(1,3-benzodioxol-5-yl)ethylamino]-3,4,7,8,9,10-hexahydro-2H-pyrazino[1,2-b]indazol-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)COC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O
312;372129017;10;1685178;461540828;146641802;27346;336039610;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);[5-(3,4-dihydro-1H-isoquinolin-2-yl)-1-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)COC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O
313;372129018;10;1685178;461553932;146641807;27346;336039610;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;<;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);[5-(Oxan-4-ylmethylamino)-1-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NC=CC(=C1)N2CC3(C2)CN(C3)CCC4CC5(CCCCC5)C(=O)O4
314;372129019;10;1685178;461522750;153601027;27346;336039610;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);9-[(4-Fluorophenyl)methylamino]-2-methyl-3,4,7,8,9,10-hexahydropyrazino[1,2-b]indazol-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)COC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)F)O
315;372143646;34;1692687;103460177;644019;27346;328045020;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma2 receptor (unknown origin);Cannabidiol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)COC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)F)O
316;372337603;152;1718134;461515217;162643475;27346;331115250;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma-2 receptor (unknown origin);(1S,6R)-9-methoxy-17-methylidene-14-azatetracyclo[12.4.0.01,6.07,12]octadeca-7(12),8,10-triene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)COC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)F)O
317;372337604;188;1718134;103178693;441278;27346;331115250;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma-2 receptor (unknown origin);Pentazocine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=CC=C1)OC)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
318;372337605;221;1718134;103167216;3559;27346;331115250;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma-2 receptor (unknown origin);Haloperidol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=CC=C1)OC)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
319;372337606;1953;1718134;103272786;2562;27346;331115250;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma-2 receptor (unknown origin);Carbetapentane;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=CC=C1)OC)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
320;372352927;78;1725048;461547259;162665987;27346;330621630;Confirmatory;20220830;0;0;Active;Q5BJF2;IC50;=;ChEMBL;Inhibition of sigma2 receptor (unknown origin);[3-(3,4-Dichlorophenyl)imidazo[4,5-b]pyridin-2-yl]-(3,3-difluoroazetidin-1-yl)methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC4=CC=CC=C4C=C3C2
321;372400685;146;1744236;461556559;162672543;27346;333727820;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;5-(4-Tert-butylphenyl)-1-propan-2-yl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC4=CC=CC=C4C=C3C2
322;372400686;171;1744236;461563521;162677436;27346;333727820;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;5-(4-Tert-butylphenyl)-1-ethyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC4=CC=CC=C4C=C3C2
323;372400687;10;1744236;461562474;154929638;27346;333727820;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;1-Methyl-3-(pyrrolidin-1-ylmethyl)-5-[4-(trifluoromethyl)phenyl]-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=CC(=N1)C)N2CC3(C2)CN(C3)CCC4CC5(CCCCC5)C(=O)O4
324;372400688;10;1744236;461560115;162675033;27346;333727820;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;1-Methyl-3-(pyrrolidin-1-ylmethyl)-5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)OC
325;372400689;10;1744236;461515490;162643678;27346;333727820;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;1-Methyl-3-(pyrrolidin-1-ylmethyl)-5-[3-[1-(trifluoromethyl)cyclopropyl]phenyl]-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C4=CC=CC=C4C=C3
326;372400690;75;1744236;461561918;162676329;27346;333727820;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;5-(4-Tert-butylphenyl)-1-cyclopropyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)OC)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
327;372400691;10;1744236;461553307;162670209;27346;333727820;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;5-(1-Benzothiophen-6-yl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C4=CC=CC=C4C=C3
328;372400692;10;1744236;461553907;154929738;27346;333727820;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;1-Methyl-5-(3-phenylphenyl)-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)OC)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
329;372400693;10;1744236;461542100;154929697;27346;333727820;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;1-Methyl-5-(4-methylphenyl)-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C4=CC=CC=C4C=C3
330;372400694;10;1744236;461546621;153610500;27346;333727820;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;5-(2,3-dihydro-1H-inden-5-yl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)OC)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
331;372400695;10;1744236;163334751;44247568;27346;333727820;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC1(CC(OC1=O)CCN2CC3CN(CC3C2)C4=CC=CC=C4C(C)C)CC
332;372400696;10;1744236;461552545;154929834;27346;333727820;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;1-Methyl-5-(3-phenoxyphenyl)-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=C(C=C1)OCC[18F])C(=O)NCCCCN2CCC3=CC(=C(C=C3C2)OC)OC
333;372400697;10;1744236;461543540;162663358;27346;333727820;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;5-(3,4-Dimethylphenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2CC(CC1N2CCCSC3=CC=CC=C3F)(C4=CC=C(C=C4)Cl)O
334;372400698;10;1744236;461514518;152658541;27346;333727820;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;5-(4-Cyclopropylphenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2CC(CC1N2CCCSC3=CC=CC=C3F)(C4=CC=C(C=C4)Cl)O
335;372400699;10;1744236;461561353;150285231;27346;333727820;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;1-Methyl-3-(pyrrolidin-1-ylmethyl)-5-[4-[1-(trifluoromethyl)cyclopropyl]phenyl]-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN(C1)C2=NC=C(C=C2)Cl)CCCSC3=CC=C(C=C3)F
336;372400700;10;1744236;461562330;154929730;27346;333727820;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;1-Methyl-5-(4-propan-2-ylphenyl)-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C=C(C=C3)C(F)(F)F
337;372400701;10;1744236;461544083;154929836;27346;333727820;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;5-(3,4-Dichlorophenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C=C(C=C3)C(F)(F)F
338;372400912;10;1744236;461543410;162663264;27346;333727820;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;5-(4-Chlorophenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C=C(C=C3)C(F)(F)F
339;372400913;17;1744236;461555458;154929675;27346;333727820;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;1-[[5-(4-Tert-butylphenyl)-1-methyl-1,2,4-triazol-3-yl]methyl]-4-(2-phenylethyl)piperazine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN(C1)C2=NC=C(C=C2)Cl)CCCSC3=CC=C(C=C3)F
340;372400914;10;1744236;461516332;162644273;27346;333727820;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;5-(3-Tert-butylphenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)C1=CC=CC=C1N2CC3CN(CC3C2)CCC4CC5(CCCCC5)C(=O)O4
341;372400915;10;1744236;461562359;162676630;27346;333727820;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;5-(4-Tert-butylphenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4CCCCC4
342;372400916;83;1744236;103167216;3559;27346;333727820;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;Haloperidol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN(C1)C2=NC=C(C=C2)Cl)CCC/C(=N/O)/C3=CC=C(C=C3)F
343;372400917;10;1744236;461559469;162674577;27346;333727820;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;5-(2-Chloro-1-benzothiophen-6-yl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
344;372400918;10;1744236;461549001;162667190;27346;333727820;Confirmatory;20220830;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-DTG from sigma-2 receptor in human Jurkat cell membrane incubated for 1 hr by liquid scintillation counting method;1-Methyl-5-[3-methyl-4-(trifluoromethyl)phenyl]-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C)O
345;373790227;478;1750147;469812867;164585602;27346;337872730;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);4-[4-[5-(Hydroxymethyl)-1,2-oxazol-3-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
346;373790228;226;1750147;469826621;164585522;27346;337872730;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);3-[4-(2H-tetrazol-5-yl)phenyl]-5-[4-[4-(trifluoromethyl)phenyl]triazol-1-yl]benzoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C)O
347;373790392;;1750162;469804618;164585473;27346;337872730;Literature-derived;20220830;0;0;Unspecified;Q5BJF2;;;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) at 10 uM relative to control;4-[4-(1-Formylpiperidin-4-yl)phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
348;373790867;931;1750147;469800370;164585459;27346;337872730;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);3-[4-(2-Amino-2-oxoethyl)phenyl]-5-[4-[4-(trifluoromethyl)phenyl]triazol-1-yl]benzoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C)O
349;373790868;59;1750147;469810438;164585412;27346;337872730;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);[2-(Dimethylamino)-2-oxoethyl] 4-[4-(1-acetylpiperidin-4-yl)phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN(C1)C2=NC=C(C=C2)Cl)CCC/C(=N/O)/C3=CC=C(C=C3)F
350;373797113;;1751670;404719049;86705695;27346;342695760;Literature-derived;20220830;0;0;Inactive;Q5BJF2;;;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) at 0.1 to 1 uM;Pemigatinib;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)Cl)Cl
351;373860269;;1763018;469822503;164625966;27346;338822730;Literature-derived;20220830;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin) at 10 uM;4-fluoro-N-[[2-[(7-hydroxy-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)Cl)Cl
352;373860270;;1763018;469799464;164609519;27346;338822730;Literature-derived;20220830;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin) at 10 uM;3-cyano-N-[[2-[(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)Cl)Cl
353;373860271;;1763018;469823939;164626655;27346;338822730;Literature-derived;20220830;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin) at 10 uM;4-cyano-N-[[2-[(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(C1)N2CCN(CC2)C3=CC4=C(CCN(C4)C(=O)OCC5=CC=CC=C5)C=C3
354;373860272;;1763018;469803027;164612095;27346;338822730;Literature-derived;20220830;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin) at 10 uM;4-bromo-N-[[2-[(7-hydroxy-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC2(C1)SCC(S2)CN3CCC(CC3)CC4=CC=CC=C4.C(=O)(C(=O)O)O
355;373860273;;1763018;469801216;164610779;27346;338822730;Literature-derived;20220830;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin) at 10 uM;N-[[2-[(7-hydroxy-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]-4-iodo-3-methoxybenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1(C2=CC=CC=C2[N+](=C1/C=C/C=C/C=C\3/C(C4=CC=CC=C4N3CCCCCC(=O)NCCCCCCN5C=C(C6=CC=CC=C65)CCCCN7CCC8(CC7)C9=CC=CC=C9CO8)(C)C)C)C.[I-]
356;373860274;;1763018;469804701;164613304;27346;338822730;Literature-derived;20220830;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin) at 10 uM;3-cyano-N-[[2-[(6,7-dihydroxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=C(C2)C(=CC=C3)F
357;373860275;;1763018;469808137;164615768;27346;338822730;Literature-derived;20220830;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin) at 10 uM;N-[[2-[(7-hydroxy-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]naphthalene-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=C(C2)C(=CC=C3)F
358;373860276;;1763018;469801947;164611312;27346;338822730;Literature-derived;20220830;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin) at 10 uM;4-chloro-N-[[2-[(7-hydroxy-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=C(C2)C(=CC=C3)F
359;373860277;;1763018;469803423;164612385;27346;338822730;Literature-derived;20220830;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin) at 10 uM;N-[[2-[(7-hydroxy-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]-4-phenylbenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1(SCC(S1)CN2CCN(CC2)CC3=CC=CC=C3)C.C(=O)(C(=O)O)O.C(=O)(C(=O)O)O
360;373860278;;1763018;469805306;164613736;27346;338822730;Literature-derived;20220830;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin) at 10 uM;4-cyano-N-[[2-[(6,7-dihydroxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC1(CC(OC1=O)CCN2CC3CN(CC3C2)C4=CC=CC=C4)CC
361;373860279;;1763018;469811191;164617989;27346;338822730;Literature-derived;20220830;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin) at 10 uM;N-[[2-[(7-hydroxy-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]-4-iodobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C(=CC=C3)F
362;373860280;;1763018;469827880;164628625;27346;338822730;Literature-derived;20220830;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin) at 10 uM;N-[[2-[(7-hydroxy-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]-2,3-dimethoxybenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=C(C2)C=C(C=C3)F
363;373860281;;1763018;469828398;164628883;27346;338822730;Literature-derived;20220830;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin) at 10 uM;4-cyano-N-[[2-[(7-hydroxy-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C(=CC=C3)F
364;373951583;5;1780129;469816999;52514484;27346;345319470;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to Sigma 2-receptor (unknown origin);(2R)-4-(4-chlorophenyl)-N-[[4-(trifluoromethyl)phenyl]methyl]butan-2-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=C(C2)C=C(C=C3)F
365;373951584;85;1780129;469799520;118278088;27346;345319470;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to Sigma 2-receptor (unknown origin);Sigma-2 receptor antagonist 1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C(=CC=C3)F
366;373951585;48;1780129;469800109;52516005;27346;345319470;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to Sigma 2-receptor (unknown origin);(2R)-4-(3,4-dichlorophenyl)-N-[[4-(trifluoromethyl)phenyl]methyl]butan-2-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=C(C2)C=C(C=C3)F
367;373951586;11;1780129;469816489;91826734;27346;345319470;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to Sigma 2-receptor (unknown origin);US10207991, Ex. Cpd. No. 28;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CC=C1C2=CNC3=C2C=CC=N3)CCCC4=CC=CC=C4
368;373951587;44;1780129;469805670;118282969;27346;345319470;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to Sigma 2-receptor (unknown origin);Isoindoline derivative 2;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCCN(CC1)CCCCN2C3=C(C=CC(=C3)Cl)OC2=O
369;373951588;79;1780129;469825195;118282956;27346;345319470;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to Sigma 2-receptor (unknown origin);US10207991, Ex. Cpd. No. 8;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=CN=C1)N2CC3(C2)CN(C3)CCC4CC5(CCCCC5)C(=O)O4
370;373951589;12;1780129;469811932;52516003;27346;345319470;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to Sigma 2-receptor (unknown origin);(2S)-4-(3,4-dichlorophenyl)-N-[[4-(trifluoromethyl)phenyl]methyl]butan-2-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=CN=C1)N2CC3CN(CC3C2)CCC4CC5(CCCCC5)C(=O)O4
371;373951590;9;1780129;469813437;66731659;27346;345319470;Confirmatory;20220830;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to Sigma 2-receptor (unknown origin);4-(3-(4-(Trifluoromethyl)benzylamino)butyl)-2-methoxyphenol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(CC1)N2CCN(CC2)C3=CC4=C(CCN(C4)C(=O)OCC5=CC=CC=C5)C=C3
372;373985320;;1788309;440224957;6451154;27346;;Other;20220830;0;0;Inactive;Q5BJF2;;;ChEMBL;Sigma (non selective) Ligand binding assay;4-[(2S)-2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-[4-(trifluoromethoxy)phenyl]benzonitrile;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)([C@H](C1=CC=CC=C1)O)NCC2=CC3=C(C=C2)N(C(=O)CC3)C
373;373985322;;1788309;440224957;6451154;27346;;Other;20220830;0;0;Unspecified;Q5BJF2;;;ChEMBL;Sigma (non selective) Ligand binding assay;4-[(2S)-2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-[4-(trifluoromethoxy)phenyl]benzonitrile;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1(C2=CC=CC=C2[N+](=C1/C=C/C=C/C=C\3/C(C4=CC=CC=C4N3CCCCCC(=O)NCCCCCCN5C=C(C6=CC=CC=C65)CCCCN7CCC8(CC7)C9=CC=CC=C9CO8)(C)C)C)C.[I-]
374;373988012;;1790448;312372725;44543970;27346;;Other;20220830;0;0;Inactive;Q5BJF2;;;ChEMBL;SIGMA/NS/GP Eurofins-Panlabs selectivity data (BI);Unii-KQ33evh4KU;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CC1CCCCC1)C2CCC3(CC2)C4=CC=CC=C4C=CO3
375;373988122;;1790629;134461578;51346964;27346;;Other;20220830;0;0;Inactive;Q5BJF2;;;ChEMBL;SIGMA2/R Eurofins-Panlabs selectivity data (BI);S2JB42Bbp5;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC4=C(C=C3C2)OCO4
376;373988320;;1790745;440170924;58431184;27346;;Other;20220830;0;0;Inactive;Q5BJF2;;;ChEMBL;SIGMA/NS/GP Eurofins-Panlabs selectivity data (BI);(5R)-5-[(4-cyanophenyl)methyl]-7-(3,5-dichloro-4-fluorophenyl)-5-methyl-6-oxo-N-[(2S)-1-oxo-1-[(1-pyridin-2-ylcyclopropyl)amino]propan-2-yl]imidazo[1,2-a]imidazole-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC4=C(C=C3C2)OCO4
377;373988348;;1790592;163338225;51031001;27346;;Other;20220830;0;0;Inactive;Q5BJF2;;;ChEMBL;SIGMA2/R Eurofins-Panlabs selectivity data (BI);4-(1-Acetylpiperidin-4-yl)-N-carbamimidoyl-3-(trifluoromethyl)benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC4=C(C=C3C2)OCO4
378;374059615;14;1763013;469803481;164612428;27346;338822730;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin);N-[[2-[(7-hydroxy-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]-4-methoxybenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1(C2=CC=CC=C2[N+](=C1/C=C/C=C/C=C/3\C(C4=CC=CC=C4N3CCCCCC(=O)NC5=CC6=C(C=C5)C=CN6CCCCN7CCC8(CC7)C9=CC=CC=C9CO8)(C)C)C)C.[I-]
379;374059616;24;1763013;469804164;164612933;27346;338822730;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin);3-chloro-N-[[2-[(7-hydroxy-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1CCCOC2=CC=C(C=C2)F)C3=CC=CC=C3
380;374059617;61;1763013;469818518;164623294;27346;338822730;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin);N-[[2-[(7-hydroxy-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]-3-methoxybenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCCC(=O)C3=CC=C(C=C3)F
381;374059618;29;1763013;469828891;164629139;27346;338822730;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin);3-bromo-N-[[2-[(7-hydroxy-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=C(C=C1)OC)NC(=O)OC2C[C@H]3CCC[C@H](C2)N3CCCCCCN
382;374059619;14;1763013;469824847;164627090;27346;338822730;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin);N-[[2-[(7-hydroxy-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]-2-methoxybenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=CC4=C(C=C3C2)OCO4
383;374059620;44;1763013;469817606;164622629;27346;338822730;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin);2-chloro-N-[[2-[(7-hydroxy-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=CC4=C(C=C3C2)OCO4
384;374059621;27;1763013;404709609;145988474;27346;338822730;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin);4-cyano-N-[4-(7-hydroxy-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)butyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=CC4=C(C=C3C2)OCO4
385;374059622;103;1763013;103252210;10458892;27346;338822730;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin);5-bromo-N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2,3-dimethoxybenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CC1CCCCC1)C2CCC3(CC2)C4=CC=CC=C4CCO3
386;374059623;36;1763013;469800510;164610259;27346;338822730;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin);2-bromo-N-[[2-[(7-hydroxy-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCCC(=O)C3=CC=C(C=C3)F
387;374059624;721;1763013;103187121;4452;27346;338822730;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin);n-(1-Benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCCOC3=CC=C(C=C3)F
388;374059625;48;1763013;469817548;164622586;27346;338822730;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin);2,3-dichloro-N-[[2-[(7-hydroxy-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCCOC3=CC=C(C=C3)F
389;374059626;100;1763013;469826085;164627741;27346;338822730;Confirmatory;20230314;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]DTG from sigma2 receptor(unknown origin);3-cyano-N-[[2-[(7-hydroxy-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methyl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1(OCC(O1)CN2CCC(CC2)CC3=CC=CC=C3)C.C(=O)(C(=O)O)O
390;374441078;;1794589;440175888;85469632;27346;;Other;20230314;0;0;Inactive;Q5BJF2;;;ChEMBL;Sigma 2 Eurofins-Panlabs radioligand binding assay;Unii-66vrx9TN9T;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)OC1=C(C=C(C=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)F)OC(C)C
391;380273760;;1813193;475994656;156782580;27346;346282360;Literature-derived;20230314;0;0;Unspecified;Q5BJF2;;;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) at 10 uM relative to control;N-[(2S)-2-(4-benzylpiperidin-1-yl)propyl]-N-phenylpropanamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)OC1=C(C=C(C=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)F)OC(C)C
392;380273761;;1813193;475997149;156782585;27346;346282360;Literature-derived;20230314;0;0;Unspecified;Q5BJF2;;;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) at 10 uM relative to control;N-[2-(4-benzylpiperidin-1-yl)propyl]-N-phenylpropanamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)OC1=C(C=C(C=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)F)OC(C)C
393;380273762;;1813193;475987833;166630196;27346;346282360;Literature-derived;20230314;0;0;Unspecified;Q5BJF2;;;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) at 10 uM relative to control;N-[2-(4-benzylpiperidin-1-yl)propyl]-N-(4-fluorophenyl)propanamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC1(CC(OC1=O)CCN2CC3CN(CC3C2)C4=CC=CC=C4OC)CC
394;380299451;862;1819826;475977722;6916184;27346;354503790;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Citalopram from sigma-2 receptor (unknown origin) expressed in HEK cell membrane incubated for 2 hrs by liquid scintillation counter analysis;(1R,9R,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)OC1=C(C=C(C=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)OC(C)(C)C
395;380299536;369;1819776;475994562;166633518;27346;354503510;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to human sigma2 receptor by radioligand binding assay;N-[4-(3-iodo-5-methylphenyl)-5-pyridin-4-yl-1,3-thiazol-2-yl]pyridine-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)OC1=C(C=C(C=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)OC(C)(C)C
396;380299627;100;1819826;374298394;5416975;27346;354503790;Confirmatory;20230314;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-Citalopram from sigma-2 receptor (unknown origin) expressed in HEK cell membrane incubated for 2 hrs by liquid scintillation counter analysis;rac-3-Hydroxy-N-methyl-isomorphinan;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)OC1=C(C=C(C=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)OC(C)(C)C
397;380299628;833;1819826;475987193;24997117;27346;354503790;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Citalopram from sigma-2 receptor (unknown origin) expressed in HEK cell membrane incubated for 2 hrs by liquid scintillation counter analysis;CID 24997117;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(CC1)CNC2CCC3(CC2)C4=CC=CC=C4C=CO3
398;380299629;885;1819826;475994583;166633527;27346;354503790;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Citalopram from sigma-2 receptor (unknown origin) expressed in HEK cell membrane incubated for 2 hrs by liquid scintillation counter analysis;(1S,9S,10S)-17-methyl-4-(trifluoromethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC1(CC(OC1=O)CCN2CC3CN(CC3C2)C4=CC=CC=C4C#N)CC
399;380299630;353;1819826;475982920;166627732;27346;354503790;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Citalopram from sigma-2 receptor (unknown origin) expressed in HEK cell membrane incubated for 2 hrs by liquid scintillation counter analysis;(1S,9S,10S)-4-(difluoromethyl)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
400;380299631;826;1819826;475994936;166633719;27346;354503790;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Citalopram from sigma-2 receptor (unknown origin) expressed in HEK cell membrane incubated for 2 hrs by liquid scintillation counter analysis;(1S,9S,10S)-4-(1,1-difluoroethyl)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
401;380299632;1281;1819826;475995038;24997107;27346;354503790;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Citalopram from sigma-2 receptor (unknown origin) expressed in HEK cell membrane incubated for 2 hrs by liquid scintillation counter analysis;(1S,9S,10S)-4-(difluoromethoxy)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
402;380299633;1404;1819826;475983604;166628082;27346;354503790;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-Citalopram from sigma-2 receptor (unknown origin) expressed in HEK cell membrane incubated for 2 hrs by liquid scintillation counter analysis;(1S,9S,10S)-17-methyl-4-(1,1,2,2,2-pentafluoroethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)C1=CC2=C(C=C1)C(=O)N(C2=O)OC3=CC=CC4=C3CCCC4CCCN5CCN(CC5)C6CCCCC6
403;380313406;10;1822895;475994825;166633661;27346;351135560;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) assessed as binding constant;4-[4-[(1R,2S,4R)-5-methylsulfonyl-2-bicyclo[2.2.1]heptanyl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(CC1)CNC2CCC3(CC2)C4=CC=CC=C4C=CO3
404;380313407;11;1822895;475995234;164585354;27346;351135560;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) assessed as binding constant;4-[4-[(1R,2R,4R)-4-amino-2-(hydroxymethyl)cyclopentyl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC1(CC(OC1=O)CCN2CC3CN(CC3C2)C4=CC=CC(=C4)C#N)CC
405;380313408;20;1822895;475979781;164585390;27346;351135560;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) assessed as binding constant;4-[4-[(1S,2S,4S)-4-amino-2-carboxycyclopentyl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1C(CCN1CC2=CC=CC=C2)NC(=O)C3=CC(=C(C=C3OC)NC)Cl
406;380313409;10;1822895;475998095;164585652;27346;351135560;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) assessed as binding constant;4-[4-[(1R,4R,6S)-2-azabicyclo[2.2.1]heptan-6-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CC1CCCCC1)C2CCC3(CC2)C4=CC=CC=C4C(O3)OC
407;380313410;32;1822895;475995949;166634238;27346;351135560;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) assessed as binding constant;[2-(dimethylamino)-2-oxoethyl] 4-[4-[(1R,4R,6S)-3-oxo-2-azabicyclo[2.2.1]heptan-6-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCCN(CC1)CCCCN2C3=C(C=CC(=C3)Cl)SC2=O
408;380313411;14;1822895;475982545;164585550;27346;351135560;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) assessed as binding constant;4-[4-[(1S,4S,6R)-3-oxo-2-azabicyclo[2.2.1]heptan-6-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=C(C=C1)OC)NC(=O)OC2CC3CCCC(C2)N3CCCCCCCCCCN
409;380313412;21;1822895;475987677;164585542;27346;351135560;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) assessed as binding constant;4-[4-[(1R,4R,6S)-3-oxo-2-azabicyclo[2.2.1]heptan-6-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCCN(CC1)CCCSC2=NC3=C(S2)C=CC(=C3)Cl
410;380313413;17;1822895;475980514;166626545;27346;351135560;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) assessed as binding constant;4-[4-[(1R,4R,5R)-2-acetyl-2-azabicyclo[2.2.1]heptan-5-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN(C1)C2=NC=C(C=C2)Cl)CCCC(=O)C3=CC=C(C=C3)F
411;380313414;65;1822895;475993815;163322040;27346;351135560;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) assessed as binding constant;4-[4-[(1S,4S,5S)-2-azabicyclo[2.2.1]heptan-5-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCN(CC1)C2=CC3=C(C=C2)C4CCN(C3C4)C(=O)OCC5=CC=CC=C5
412;380313867;71;1822895;475993815;163322040;27346;351135560;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) assessed as binding constant;4-[4-[(1S,4S,5S)-2-azabicyclo[2.2.1]heptan-5-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(CC1)CNC2CCC3(CC2)C4=CC=CC=C4CCO3
413;380313868;14;1822895;475980390;164946890;27346;351135560;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) assessed as binding constant;Ethyl (1S,4S,5S)-5-(4-(3-((2-(dimethylamino)-2-oxoethoxy)carbonyl)-6-(4-(trifluoromethyl)phenyl)naphthalen-1-yl)phenyl)-2-azabicyclo[2.2.1]heptane-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN(C1)C2=NC=C(C=C2)Cl)CCCC(=O)C3=CC=C(C=C3)F
414;380313869;19;1822895;475981459;164585387;27346;351135560;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) assessed as binding constant;4-[4-[(1R,4R,5R)-3-oxo-2-azabicyclo[2.2.1]heptan-5-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2CC(CC1N2CCCSC3=CC=CC(=C3)F)(C4=CC=C(C=C4)Cl)O
415;380313870;39;1822895;475990079;164585325;27346;351135560;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) assessed as binding constant;[2-(dimethylamino)-2-oxoethyl] 4-[4-[(1S,4S,5S)-2-azabicyclo[2.2.1]heptan-5-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCCC2(CC1)SCC(S2)CN3CCC(CC3)CC4=CC=CC=C4.C(=O)(C(=O)O)O
416;380313871;12;1822895;476000732;164585447;27346;351135560;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) assessed as binding constant;4-[4-[(1R,4R,5R)-2-azabicyclo[2.2.1]heptan-5-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C
417;380313872;17;1822895;475982511;166627539;27346;351135560;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) assessed as binding constant;4-[4-[(1S,5S)-8-hydroxy-3-azabicyclo[3.2.1]octan-8-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C
418;380313873;12;1822895;475993042;164585339;27346;351135560;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) assessed as binding constant;4-(4-Pyrrolidin-3-ylphenyl)-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C
419;380313874;86;1822895;475999926;166636212;27346;351135560;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) assessed as binding constant;[2-(dimethylamino)-2-oxoethyl] 4-[4-[(1R,4R,5R)-3-oxo-2-azabicyclo[2.2.1]heptan-5-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2CC(CC1N2CCCSC3=CC=CC(=C3)F)(C4=CC=C(C=C4)Cl)O
420;380313875;10;1822895;475987137;164585647;27346;351135560;Confirmatory;20230314;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) assessed as binding constant;CID 164585647;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1CN2CC3=CC=CC=C3C2=O)CC(=O)C4=CC=C(C=C4)F
421;380512458;132;1846431;482078059;168291610;27346;338263220;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2S,6S)-4-(oxan-4-yl)-10-[4-(trifluoromethyl)phenyl]-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(C1)N2CCN(CC2)C3=CC4=C(CN(C4)C(=O)OCC5=CC=CC=C5)C=C3
422;380512498;;1846435;482069579;168285428;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 10 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-(5-fluoropyridin-2-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CCCCNC3=CC(=C(C=C3)[N+](=O)[O-])C(F)(F)F
423;380512499;;1846435;482072612;168287632;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 10 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-10-(2-fluorophenyl)-4-[(1-methylimidazol-2-yl)methyl]-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=NC=C(C=C3)Cl
424;380512594;;1846435;482053788;86295354;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 10 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2S,6S)-10-(2-fluorophenyl)-4-[(6-methoxypyridin-3-yl)methyl]-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCCCC3=CC=C(C=C3)F
425;380512595;;1846435;482057146;168276410;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 10 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-10-(3-fluorophenyl)-4-[(6-methoxypyridin-3-yl)methyl]-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O
426;380512596;;1846435;482057955;168276975;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 10 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-10-(5-fluoropyridin-2-yl)-4-(oxan-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCN(CC1)C2=CC3=C(C=C2)C4CCN(C3C4)C(=O)OCC5=CC=CC=C5
427;380512597;;1846435;482075793;86298405;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 10 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2S,6S)-4-[(4-fluorophenyl)methyl]-10-pyridin-2-yl-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O
428;380512598;;1846435;482065033;86296794;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 10 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2S,6S)-10-(5-fluoropyridin-2-yl)-4-(oxan-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O
429;380512599;;1846435;482075824;86295356;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 10 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-10-(2-fluorophenyl)-4-[(6-methoxypyridin-3-yl)methyl]-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O
430;380512600;;1846435;482052615;86295352;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 10 uM measured after 120 mins by liquid scintillation counting analysis relative to control;CID 86295352;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCCCC3=CC=C(C=C3)F
431;380512601;;1846435;482064230;86297181;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 10 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-pyridin-3-yl-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=NC=C(C=C3)Cl
432;380512602;;1846435;482079438;168292590;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 10 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-pyrimidin-2-yl-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C
433;380512603;;1846435;482068888;86298403;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 10 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-pyridin-2-yl-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C
434;380512604;;1846435;482056431;86295563;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 10 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-10-(2-fluorophenyl)-4-(oxan-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C
435;380512605;;1846435;482057767;86295561;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 10 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2S,6S)-10-(2-fluorophenyl)-4-(oxan-4-ylmethyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(C)C)OC(C)C)N2CC3=CC4=C(C=C3C2)OCO4
436;380512606;;1846435;482054756;86297989;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 10 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-10-(2-fluorophenyl)-4-(pyridin-3-ylmethyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(C)C)OC(C)C)N2CC3=CC4=C(C=C3C2)OCO4
437;380512627;667;1846431;482078059;168291610;27346;338263220;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2S,6S)-4-(oxan-4-yl)-10-[4-(trifluoromethyl)phenyl]-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(C)C)OC(C)C)N2CC3=CC4=C(C=C3C2)OCO4
438;380512628;51;1846431;482082052;86297371;27346;338263220;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2S,6S)-10-(2-chloro-4-fluorophenyl)-4-(oxan-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(CCC1=CC(=C(C=C1)O)OC)NCC2=CC=C(C=C2)C(F)(F)F
439;380512629;100;1846431;482053788;86295354;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2S,6S)-10-(2-fluorophenyl)-4-[(6-methoxypyridin-3-yl)methyl]-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O
440;380512630;100;1846431;482057146;168276410;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-10-(3-fluorophenyl)-4-[(6-methoxypyridin-3-yl)methyl]-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O
441;380512631;100;1846431;482057955;168276975;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-10-(5-fluoropyridin-2-yl)-4-(oxan-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O
442;380512632;10;1846431;482073283;86295769;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2S,6S)-10-(2-fluorophenyl)-4-(oxan-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CC1CCCCC1)C2CCC3(CC2)C4=CC=CC=C4C(O3)OC
443;380512633;126;1846431;482087135;86297379;27346;338263220;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-10-(2,4-difluorophenyl)-4-[2-(oxan-4-yl)ethyl]-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC1(CC(OC1=O)CCN2CC3CN(CC3C2)C4=CC=C(C=C4)C#N)CC
444;380512634;100;1846431;482052615;86295352;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;CID 86295352;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC2=CC=CC=C2O1)CC3=CC=CC=C3
445;380512635;100;1846431;482064230;86297181;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-pyridin-3-yl-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CC(C2=C1C=C(C=C2)O)O)CCCCC3=CC=CC=C3
446;380512636;100;1846431;482079438;168292590;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-pyrimidin-2-yl-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C2=C(C=C(C=C2)CN3CCC(CC3)OCC4=CC(=C(C=C4)F)F)C=N1
447;380512637;10;1846431;482055825;86297183;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-(3-fluoropyridin-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC(=CC(=C1OC)C(=O)NCCCCN2CCC3=CC(=C(C=C3C2)OC)OC)Br
448;380512638;10;1846431;482068443;86295555;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-10-(2-fluorophenyl)-4-(oxan-4-ylmethyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=C(C=C1)OC)C(=O)NCCCCN2CCC3=CC(=C(C=C3C2)OC)OC
449;380512697;;1846434;482048991;86296201;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 1 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-(3-fluoropyridin-2-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1C2=CC=CC=C2C3(O1)CCC(CC3)NCC4CCCCC4
450;380512698;;1846434;482055825;86297183;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 1 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-(3-fluoropyridin-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCCN(CC1)CCCCSC2=NC3=C(O2)C=CC(=C3)Cl
451;380512699;;1846434;482068443;86295555;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 1 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-10-(2-fluorophenyl)-4-(oxan-4-ylmethyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)F)O
452;380512700;;1846434;482069872;44594147;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 1 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2S,6S)-4-benzyl-10-(2-fluorophenyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)F)O
453;380512701;;1846434;482069788;24862231;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 1 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-4-benzyl-10-(2-fluorophenyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OC)OC)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
454;380512702;;1846434;482066921;24862176;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 1 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-4-benzyl-10-(3-fluorophenyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)F)O
455;380512703;;1846434;482059757;44594288;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 1 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2S,6S)-4-benzyl-10-(3-fluorophenyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OC)OC)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
456;380512704;;1846434;482074018;168288651;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 1 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-(1-methylpiperidin-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)F)O
457;380512705;;1846434;482065133;86297983;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 1 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-(oxan-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OC)OC)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
458;380512706;;1846434;482073283;86295769;27346;338263220;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes at 1 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2S,6S)-10-(2-fluorophenyl)-4-(oxan-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NC=CC(=C1)N2CC3CN(CC3C2)CCC4CC5(CCCCC5)C(=O)O4
459;380512712;10;1846431;482069872;44594147;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2S,6S)-4-benzyl-10-(2-fluorophenyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCOC(=O)CCN1CCN(CC1)C2=CC=CC3=C2CN(CC3)C(=O)OCC4=CC=CC=C4
460;380512713;100;1846431;482075824;86295356;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-10-(2-fluorophenyl)-4-[(6-methoxypyridin-3-yl)methyl]-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CC1CCCCC1)C2CCC3(CC2)C4=CC=CC=C4CCO3
461;380512714;100;1846431;482069579;168285428;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-(5-fluoropyridin-2-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3CSCS3.C(=O)(C(=O)O)O
462;380512715;10;1846431;482069788;24862231;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-benzyl-10-(2-fluorophenyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC=C(C=C1)F)N2CC3=C(C2)C(=CC=C3)F
463;380512716;42;1846431;482070072;86297577;27346;338263220;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-10-(2,4-dichlorophenyl)-4-(oxan-4-ylmethyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC=C(C=C1)F)N2CC3=C(C2)C(=CC=C3)F
464;380512717;100;1846431;482072612;168287632;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-10-(2-fluorophenyl)-4-[(1-methylimidazol-2-yl)methyl]-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC=C(C=C1)F)N2CC3=C(C2)C(=CC=C3)F
465;380512718;100;1846431;482068888;86298403;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-pyridin-2-yl-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(CC1)N2CCN(CC2)CCCN3C4=CC=CC=C4C5=CC=CC=C53
466;380512719;10;1846431;482074018;168288651;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-(1-methylpiperidin-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC12C3=CC=CC=C3CO2)CCCCC4=CN(C5=CC=CC=C54)C6=CC=C(C=C6)F
467;380512720;100;1846431;482075793;86298405;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2S,6S)-4-[(4-fluorophenyl)methyl]-10-pyridin-2-yl-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC12C3=CC=CC=C3CO2)CCCCC4=CN(C5=CC=CC=C54)C6=CC=C(C=C6)F
468;380512721;10;1846431;482048991;86296201;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-(3-fluoropyridin-2-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CC1CCCCC1)C2CCC3(CC2)C4=CC=CC=C4CC(O3)OC
469;380512722;100;1846431;482065033;86296794;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2S,6S)-10-(5-fluoropyridin-2-yl)-4-(oxan-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC=C(C=C1)F)N2CC3=CC4=C(C=C3C2)OCO4
470;380512723;100;1846431;482054756;86297989;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-10-(2-fluorophenyl)-4-(pyridin-3-ylmethyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=CC4=C(C=C3C2)OCO4)O
471;380512791;100;1846431;482056431;86295563;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-10-(2-fluorophenyl)-4-(oxan-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC=C(C=C1)F)N2CC3=CC4=C(C=C3C2)OCO4
472;380512792;100;1846431;482057767;86295561;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2S,6S)-10-(2-fluorophenyl)-4-(oxan-4-ylmethyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=CC4=C(C=C3C2)OCO4)O
473;380512793;10;1846431;482059757;44594288;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2S,6S)-4-benzyl-10-(3-fluorophenyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC=C(C=C1)F)N2CC3=CC4=C(C=C3C2)OCO4
474;380512794;10;1846431;482066921;24862176;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-benzyl-10-(3-fluorophenyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=CC4=C(C=C3C2)OCO4)O
475;380512795;10;1846431;482065133;86297983;27346;338263220;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-(oxan-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(C1)N2CCN(CC2)C3=CC4=C(CCCN(C4)C(=O)OCC5=CC=CC=C5)C=C3
476;380512796;23;1846431;482067157;86297179;27346;338263220;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;CID 86297179;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN(C1)C2=CC=CC=N2)CCC/C(=N/O)/C3=CC=C(C=C3)F
477;380512797;422;1846431;482067157;86297179;27346;338263220;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-1,3-di-O-tolylguanidine from human sigma 2 receptor/TMEM97 transfected in sigma 1 receptor knockout HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;CID 86297179;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCOC1CC2=CC=CC=C2C3(O1)CCC(CC3)N(C)CC4CCCCC4
478;380523527;907;1849427;482067213;168283716;27346;363677490;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from human sigma2 receptor expressed in human HEK293T cell membrane incubated for 90 mins by radioligand binding assay;2-cyclononyl-N-(3,4-dichlorophenyl)-3H-imidazo[4,5-c]quinolin-4-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3C(=O)OCC4=CC=CC=C4
479;380523528;891;1849427;482046714;166176970;27346;363677490;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from human sigma2 receptor expressed in human HEK293T cell membrane incubated for 90 mins by radioligand binding assay;A3AR modulator 1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCN(CC1)C2=CC=C(C=C2)C3CCCCN3C(=O)OCC4=CC=CC=C4
480;380523529;343;1849427;482053284;168273532;27346;363677490;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from human sigma2 receptor expressed in human HEK293T cell membrane incubated for 90 mins by radioligand binding assay;2-[(1R,5S)-3-bicyclo[3.3.1]nonanyl]-N-(3,4-dichlorophenyl)-3H-imidazo[4,5-c]quinolin-4-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCN(CC1)C2=CC3=C(CCCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
481;380523530;136;1849427;482058377;168277287;27346;363677490;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from human sigma2 receptor expressed in human HEK293T cell membrane incubated for 90 mins by radioligand binding assay;N-(3,4-dichlorophenyl)-2-heptan-4-yl-3H-imidazo[4,5-c]quinolin-4-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3C(=O)OCC4=CC=CC=C4
482;380523531;284;1849427;482048801;168270412;27346;363677490;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from human sigma2 receptor expressed in human HEK293T cell membrane incubated for 90 mins by radioligand binding assay;2-cyclododecyl-N-(3,4-dichlorophenyl)-3H-imidazo[4,5-c]quinolin-4-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1NC2CCOCC2O)C3=NC=C(C=C3)C(F)(F)F
483;380523532;362;1849427;482067433;168283888;27346;363677490;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from human sigma2 receptor expressed in human HEK293T cell membrane incubated for 90 mins by radioligand binding assay;2-cyclodecyl-N-(3,4-dichlorophenyl)-3H-imidazo[4,5-c]quinolin-4-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C=C(C=C3)N4CCNCC4
484;380523533;575;1849427;482066038;167312259;27346;363677490;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from human sigma2 receptor expressed in human HEK293T cell membrane incubated for 90 mins by radioligand binding assay;2-(Cyclohept-4-en-1-yl)-N-(3,4-dichlorophenyl)-1H-imidazo[4,5-c]quinolin-4-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C=C(C=C3)N4CCNCC4
485;380523534;301;1849427;482070757;168286277;27346;363677490;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from human sigma2 receptor expressed in human HEK293T cell membrane incubated for 90 mins by radioligand binding assay;2-cyclohexyl-N-(4-iodophenyl)-3H-imidazo[4,5-c]quinolin-4-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C=C(C=C3)N4CCNCC4
486;380523535;134;1849427;482059142;168277830;27346;363677490;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-DTG from human sigma2 receptor expressed in human HEK293T cell membrane incubated for 90 mins by radioligand binding assay;2-(1-bicyclo[3.3.1]nonanyl)-N-(3,4-dichlorophenyl)-3H-imidazo[4,5-c]quinolin-4-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCN(CC1)C2=CC=C(C=C2)C3CCCCN3C(=O)OCC4=CC=CC=C4
487;380550125;16;1855148;103341547;10499156;27346;359393910;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant;1-[2-[(2R)-1-[(3-Methoxyphenyl)sulfonyl]-2-pyrrolidinyl]ethyl]-4-methylpiperidine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN[C@@]1(CCCC[C@@H]1NCCCC2=CC=CC=C2)C3=CC=CC=C3Cl
488;380551576;4482;1855467;482052157;164851904;27346;359610670;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma2 receptor (unknown origin) measured by radioligand binding assay;N-[(3-fluorophenyl)methyl]-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
489;380551577;6701;1855467;482085923;164851900;27346;359610670;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma2 receptor (unknown origin) measured by radioligand binding assay;N-[(4-fluorophenyl)methyl]-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CC1CCCCC1)C2CCC3(CC2)C4=CC=CC=C4C=CO3
490;380551578;1448;1855467;482054553;164851917;27346;359610670;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma2 receptor (unknown origin) measured by radioligand binding assay;N-[(4-fluorophenyl)methyl]-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCOC1CC2=CC=CC=C2C3(O1)CCC(CC3)NCC4CCCCC4
491;380581233;;1861764;440110049;155510683;27346;357532630;Literature-derived;20230629;0;0;Active;Q5BJF2;;;ChEMBL;Displacement of [3H]-DTG/(+) pentazocine from human sigma2 receptor at 3 uM measured after 60 mins by scintillation counting analysis;1-Benzyl-4-(4-benzyl-1H-1,2,3-triazol-1-yl)piperidine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCCN(CC1)CCCSC2=NC3=C(O2)C=CC(=C3)Cl
492;380581423;1465;1861724;103178693;441278;27346;357249250;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;Pentazocine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
493;380581424;18;1861724;103186197;7333;27346;357249250;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;1,3-Di-o-tolylguanidine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
494;380581425;21;1861724;482077375;41306366;27346;357249250;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;N-[3-[benzyl(methyl)amino]propyl]quinoline-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=NC2=CC=CC=C2C=C1)CC3=CC(=C(C=C3)OC)OC
495;380581426;16;1861724;103167216;3559;27346;357249250;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;Haloperidol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCN1CCN([C@H](C1)CCO)CC2=CC=CC3=CC=CC=C32
496;380581427;126;1861724;482085369;168296268;27346;357249250;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;N-[3-[(3,4-dimethoxyphenyl)methyl-methylamino]propyl]naphthalene-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C/C=C/CN1CCN(CC1)C2=CC3=C(C=C2)[C@H]4CCN([C@@H]3C4)C(=O)OCC5=CC=CC=C5
497;380581428;1067;1861724;482086594;43043710;27346;357249250;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;N-[3-[benzyl(methyl)amino]propyl]furan-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CCCNC3=CC(=C(C=C3)[N+](=O)[O-])C(F)(F)F)OC
498;380581429;50;1861724;482076266;168290278;27346;357249250;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;N-[3-[(3,4-dimethoxyphenyl)methyl-methylamino]propyl]furan-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCOC(=O)CCN1CCN(CC1)C2=CC3=C(C=C2)[C@H]4CCN([C@@H]3C4)C(=O)OCC5=CC=CC=C5
499;380581430;46;1861724;482054361;168274328;27346;357249250;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;N-[3-[(3,4-dimethoxyphenyl)methyl-methylamino]propyl]-1-benzofuran-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)C1=CC=C(C=C1)C2=NC(=NN2C)CN3CCN(CC3)CCC4=CC=CC=C4
500;380581431;106;1861724;482062499;9245765;27346;357249250;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;N-[3-[benzyl(methyl)amino]propyl]naphthalene-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)F
501;380581432;;1861724;103697951;5497186;27346;357249250;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;Naltrindole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)F
502;380581433;;1861724;103217856;5462471;27346;357249250;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;Damgo;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)F
503;380581434;99;1861724;482049187;41306319;27346;357249250;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;N-[3-[benzyl(methyl)amino]propyl]-1-benzofuran-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C=CCN1CCN(CC1)C2=CC3=C(CCN(C3)S(=O)(=O)C4=CC(=CC(=C4)Cl)Cl)C=C2
504;380581891;16;1861724;482064615;168281846;27346;357249250;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;N-[3-[(3,4-dimethoxyphenyl)methyl-methylamino]propyl]quinoline-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(C1)N2CCN(CC2)C3=CC=CC4=C3CN(CC4)C(=O)OCC5=CC=CC=C5
505;380581892;;1861724;123099351;3036289;27346;357249250;Confirmatory;20230629;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;trans-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzeneacetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
506;380644566;;1877642;482074287;168288869;27346;348962130;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Inhibition of sigma 2 receptor (unknown origin) at 50 uM by radioligand receptor binding assay relative to control;Propyl 2-[3-ethoxy-4-[2-oxo-2-(4-phenylpiperazin-1-yl)ethoxy]phenyl]acetate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1CCN(CC1)CCCCC2=CC=CC3=C2C=CC(=C3)OCCCCCCN4C(=O)C5=C(C4=O)C=C(C=C5)N(C)C
507;380647245;19;1877936;381859220;702501;27346;350161130;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]-di-o-tolylguanidine from Sigma 2-receptor (unknown origin);N-(1-benzylpiperidin-4-yl)-4-fluorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2CC(CC1N2CCCOC3=CC=C(C=C3)F)(C4=CC=C(C=C4)Cl)O
508;380656929;;1880176;482081205;168293874;27346;354503690;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Inhibition of sigma 2 receptor (unknown origin);2-(6-fluoro-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)-5-methoxyphenol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O
509;380656930;;1880176;482082442;168294634;27346;354503690;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Inhibition of sigma 2 receptor (unknown origin);"6-chloro-1-(2,4,5-trimethoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole;hydrochloride";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
510;380656931;;1880176;482046560;168268877;27346;354503690;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Inhibition of sigma 2 receptor (unknown origin);2-(6-chloro-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)-5-methoxyphenol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)F
511;380658227;2328;1880175;482062771;168280485;27346;354503690;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant;"6-fluoro-1-(2,4,5-trimethoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole;hydrochloride";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)F
512;380723284;66;1895501;482047729;9727;27346;342640890;Confirmatory;20230629;0;0;Active;Q5BJF2;Kd;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as dissociation constant by competitive binding assay;N-Methyltyramine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)F
513;380785321;;1910937;482085820;164886639;27346;355941500;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Inhibition of sigma-2 receptor (unknown origin) at 10 uM relative to control;N-(4-(3-(4-Chlorophenyl)-1,2,4-oxadiazol-5-yl)phenyl)-1-(furan-2-ylmethyl)-5-oxopyrrolidine-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN[C@@]1(CCCC[C@@H]1NCCCC2=CC=C(C=C2)F)C3=CC=CC=C3Cl
514;380790779;244;1912424;440200558;50985821;27346;356966460;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma2 receptor (unknown origin) by radioligand displacement assay;Metarrestin;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
515;380793202;7943;1907475;482054008;129056976;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 8-(4-propylpiperazin-1-yl)-1,3,4,5-tetrahydro-2H-1,5-methanobenzo[c]azepine-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1NC(=O)C2=CC=CC(=C2)CO[N+](=O)[O-])CC3=CC=CC=C3
516;380793203;85;1907475;482054008;129056976;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 8-(4-propylpiperazin-1-yl)-1,3,4,5-tetrahydro-2H-1,5-methanobenzo[c]azepine-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(C(C1)C2=CC(=CC=C2)N3CCN(CC3)C4CCCC4)C(=O)OCC5=CC=CC=C5
517;380793204;1995;1907475;482051358;168272172;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 2-[3-(4-cyclopentylpiperazin-1-yl)phenyl]piperidine-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=C)CN1CCN(CC1)C2=CC3=C(CCCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
518;380793205;2;1907475;482051358;168272172;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 2-[3-(4-cyclopentylpiperazin-1-yl)phenyl]piperidine-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(C(C1)C2=CC(=CC=C2)N3CCN(CC3)C4CCCC4)C(=O)OCC5=CC=CC=C5
519;380793206;1413;1907475;482085106;168296125;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 2-[3-(4-propylpiperazin-1-yl)phenyl]piperidine-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2CC(CC1N2CCCOC3=CC=C(C=C3)F)(C4=CC=C(C=C4)Cl)O
520;380793207;14;1907475;482085106;168296125;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 2-[3-(4-propylpiperazin-1-yl)phenyl]piperidine-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(C1)N2CCN(CC2)C3=CC=CC(=C3)C4CCCCN4C(=O)OCC5=CC=CC=C5
521;380793208;3802;1907475;482065550;168282509;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;(E)-3-phenyl-1-[2-[3-(4-propylpiperazin-1-yl)phenyl]piperidin-1-yl]prop-2-en-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCCNC(=O)C1=CC=C(C=C1)Cl)CC2=CC=CC=C2
522;380793209;38;1907475;482065550;168282509;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;(E)-3-phenyl-1-[2-[3-(4-propylpiperazin-1-yl)phenyl]piperidin-1-yl]prop-2-en-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
523;380793828;53703;1907475;482066428;168283172;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 4-methyl-2-[3-(4-propylpiperazin-1-yl)phenyl]piperazine-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(C1)N2CCN(CC2)C3=CC=CC(=C3)C4CCCCN4C(=O)OCC5=CC=CC=C5
524;380793829;542;1907475;482066428;168283172;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 4-methyl-2-[3-(4-propylpiperazin-1-yl)phenyl]piperazine-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCCNC(=O)C1=CC=C(C=C1)Cl)CC2=CC=CC=C2
525;380793830;7943;1907475;482049024;168270573;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 3-[3-(4-propylpiperazin-2-yl)phenyl]morpholine-4-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=NC2=CC=CC=C2C=C1)CC3=CC=CC=C3
526;380793831;79;1907475;482049024;168270573;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 3-[3-(4-propylpiperazin-2-yl)phenyl]morpholine-4-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(C)C)OC(C)C)N2CC3=C(C2)C=C(C=C3)F
527;380793832;8913;1907475;482060034;168278492;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 2-[3-[4-(3-ethoxy-3-oxopropyl)piperazin-1-yl]phenyl]piperidine-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(C)C)OC(C)C)N2CC3=C(C2)C(=CC=C3)F
528;380793833;9;1907475;482060034;168278492;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 2-[3-[4-(3-ethoxy-3-oxopropyl)piperazin-1-yl]phenyl]piperidine-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(C)C)OC(C)C)N2CC3=C(C2)C=C(C=C3)F
529;380793834;5129;1907475;482086678;168297018;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 2-[3-[4-(3-hydroxypropyl)piperazin-1-yl]phenyl]piperidine-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(C)C)OC(C)C)N2CC3=C(C2)C(=CC=C3)F
530;380793835;52;1907475;482086678;168297018;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 2-[3-[4-(3-hydroxypropyl)piperazin-1-yl]phenyl]piperidine-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(C)C)OC(C)C)N2CC3=C(C2)C=C(C=C3)F
531;380793836;1514;1907475;482086231;168296763;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 2-[4-(4-propylpiperazin-1-yl)phenyl]piperidine-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(C)C)OC(C)C)N2CC3=C(C2)C(=CC=C3)F
532;380793837;14;1907475;482086231;168296763;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 2-[4-(4-propylpiperazin-1-yl)phenyl]piperidine-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCCN(CC1)CCCCSC2=NC3=C(S2)C=CC(=C3)Cl
533;380793838;54954;1907475;482055487;168275182;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 2-[3-[4-(3-hydroxypropyl)piperazin-1-yl]phenyl]-4-methylpiperazine-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=CC(=C(C=C3C2)OC)OC
534;380793839;554;1907475;482055487;168275182;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 2-[3-[4-(3-hydroxypropyl)piperazin-1-yl]phenyl]-4-methylpiperazine-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=CC(=C(C=C3C2)OC)OC
535;380793840;7586;1907475;482074897;168289302;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;(3,5-Dichlorophenyl)methyl 2-[3-(4-propylpiperazin-1-yl)phenyl]piperidine-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=CC(=C(C=C3C2)OC)OC
536;380794378;75;1907475;482074897;168289302;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;(3,5-Dichlorophenyl)methyl 2-[3-(4-propylpiperazin-1-yl)phenyl]piperidine-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC1(CC(OC1=O)CCN2CC3CN(CC3C2)C4=CC=C(C=C4)OC)CC
537;380794379;48978;1907475;482059330;168277973;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 3-[3-[4-(3-hydroxypropyl)piperazin-1-yl]phenyl]morpholine-4-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CCCNC3=CC(=C(C=C3)[N+](=O)[O-])C(F)(F)F
538;380794380;491;1907475;482059330;168277973;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 3-[3-[4-(3-hydroxypropyl)piperazin-1-yl]phenyl]morpholine-4-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CCCCNC3=CC(=C(C=C3)[N+](=O)[O-])C(F)(F)F)OC
539;380794381;1905;1907475;482064012;168281403;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 2-[3-(4-cyclopentylpiperazin-1-yl)phenyl]-4-methylpiperazine-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1N2C[C@H]3[C@H](C2)OCC4=C(N=NN34)C5=C(C=C(C=C5)C(F)(F)F)Cl
540;380794382;19;1907475;482064012;168281403;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 2-[3-(4-cyclopentylpiperazin-1-yl)phenyl]-4-methylpiperazine-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC=C(C=C1)F)N2CC3=C(C2)C=C(C=C3)F
541;380794383;3311;1907475;482065364;168282372;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 3-[3-(4-cyclopentylpiperazin-1-yl)phenyl]morpholine-4-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC=C(C=C1)F)N2CC3=C(C2)C=C(C=C3)F
542;380794384;32;1907475;482065364;168282372;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;Benzyl 3-[3-(4-cyclopentylpiperazin-1-yl)phenyl]morpholine-4-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC=C(C=C1)F)N2CC3=C(C2)C=C(C=C3)F
543;380794385;631;1907475;482074600;168289094;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;1-[3-[1-(3,5-Dichlorophenyl)sulfonylpiperidin-2-yl]phenyl]-4-propylpiperazine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2(CCN(C2)CC3=CC4=C(N3)C=C(C=C4)Cl)N(C1)CC5=CC(=C(C=C5)F)F
544;380794386;63;1907475;482074600;168289094;27346;353955110;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H](+)-ditolylguanidine from human sigma 2 receptor/TMEM97 transfected in human HEK293T cells assessed as inhibition constant in presence of (+)-pentazocine by radioligand competition binding assay;1-[3-[1-(3,5-Dichlorophenyl)sulfonylpiperidin-2-yl]phenyl]-4-propylpiperazine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2(CCN(C2)CC3=CN4C=CC=CC4=N3)N(C1)CC5=CC(=C(C=C5)F)F
545;380795034;;1907591;482076392;168290376;27346;353974000;Literature-derived;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Inhibition of human Sigma 2 receptor at 10 uM relative to control;Mao-B-IN-4;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=CCN1CCN(CC1)C2=CC3=C(C=C2)[C@H]4CCN([C@@H]3C4)C(=O)OCC5=CC=CC=C5)C
546;380796283;490343;1914044;440132040;154701643;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000708a TMEM97;[2-Amino-4-(trifluoromethoxy)phenyl]-[4-[2-methyl-7-(4-methylpiperazin-1-yl)pyrido[3,2-d]pyrimidin-4-yl]piperidin-1-yl]methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CCNC3=CC(=C(C=C3)[N+](=O)[O-])C(F)(F)F)OC
547;380796685;447095;1914038;442046236;156009444;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000707a TMEM97;N-[5-(3,5-dicyano-2,6-dimethyl-1,4-dihydropyridin-4-yl)-1-methylindazol-3-yl]-2-methylbenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CCCCCNC3=CC(=C(C=C3)[N+](=O)[O-])C(F)(F)F
548;380797899;396;1914533;134457814;56678756;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000738a TMEM97;(1S,3R)-N-[4-(1,3-benzoxazol-2-yl)phenyl]-N-methyl-3-propanamidocyclopentane-1-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=CC(=N1)C)N2CC3CN(CC3C2)CCC4CC5(CCCCC5)C(=O)O4
549;380799590;796;1913996;440165545;155544007;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000703a TMEM97;N-[3-methyl-5-(6-pyridin-3-ylimidazo[1,2-b]pyrazol-1-yl)phenyl]-3-(pentafluoro-lambda6-sulfanyl)benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C=C(C=C3)Cl
550;380799750;676;1915001;440228548;155568985;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000340a TMEM97;(5R)-N-[4-(4-fluorophenoxy)phenyl]-5-(4-fluorophenyl)-7,8-dihydro-5H-1,6-naphthyridine-6-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC)N2CC3=C(C2)C(=CC=C3)F
551;380799753;973;1915026;440175420;95882508;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000345a TMEM97;(S)-ZINC-3573;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C=C(C=C3)Cl
552;380799973;4553;1914325;312359683;11525848;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000729a TMEM97;4-(((2-((3-Methoxybenzyl)carbamoyl)-4-oxo-1,4-dihydrothieno[2,3-d]pyrimidin-5-yl)methoxy)methyl)benzoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC)N2CC3=C(C2)C(=CC=C3)F
553;380800442;205116;1914884;440134679;139600336;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (Eurofins, Bayer)) EUB0000240b TMEM97;CID 139600336;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C=C(C=C3)Cl
554;380800451;11079;1915034;440175888;85469632;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000347a TMEM97;Unii-66vrx9TN9T;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC)N2CC3=C(C2)C(=CC=C3)F
555;380801357;32;1910938;482085820;164886639;27346;355941500;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma-2 receptor (unknown origin);N-(4-(3-(4-Chlorophenyl)-1,2,4-oxadiazol-5-yl)phenyl)-1-(furan-2-ylmethyl)-5-oxopyrrolidine-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=C)CN1CCN(CC1)C2=CC3=C(CCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
556;380807970;107498;1914031;440201576;155558331;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000706a TMEM97;MLi-2-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C=CCN1CCN(CC1)C2=CC3=C(CN(C3)S(=O)(=O)C4=CC(=CC(=C4)Cl)Cl)C=C2
557;380808689;65;1915269;312387359;72551585;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000209b TMEM97;N-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-1-propan-2-yl-6-[6-(4-propan-2-ylpiperazin-1-yl)pyridin-3-yl]indazole-4-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC1(CC(OC1=O)CCN2CC3CN(CC3C2)C4=CC(=CC=C4)OC)CC
558;380819575;80612;1914439;312361687;59447577;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000262b TMEM97;2-[8-(1,3-Benzothiazol-2-Ylcarbamoyl)-3,4-Dihydroisoquinolin-2(1h)-Yl]-5-(3-{4-[3-(Dimethylamino)prop-1-Yn-1-Yl]-2-Fluorophenoxy}propyl)-1,3-Thiazole-4-Carboxylic Acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1CCCOC2=CC=CC=C2)C3=CC=CC=C3
559;380821095;88982;1914634;440210612;155561913;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000747a TMEM97;Nvs-malt1-C;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@](C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCC[C@H]3CCCN3C
560;380821394;;1915193;440170924;58431184;27346;;Other;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000310b TMEM97;(5R)-5-[(4-cyanophenyl)methyl]-7-(3,5-dichloro-4-fluorophenyl)-5-methyl-6-oxo-N-[(2S)-1-oxo-1-[(1-pyridin-2-ylcyclopropyl)amino]propan-2-yl]imidazo[1,2-a]imidazole-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN(C1)C2=NC=CC=N2)CCC/C(=N/O)/C3=CC=C(C=C3)F
561;380821396;58398;1915220;381872584;121301295;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000264b TMEM97;CFTR corrector 4;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2CC(CC1N2CCCCC3=CC=C(C=C3)F)(C4=CC=C(C=C4)Cl)O
562;380823177;17981;1914521;440174729;137322663;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000320b TMEM97;(R)-6,7-Dimethoxy-2-methyl-N-(1-(4-(2-((methylamino)methyl)phenyl)thiophen-2-yl)ethyl)quinazolin-4-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1NC(=O)C2=CC=C(C=C2)I)CC3=CC=CC=C3
563;380823396;;1914939;442046237;156009445;27346;;Other;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000333a TMEM97;(1,1-dioxo-1,3-thiazolidin-3-yl)-[(3S,5S)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CCCCCNC3=CC(=C(C=C3)[N+](=O)[O-])C(F)(F)F)OC
564;380823400;1705;1914987;461521123;162647678;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000337aCl TMEM97;"1-Methyl-4-(4-piperidin-4-ylphenyl)-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;hydrochloride";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN(C1)C2=NC=CC=N2)CCC/C(=N/O)/C3=CC=C(C=C3)F
565;380823626;574;1915324;374350157;53868701;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000103c TMEM97;N-methyl-2-(4-phenylmethoxypiperidin-1-yl)ethanamine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2CC(CC1N2CCCCC3=CC=C(C=C3)F)(C4=CC=C(C=C4)Cl)O
566;380825538;2195;1913937;440179305;137479135;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000701a TMEM97;1-[4-[[2-[[6-[5-chloro-6-(dimethylamino)pyrimidin-4-yl]-1H-benzimidazol-2-yl]amino]pyridin-4-yl]methyl]piperazin-1-yl]-3,3,3-trifluoropropan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(CC1)C2=CC3=C(CCN(C3)S(=O)(=O)C4=CC(=CC(=C4)Cl)Cl)C=C2
567;380825541;447095;1914037;442046236;156009444;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000707a TMEM97;N-[5-(3,5-dicyano-2,6-dimethyl-1,4-dihydropyridin-4-yl)-1-methylindazol-3-yl]-2-methylbenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(CC1)C2=CC3=C(C=C2)[C@H]4CCN([C@@H]3C4)S(=O)(=O)C5=CC(=CC(=C5)Cl)Cl
568;380826156;98368;1914102;374280463;71623052;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000713a TMEM97;[3-Cyano-5-[[[2,4-dimethyl-5-[6-(3-pyridinyl)-1H-imidazo[1,2-b]pyrazol-1-yl]phenyl]amino]carbonyl]phenyl]pentafluorosulfur;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
569;380826176;959;1914571;461514852;155557564;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000741a TMEM97;Gsi-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2CC(CC1N2CCCSC3=CC=C(C=C3)F)(C4=CC=C(C=C4)Cl)O
570;380826501;63788;1914605;440162068;138973681;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000743a TMEM97;BAY 293 Negative Control;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC1(CC(OC1=O)CCN2CC3CN(CC3C2)C4=CC=NC=C4)CC
571;380826502;525278;1914621;318377030;118430525;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000745a TMEM97;Ipp/cnrs-A019;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2CC(CC1N2CCCSC3=CC=C(C=C3)F)(C4=CC=C(C=C4)Cl)O
572;380826505;15189;1914638;440189837;155553652;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000748a TMEM97;2-[1-(3a,7a-dihydro-1H-imidazo[4,5-b]pyridin-2-ylmethyl)piperidin-4-yl]-4-(1-methylbenzimidazol-2-yl)-1,3-thiazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)C[C@@H]3CS[C@@]4(S3)CCC5=CC=CC=C45.C(=O)(C(=O)O)O
573;380826514;605;1914920;103478702;11386747;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000296b TMEM97;CB1 inverse agonist 1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC2(CC1)CC(OC2=O)CCN3CC4(C3)CN(C4)C5=CC=CC=C5
574;380827229;460045;1914127;381885815;78319901;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000715a TMEM97;MLi-2-Bio-X;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2(CCN(C2)CC3=CC4=C(N3)C=C(C=C4)Cl)CN(C1)CC5=CC(=C(C=C5)F)F
575;380827231;335803;1914146;163327014;45279963;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000717a TMEM97;Skepinone-L;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C(=CC=C3)N4CCNCC4
576;380827378;119234;1915145;381840647;121301422;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000544a TMEM97;CFTR corrector 8;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C(=CC=C3)N4CCNCC4
577;380827538;837144;1914628;440193399;155555047;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000746a TMEM97;4-[4-[[2-(4-Chlorophenyl)-4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-N-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C(=CC=C3)N4CCNCC4
578;380827541;335043;1914661;163339280;49821991;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000751a TMEM97;[2-(6-chloropyridin-3-yl)-4-(2-methoxyethoxy)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl]-imidazo[1,5-a]pyridin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCN1CCN(CC1)C2=CC3=C(CCCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
579;380827764;55765;1915213;440190963;155554081;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000549a TMEM97;(5R)-5-[(4-cyanophenyl)methyl]-N-[1-(3-cyclobutyl-1,2,4-oxadiazol-5-yl)cyclopropyl]-7-(3,5-dichlorophenyl)-5-methyl-6-oxoimidazo[1,2-a]imidazole-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=C3CC(CCC3=NN2C4=CC=CC=C4)NCCC5=CC6=C(C=C5)OCO6
580;380832489;115557;1913915;440175882;145925685;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000305b TMEM97;(R)-1-(4-(1-(2-((6-(6-(Dimethylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-yl)amino)pyridin-4-yl)ethyl)piperazin-1-yl)-3,3,3-trifluoropropan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCN1C2=CC=CC=C2N(C1=O)C(=O)NC3C[C@@H]4CC[C@@H](C3)N4C
581;380832494;212324;1913972;440159327;11996298;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000702a TMEM97;N-methyl-N-[2-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]methyl]pyrimidin-4-yl]methanesulfonamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN(C1)C2=CC=CC=N2)CCCC(=O)C3=CC=C(C=C3)F
582;380832763;83475;1914542;461528587;162652871;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000739a TMEM97;(3S)-3-[4-[3-methoxy-4-(3-methylpyrazol-1-yl)phenyl]triazol-1-yl]-1-(2,2,2-trifluoroethyl)-4,5-dihydro-3H-1-benzazepin-2-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(C1)N2CCN(CC2)C3=CC=CC(=C3)C4COCCN4C(=O)OCC5=CC=CC=C5
583;380832995;3273;1914690;461525770;162650902;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000326a TMEM97;N-[(4-fluorophenyl)methyl]-2-[(3S)-5-(methylcarbamoylamino)-2',4'-dioxospiro[1,2-dihydroindene-3,5'-1,3-oxazolidine]-3'-yl]-N-[(2S)-1,1,1-trifluoropropan-2-yl]acetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)F)O
584;380833007;120322;1914901;461540675;162661374;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000291b TMEM97;[(3S,5S)-3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-3,5-bis(sulfanyl)-5-[4-(trifluoromethoxy)phenyl]piperidin-1-yl]-(1,1-dioxo-1,4-thiazinan-4-yl)methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)F)O
585;380833016;437;1915103;461542924;162662928;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000540a TMEM97;N-pyridazin-3-yl-3-[(E)-3-[6-[5-(trifluoromethyl)pyridin-2-yl]oxypyrazin-2-yl]prop-2-enyl]azetidine-1-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)F)O
586;380833184;194133;1915210;440157481;155540682;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000548a TMEM97;N-[4-(3-chlorophenoxy)-3-sulfamoylphenyl]-1-(2-chlorophenyl)cyclopropane-1-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN(C1)C2=CC=CC=N2)CCCC(=O)C3=CC=C(C=C3)F
587;380833926;111832;1914676;461560318;162675169;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000752a TMEM97;2-(1-((1H-Imidazo[4,5-b]pyridin-2-yl)methyl)piperidin-4-yl)-4-(benzofuran-2-yl)thiazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(CC1)CNC2CCC3(CC2)C4=CC=CC=C4CCO3
588;380834108;43672;1915092;124963756;24771824;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000306b TMEM97;N-pyridazin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methylidene]piperidine-1-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1CCCOC2=CC=CC=C2)C3=CC=C(C=C3)Cl
589;380835828;149108;1914448;404679711;49846946;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000263b TMEM97;Bcl2-IN-1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CC2=C1C=C(C=C2)N3CCOCC3)CC4=CC=CC=C4
590;380835879;;1914413;440207296;155560620;27346;;Other;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000239b TMEM97;Nvs-malt1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1CCCOC2=CC=CC=C2)C3=CC=C(C=C3)Cl
591;380835938;70778;1914609;440159052;155541355;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000744a TMEM97;Thpp-1-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(C1)N2CCN(CC2)C3=CC=CC(=C3)C4COCCN4C(=O)OCC5=CC=CC=C5
592;380836027;2001;1914963;440205039;118877194;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000335a TMEM97;CID 118877194;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC2(CC1)CC(OC2=O)CCN3CC4(C3)CN(C4)C5=CC=NC=C5
593;380836051;48944;1915066;440160912;95882507;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (PRESTO-Tango GPCR-ome screening) EUB0000353a TMEM97;(R)-ZINC-3573;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C=CCN1CCN(CC1)C2=CC3=C(C=C2)[C@H]4CCN([C@@H]3C4)C(=O)OCC5=CC=CC=C5
594;380836056;;1915134;440194870;124203924;27346;;Other;20230629;0;0;Unspecified;Q5BJF2;;;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000251b TMEM97;4-N-[1-[(4-tert-butylphenyl)methyl]-5-methyl-3-(trifluoromethyl)pyrazol-4-yl]-7-fluoroquinoline-2,4-dicarboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC)N2CC3=C(C2)C=C(C=C3)F
595;380836106;48944;1915065;440160912;95882507;27346;;Confirmatory;20230629;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000353a TMEM97;(R)-ZINC-3573;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC)N2CC3=C(C2)C=C(C=C3)F
596;388740094;13;1797293;386051268;118282975;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 23;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC)N2CC3=C(C2)C=C(C=C3)F
597;388740095;25;1797293;386051010;71277004;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCN1CCN([C@@H](C1)CCO)CC2=CC=CC3=CC=CC=C32
598;388740097;21;1797293;386051282;118282836;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 38;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3C(=O)/C=C/C4=CC=CC=C4
599;388740098;68;1797293;386051083;118282951;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 7;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)F
600;388740099;19;1797293;386051289;118282889;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 45;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)F
601;388740101;38;1797293;386051308;118282908;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 63;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)F
602;388740102;11;1797293;386051273;91826734;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 28;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3C(=O)/C=C/C4=CC=CC=C4
603;388740103;52;1797293;386051280;118282888;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 36;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1C2=CC=CC=C2C3(O1)CCC(CC3)NCC4CCCCC4
604;388740105;24;1797293;386051028;71276947;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 3;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC(C1)N2CCN(CC2)C3=CC4=C(CCN(C4)C(=O)OCC5=CC=CC=C5)C=C3
605;388740106;17;1797293;386051297;118282885;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 53;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC2(CC1)CC(OC2=O)CCN3CC4CN(CC4C3)C5=CC=NC=C5
606;388740107;62;1797293;386051286;118282881;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 42;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(CC1)CN2CCN([C@@H](C2)CCO)CC3=CC=C(C=C3)C4=CC=CC=C4
607;388740109;5;1797293;386051125;118282972;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 10;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN(C1)C2=NC=CC=N2)CCCC(=O)C3=CC=C(C=C3)F
608;388740211;67;1797293;386051265;118282824;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 20;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC=C(C=C1)CN2CCC[C@@H](C2)OCC3=CC(=C(C=C3)OC)F
609;388740215;36;1797293;386051085;118282963;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 9;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=C(C2)C(=CC=C3)F
610;388740219;18;1797293;386051238;118282967;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';Isoindoline derivative 3;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=C(C2)C(=CC=C3)F
611;388740220;27;1797293;386051076;71276955;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 5;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=C(C2)C(=CC=C3)F
612;388740223;11;1797293;386051270;118282850;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 25;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1[C@@H]2CC3=CC=CC=C3[C@@]1(CCN2CCN4CCCC4)C
613;388740225;32;1797293;386051277;118282880;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 33;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1CCCCC2=CC=C(C=C2)F)C3=NC=C(C=C3)Cl
614;388740248;22;1797293;386051067;71276953;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 4;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1CCCCC2=CC=C(C=C2)F)C3=NC=C(C=C3)Cl
615;388740249;53;1797293;386051278;118282831;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 34;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(CC1)CN2CCN([C@H](C2)CCO)CC3=CC=C(C=C3)C4=CC=CC=C4
616;388740251;37;1797293;386051294;118282887;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 50;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=CC=C1Cl)NC(=O)CN2CCC3(C2)CCCN3CC4=CC(=C(C=C4)F)F
617;388740252;69;1797293;386051306;118282978;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 61;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN(C1)C2=NC=CC=N2)CCCC(=O)C3=CC=C(C=C3)F
618;388740253;15;1797293;386051147;118282959;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 18;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCN(C/C=C\C1=CC(=C(C=C1)C2CCCCC2)Cl)C3CCCCC3
619;388740254;14;1797293;386051322;118283022;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 80;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=CC(=C1)NC(=O)CN2CCC3(C2)CCCN(C3)CC4=CC(=C(C=C4)F)F)F
620;388740255;13;1797293;386051274;118282878;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 29;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCOC1CC2=CC=CC=C2C3(O1)CCC(CC3)NCC4CCCCC4
621;388740256;14;1797293;386051281;118282962;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 37;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC2=CC=CC=C2O1)CC3=CC(=C(C=C3)OC)OC
622;388740257;79;1797293;386051084;118282956;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 8;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=CC(=C1)NC(=O)CN2CCC3(C2)CCCN3CC4=CC(=C(C=C4)F)F)F
623;388740258;23;1797293;386051267;118282970;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 22;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC(=CC(=C1)Cl)Cl)CC2=CC=CC=C2
624;388740259;31;1797293;386051299;118282977;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 55;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)NCC2=CC=C(C=C2)C(F)(F)F
625;388740260;25;1797293;386051293;118283107;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 49;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC(=CC(=C1)Cl)Cl)CC2=CC=CC=C2
626;388740261;41;1797293;386051271;118282827;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 26;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCCC1=CC=C(C=C1)C(=O)NCCCN(C)CC2=CC=CC=C2
627;388740262;100;1797293;386051320;118283021;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 78;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCCC1=CC=C(C=C1)C(=O)NCCCN(C)CC2=CC=CC=C2
628;388740380;52;1797293;386051269;118282826;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 24;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC=C(C=C1)Cl)NCC2=CC=C(C=C2)C(F)(F)F
629;388740384;100;1797293;386051323;118283077;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 81;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCN(CC1)C2=CC3=C(CCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
630;388740385;100;1797293;386051318;118282845;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;>;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 75;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=CC=CC=N3
631;388740386;22;1797293;386051292;118282882;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 48;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1N2C[C@H]3[C@H](C2)OCC4=C(N=NN34)C5=C(C=C(C=C5)F)Cl
632;388740408;19;1797293;386051310;118282842;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 65;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(C(C1)C2=CC(=CC=C2)N3CCN(CC3)CCCO)C(=O)OCC4=CC=CC=C4
633;388740409;85;1797293;386051307;118278088;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';Sigma-2 receptor antagonist 1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1CCCCC2=CC=C(C=C2)F)C3=CC=C(C=C3)Cl
634;388740411;76;1797293;386051339;118282811;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 104;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=CC=CC=N3
635;388740412;14;1797293;386051288;118282886;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 44;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(C(C1)C2=CC(=CC=C2)N3CCN(CC3)CCCO)C(=O)OCC4=CC=CC=C4
636;388740413;100;1797293;386051300;118278067;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 56;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=CC4=C(C=C3C2)OCO4
637;388740415;58;1797293;386051276;118282976;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 31;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=CC4=C(C=C3C2)OCO4
638;388740416;76;1797293;386051314;118282901;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 69;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=CC4=C(C=C3C2)OCO4
639;388740417;8;1797293;386051295;118282906;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 51;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(CC1)C2=CC3=C(CCCN(C3)S(=O)(=O)C4=CC(=CC(=C4)Cl)Cl)C=C2
640;388740419;100;1797293;386051342;118282815;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 107;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC1(CC(OC1=O)CCN2CC3(C2)CN(C3)C4=CC=CC=C4)CC
641;388740422;21;1797293;386051283;118282961;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 39;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(CC1)C2=CC=CC3=C2CN(CC3)C(=O)OCC4=CC=CC=C4
642;388740467;44;1797293;386051128;118282969;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';Isoindoline derivative 2;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)C)O
643;388740468;81;1797293;386051312;118282942;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 67;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)C)O
644;388740470;13;1797293;386051330;118282855;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 88;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)C)O
645;388740471;71;1797293;386051272;118282877;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 27;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=CC(=C1)C2=CC3=C(CN(CC3)CC4=CC=CC=C4)C=C2
646;388740475;36;1797293;386051279;118282879;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 35;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)F
647;388740476;100;1797293;386051326;118283024;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 84;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)F
648;388740477;36;1797293;386051327;118283004;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 85;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)F
649;388740478;1;1797293;386051331;118283078;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 95;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC(=C(C=C1)Cl)Cl)CC2=CC=CC=C2
650;388740479;54;1797293;386051296;118282902;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 52;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC1(CC(OC1=O)CCN2CC3(C2)CN(C3)C4=CC=NC=C4)CC
651;388740480;100;1797293;386051335;118282847;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 100;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC(=C(C=C1)Cl)Cl)CC2=CC=CC=C2
652;388740481;26;1797293;386051319;118278079;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';Isoindoline derivative 1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN[C@@]1(CCCC[C@@H]1NCCCN2CCCC2)C3=CC=CC=C3Cl
653;388740565;100;1797293;386051324;118283000;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 82;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@]1(SC[C@@H](S1)CN2CCC(CC2)CC3=CC=CC=C3)C4=CC=CC=C4.C(=O)(C(=O)O)O
654;388740566;12;1797293;386051266;118282965;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 21;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3S(=O)(=O)C4=CC(=CC(=C4)Cl)Cl
655;388740567;100;1797293;386051333;118282860;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 98;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3S(=O)(=O)C4=CC(=CC(=C4)Cl)Cl
656;388740568;76;1797293;386051305;118282907;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 60B;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCCN(CC1)CCCN2C3=C(C=CC(=C3)Cl)OC2=O
657;388740569;16;1797293;386051304;118282905;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 60A;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)C[C@H]3CS[C@@]4(S3)CCC5=CC=CC=C45.C(=O)(C(=O)O)O
658;388740570;89;1797293;386051284;118282964;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 40;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCC1=C(C(=O)NC(=C1)C)CNC(=O)C2=C3C=NN(C3=CC(=C2)C4=CN=C(C=C4)N5CCN(CC5)C(C)C)C(C)C
659;388740571;11;1797293;386051336;118282849;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 101;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=CC(=C1)C2=CC3=C(CN(C3)CC4=CC=CC=C4)C=C2
660;388740572;9;1797293;386051315;118283052;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 70;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=CC(=C(C=C3C2)OC)OC
661;388740573;16;1797293;386051290;118282904;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 46;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=CC(=C(C=C3C2)OC)OC
662;388740576;18;1797293;386051337;118282800;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 102;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=CC(=C(C=C3C2)OC)OC
663;388740580;31;1797293;386051344;118282805;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 109;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCCN(CC1)CCCN2C3=C(C=CC(=C3)Cl)SC2=O
664;388740622;11;1797293;386051329;118282867;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 87;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CCCCCNC(=O)C3=CC=C(C=C3)CO[N+](=O)[O-]
665;388740624;100;1797293;386051325;123982988;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 83;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)Cl)F)CC3=CC4=C(C=C3)N=CN4
666;388740626;91;1797293;386051275;118282966;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 30;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3CSC4(S3)C5=CC=CC=C5C6=CC=CC=C46.C(=O)(C(=O)O)O
667;388740628;18;1797293;386051298;118282883;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 54;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)F)O
668;388740629;38;1797293;386051285;118282835;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 41;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)F)O
669;388740630;18;1797293;386051340;118282812;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 105;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)F)O
670;388740631;32;1797293;386051302;118282837;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 58;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(CC1)C2=CC3=C(C=C2)[C@H]4CCN([C@@H]3C4)C(=O)OCC5=CC=CC=C5
671;388740632;57;1797293;386051303;118282980;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 59;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1OCC2=CC(=CC=C2)C(F)(F)F)CC3=CC4=C(C=C3)N=CN4
672;388740633;4;1797293;386051313;118282843;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 68;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CCCCNC(=O)C3=CC=CC(=C3)CO[N+](=O)[O-]
673;388740634;24;1797293;386051341;118282813;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 106;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3C(=O)OCC4=CC(=CC(=C4)Cl)Cl
674;388740635;14;1797293;386051291;118283044;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 47;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3C(=O)OCC4=CC(=CC(=C4)Cl)Cl
675;388740701;14;1797293;386051316;118282903;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 73;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
676;388740702;14;1797293;386051287;118282968;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 43;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)(C)C)N2CC3=C(C2)C(=CC=C3)F
677;388740703;46;1797293;386051321;118283019;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 79;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
678;388740704;14;1797293;386051338;118282911;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 103;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)(C)C)N2CC3=C(C2)C(=CC=C3)F
679;388740705;66;1797293;386051332;118282857;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 96;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
680;388740708;86;1797293;386051309;118278087;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 64;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)(C)C)N2CC3=C(C2)C(=CC=C3)F
681;388740709;100;1797293;386051328;118282913;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 86;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC=C(C=C1)CN2CCC[C@@H](C2)OCC3=CC(=C(C=C3)F)C
682;388740710;95;1797293;386051301;118282979;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 57;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CCNC3=CC(=C(C=C3)[N+](=O)[O-])C(F)(F)F
683;388740711;74;1797293;386051346;118282806;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 111;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCN(CC1)C2=CC3=C(CN(C3)C(=O)OCC4=CC=CC=C4)C=C2
684;388740714;26;1797293;386051311;118283049;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 66;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)F
685;388740715;55;1797293;386051317;118282884;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 74;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCNC(C1)C2=CC(=CC=C2)C3COCCN3C(=O)OCC4=CC=CC=C4
686;388740716;12;1797293;386051334;118282848;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 99;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)F
687;388743923;15;1797293;386051343;118282810;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 108;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)F
688;388743924;100;1797293;386051345;118282802;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 110;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)F
689;388878707;25;1797475;386051010;71277004;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@]12CN(C3=C([C@@H]1CCN2)C=C(C=C3)Br)C4=CC=C(C=C4)Br
690;388878822;13;1797475;386051268;118282975;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 23;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@]12COC3=C([C@@H]1CCN2)C=C(C=C3)C4=CC=CC=C4
691;388878823;21;1797475;386051282;118282836;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 38;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCNC(C1)C2=CC(=CC=C2)C3COCCN3C(=O)OCC4=CC=CC=C4
692;388878825;19;1797475;386051289;118282889;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 45;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2=C(CN(C1)CC3=CC=CC=C3)C=CC(=C2)N4CCOCC4
693;388878826;17;1797475;386051297;118282885;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 53;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
694;388878827;5;1797475;386051125;118282972;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 10;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCOC(=O)CCN1CCN(CC1)C2=CC3=C(CCCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
695;388878829;52;1797475;386051280;118282888;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 36;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
696;388878830;11;1797475;386051273;91826734;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 28;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@]1(SC[C@H](S1)CN2CCC(CC2)CC3=CC=CC=C3)C4=CC=CC=C4.C(=O)(C(=O)O)O
697;388878831;24;1797475;386051028;71276947;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 3;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCN1CCN(CC1)C2=CC3=C(CCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
698;388878833;62;1797475;386051286;118282881;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 42;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CC2=C1C=CC(=C2)N3CCOCC3)CC4=CC(=CC(=C4)Cl)Cl
699;388878834;68;1797475;386051083;118282951;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 7;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCCN(CC1)CCSC2=NC3=C(O2)C=CC(=C3)Cl
700;388878835;38;1797475;386051308;118282908;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 63;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2=CC=CC=C2[C@@]3(C1)SC[C@H](S3)CN4CCC(CC4)CC5=CC=CC=C5.C(=O)(C(=O)O)O
701;388878944;53;1797475;386051278;118282831;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 34;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CCCCNC(=O)C3=CC=C(C=C3)CO[N+](=O)[O-]
702;388878948;11;1797475;386051270;118282850;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 25;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCN1C2=CC3=C(CN(C3)CC4=CC(=CC(=C4)Cl)Cl)C=C2
703;388878951;27;1797475;386051076;71276955;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 5;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCOC(=O)CCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3C(=O)OCC4=CC=CC=C4
704;388878952;71;1797475;386051272;118282877;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 27;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1CC2CSCS2)CC3=CC=CC=C3.C(=O)(C(=O)O)O.C(=O)(C(=O)O)O
705;388878956;36;1797475;386051085;118282963;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 9;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCOC(=O)CCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3C(=O)OCC4=CC=CC=C4
706;388878957;22;1797475;386051067;71276953;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 4;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC[C@H]1C[C@@H]2C[C@@H]3[C@H]1N(C2)CCC4=C3NC5=C4C=C(C=C5)OC
707;388878958;32;1797475;386051277;118282880;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 33;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCOC1CC2=CC=CC=C2C3(O1)CCC(CC3)N(C)CC4CCCCC4
708;388878960;67;1797475;386051265;118282824;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 20;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CCCNC(=O)C3=CC=CC(=C3)CO[N+](=O)[O-]
709;388878961;69;1797475;386051306;118282978;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 61;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2=CC=CC=C2[C@]3(C1)SC[C@H](S3)CN4CCC(CC4)CC5=CC=CC=C5.C(=O)(C(=O)O)O
710;388879030;31;1797475;386051299;118282977;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 55;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F
711;388879031;100;1797475;386051320;118283021;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 78;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNCC1=CC=C(C=C1)Cl)CC2=CC=CC=C2
712;388879032;41;1797475;386051271;118282827;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 26;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)C
713;388879033;14;1797475;386051281;118282962;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 37;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)C
714;388879034;13;1797475;386051274;118282878;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 29;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)C
715;388879035;23;1797475;386051267;118282970;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 22;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(CC1)C2=CC3=C(CN(C3)S(=O)(=O)C4=CC(=CC(=C4)Cl)Cl)C=C2
716;388879036;79;1797475;386051084;118282956;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 8;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F
717;388879037;25;1797475;386051293;118283107;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 49;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)C(F)(F)F)CC2=CC=CC=C2
718;388879038;37;1797475;386051294;118282887;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 50;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN[C@@]1(CCCC[C@@H]1NCCCN2CCN(CC2)C)C3=CC=CC=C3Cl
719;388879039;14;1797475;386051322;118283022;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 80;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)C(F)(F)F)CC2=CC=CC=C2
720;388879040;15;1797475;386051147;118282959;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 18;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@]12COC3=C([C@@H]1CCN2)C=CC(=C3)OCC4=CC=CC=C4
721;388879195;52;1797475;386051269;118282826;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 24;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCCC4=CC=C(C=C4)F)C5=CC=CC=C5
722;388879199;100;1797475;386051323;118283077;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 81;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2C=C3C=CC(=CC3=C2)S(=O)(=O)C)O
723;388879201;22;1797475;386051292;118282882;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 48;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2C=C3C=CC(=CC3=C2)S(=O)(=O)C)O
724;388879202;100;1797475;386051318;118282845;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;>;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 75;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2C=C3C=CC(=CC3=C2)S(=O)(=O)C)O
725;388879205;85;1797475;386051307;118278088;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';Sigma-2 receptor antagonist 1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC2=CC=CC=C2C=C1)CC3=CC=CC=C3
726;388879206;76;1797475;386051314;118282901;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 69;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC[C@]2(C3=CC=CC=C3C1)SC[C@H](S2)CN4CCC(CC4)CC5=CC=CC=C5.C(=O)(C(=O)O)O
727;388879207;76;1797475;386051339;118282811;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 104;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCNC(=O)C1=C(C(=CC=C1)Cl)Cl)CC2=CC=CC=C2
728;388879209;100;1797475;386051300;118278067;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 56;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=CC4=C(C=C3C2)OCO4
729;388879255;14;1797475;386051288;118282886;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 44;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=CC4=C(C=C3C2)OCO4
730;388879256;58;1797475;386051276;118282976;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 31;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=CC4=C(C=C3C2)OCO4
731;388879258;8;1797475;386051295;118282906;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 51;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCNC(=O)C1=C(C=C(C=C1)Cl)Cl)CC2=CC=CC=C2
732;388879259;19;1797475;386051310;118282842;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 65;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CCNC4=CC=CC=C4)C)C=C(C=C3)O
733;388879260;100;1797475;386051342;118282815;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 107;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC(C2=C(C1)N(N=C2)C3=CC=CC=C3)CCN4CCOCC4
734;388879265;54;1797475;386051296;118282902;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 52;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CCN4CCCCC4)C)C=C(C=C3)O
735;388879268;81;1797475;386051312;118282942;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 67;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](CCC1=CC(=C(C=C1)Cl)Cl)NCC2=CC=C(C=C2)C(F)(F)F
736;388879269;36;1797475;386051279;118282879;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 35;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=CC=C1Cl)NC(=O)CN2CCC3(CCCN3CC4=CC(=C(C=C4)F)F)CC2
737;388879270;13;1797475;386051330;118282855;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 88;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=CC(=C1)CO[C@H]2CCCN(C2)CC3=CC(=C(C=C3)OC)F)F
738;388879394;91;1797475;386051275;118282966;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 30;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=CC(=C1)NC(=O)CN2CCC(CC2)OCC3=CC(=C(C=C3)F)F)F
739;388879397;100;1797475;386051326;118283024;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 84;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CCN(C)C4=CC=CC=C4)C)C=C(C=C3)O
740;388879398;44;1797475;386051128;118282969;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';Isoindoline derivative 2;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@]12COC3=C(C=CC=C3[C@@H]1CCN2)C4=CC=CC=C4
741;388879399;1;1797475;386051331;118283078;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 95;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=C3CC(CCC3=NN2C4=CC=CC=C4)NCC5=CC=CC=C5
742;388879400;36;1797475;386051327;118283004;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 85;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1CCN2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=C(C=C(C=C5)F)F
743;388879401;100;1797475;386051335;118282847;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 100;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC2=CC=CC=C2C=C1)CC3=CC(=C(C=C3)OC)OC
744;388879402;21;1797475;386051283;118282961;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 39;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC=C(C=C1)C(=O)NCCCCN2CCC(CC2)CC3=CC=CC=C3
745;388879403;100;1797475;386051324;118283000;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 82;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(CC1)C2=CC3=C(CCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
746;388879404;9;1797475;386051315;118283052;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 70;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1[C@@H]2CC3=CC=CC=C3[C@@]1(CCN2CCN4CCCCC4)C
747;388879405;100;1797475;386051333;118282860;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 98;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1N2C[C@H]3[C@H](C2)OCC4=C(N=NN34)C5=CC=C(C=C5)C(F)(F)F
748;388879406;16;1797475;386051290;118282904;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 46;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCOC(=O)CCN1CCN(CC1)C2=CC3=C(CN(C3)C(=O)OCC4=CC=CC=C4)C=C2
749;388879407;16;1797475;386051304;118282905;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 60A;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=C)CN1CCN(CC1)C2=CC3=C(CN(CC3)C(=O)OCC4=CC=CC=C4)C=C2
750;388879408;76;1797475;386051305;118282907;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 60B;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=CC=C1C(=O)NCC2=CC=CC=C2CN3CCC4=CC(=C(C=C4C3)O)OC
751;388879409;11;1797475;386051336;118282849;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 101;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=C(C2)C=C(C=C3)F
752;388879410;89;1797475;386051284;118282964;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 40;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C(=CC=C3)F
753;388879445;26;1797475;386051319;118278079;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';Isoindoline derivative 1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=CC4=C(C=C3C2)OCO4
754;388879446;18;1797475;386052629;129155673;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';2-[(2R)-4-(3,4-dichlorophenyl)butan-2-yl]-1,3-dihydrobenzo[e]isoindole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)F
755;388879447;12;1797475;386051266;118282965;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 21;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)F
756;388879450;18;1797475;386051337;118282800;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 102;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=C(C2)C=C(C=C3)F
757;388879453;18;1797475;386051340;118282812;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 105;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C(=CC=C3)F
758;388879454;31;1797475;386051344;118282805;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 109;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=CC4=C(C=C3C2)OCO4
759;388879456;11;1797475;386051329;118282867;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 87;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)F
760;388879458;100;1797475;386051325;123982988;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 83;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)F
761;388879460;24;1797475;386051341;118282813;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 106;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=C(C2)C=C(C=C3)F
762;388879462;57;1797475;386051303;118282980;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 59;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C(=CC=C3)F
763;388879568;32;1797475;386051302;118282837;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 58;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=CC4=C(C=C3C2)OCO4
764;388879569;18;1797475;386051298;118282883;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 54;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)F
765;388879570;38;1797475;386051285;118282835;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 41;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)F
766;388879572;14;1797475;386051291;118283044;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 47;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CCCCCNC(=O)C3=CC=CC(=C3)CO[N+](=O)[O-]
767;388879574;4;1797475;386051313;118282843;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 68;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1[C@@H]2CC3=CC=CC=C3[C@@]1(CCN2CCNC4=CC=CC=C4)C
768;388879575;46;1797475;386051321;118283019;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 79;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCC(=O)N(CC1=CC=C(C=C1)F)C2CCN(CC2)CCC3=CC=CC=C3
769;388879577;14;1797475;386051316;118282903;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 73;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(CC1)C2=CC3=C(CCCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
770;388879580;14;1797475;386051338;118282911;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 103;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CCN4CCCCCC4)C)C=C(C=C3)O
771;388879581;66;1797475;386051332;118282857;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 96;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C2=CC=CC=C2N=C1C3=CSC(=N3)C4CCN(CC4)CC5=NC6C(N5)C=CC=N6
772;388879582;14;1797475;386051287;118282968;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 43;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C2=CC=CC=C2N=C1C3=CSC(=N3)C4CCN(CC4)CC5=NC6C(N5)C=CC=N6
773;388879583;100;1797475;386051328;118282913;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 86;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C2=CC=CC=C2N=C1C3=CSC(=N3)C4CCN(CC4)CC5=NC6C(N5)C=CC=N6
774;388879584;86;1797475;386051309;118278087;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 64;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC2=C(CN3CCC(=C)C[C@@]34[C@@H]2CCCC4)C=C1
775;388879585;74;1797475;386051346;118282806;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 111;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=C)CN1CCN(CC1)C2=CC3=C(CN(C3)C(=O)OCC4=CC=CC=C4)C=C2
776;388886601;95;1797475;386051301;118282979;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 57;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)F
777;388886602;26;1797475;386051311;118283049;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 66;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1[C@@H]2CC3=CC=CC=C3[C@@]1(CCN2CCN(C)C4=CC=CC=C4)C
778;388886604;12;1797475;386051334;118282848;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 99;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC[C@]2(C3=CC=CC=C3C1)SC[C@@H](S2)CN4CCC(CC4)CC5=CC=CC=C5.C(=O)(C(=O)O)O
779;388886605;55;1797475;386051317;118282884;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 74;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@]12CN(C3=CC=CC=C3[C@@H]1CCN2C)C4=CC=CC=C4
780;388886606;15;1797475;386051343;118282810;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 108;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=C3CC(CCC3=NN2C4=CC=CC=C4)NCC5=CC=C(C=C5)F
781;388886607;100;1797475;386051345;118282802;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 110;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C=CCN1CCN(CC1)C2=CC3=C(CCCN(C3)S(=O)(=O)C4=CC(=CC(=C4)Cl)Cl)C=C2
782;389383354;19;1804286;386051289;118282889;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 45;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCC1=CC=C(C=C1)C(=O)NCCCN(C)CC2=CC=CC=C2
783;389383355;11;1804286;386051273;91826734;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 28;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)Br)CC2=CC=CC=C2
784;389383356;24;1804286;386051028;71276947;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 3;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C=C(C=C3)F
785;389383358;52;1804286;386051280;118282888;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 36;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C=C(C=C3)F
786;389383359;68;1804286;386051083;118282951;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 7;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C=C(C=C3)F
787;389383360;5;1804286;386051125;118282972;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 10;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCC1=CC=C(C=C1)C(=O)NCCCN(C)CC2=CC=CC=C2
788;389383362;62;1804286;386051286;118282881;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 42;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)Br)CC2=CC=CC=C2
789;389383363;13;1804286;386051268;118282975;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 23;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCN1C2=CC3=C(CN(C3)CC4=CC=CC=C4)C=C2
790;389383364;21;1804286;386051282;118282836;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 38;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)F)F)CC3=CC4=C(C=C3)N=CN4
791;389383366;25;1804286;386051010;71277004;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCC(=O)NC1=CC=C(C=C1)Cl)CC2=CC=CC=C2
792;389383367;17;1804286;386051297;118282885;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 53;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCNC(=O)C1=CC=C(C=C1)C#N)CC2=CC=CC=C2
793;389383431;38;1804286;386051308;118282908;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 63;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCNC(=O)C1=CC=C(C=C1)C#N)CC2=CC=CC=C2
794;389383436;18;1804286;386051238;118282967;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';Isoindoline derivative 3;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN(CCC)CCC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2
795;389383440;11;1804286;386051270;118282850;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 25;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NC2=CC(=C(C=C2C(=N1)N[C@H](C)C3=CC(=CS3)C4=CC=CC=C4CNC)OC)OC
796;389383443;27;1804286;386051076;71276955;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 5;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=C)CN1CCN(CC1)C2=CC3=C(CN(CCC3)C(=O)OCC4=CC=CC=C4)C=C2
797;389383444;67;1804286;386051265;118282824;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 20;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NC2=CC(=C(C=C2C(=N1)N[C@H](C)C3=CC(=CS3)C4=CC=CC=C4CNC)OC)OC
798;389383528;15;1804286;386051147;118282959;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 18;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NC2=CC(=C(C=C2C(=N1)N[C@H](C)C3=CC(=CS3)C4=CC=CC=C4CNC)OC)OC
799;389383529;69;1804286;386051306;118282978;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 61;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)Cl)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
800;389383530;13;1804286;386051274;118282878;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 29;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)Cl)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
801;389383532;79;1804286;386051084;118282956;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 8;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)Cl)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
802;389383533;14;1804286;386051281;118282962;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 37;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1(OCC(O1)CN2CCN(CC2)CC3=CC=CC=C3)C.C(=O)(C(=O)O)O.C(=O)(C(=O)O)O
803;389383534;37;1804286;386051294;118282887;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 50;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)Cl)CC2=CC=CC=C2
804;389383535;100;1804286;386051320;118283021;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 78;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1NC(=O)C2=CC=C(C=C2)F)CC3=CC=CC=C3
805;389383536;41;1804286;386051271;118282827;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 26;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C=C(C=C3)F
806;389383537;25;1804286;386051293;118283107;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 49;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C
807;389383538;32;1804286;386051277;118282880;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 33;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C=C(C=C3)F
808;389383539;23;1804286;386051267;118282970;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 22;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C
809;389383540;53;1804286;386051278;118282831;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 34;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C=C(C=C3)F
810;389383541;22;1804286;386051067;71276953;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 4;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C
811;389383542;31;1804286;386051299;118282977;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 55;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)Cl)CC2=CC=CC=C2
812;389383543;14;1804286;386051322;118283022;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 80;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCOC(=O)CCN1CCN(CC1)C2=CC3=C(CCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
813;389383544;36;1804286;386051085;118282963;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 9;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCN1CCCNC(=O)C2=CC=C(C=C2)Cl
814;389383660;52;1804286;386051269;118282826;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 24;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=C(C=C(C=C1)Br)F)CC2=CC=CC=C2
815;389383664;100;1804286;386051323;118283077;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 81;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(C1)CCNC(=O)C2=CC=C(C=C2)Cl
816;389383666;85;1804286;386051307;118278088;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';Sigma-2 receptor antagonist 1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl
817;389383743;14;1804286;386051288;118282886;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 44;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)C1=CC=C(C=C1)C(=O)NCCCN(C)CC2=CC=CC=C2
818;389383746;100;1804286;386051300;118278067;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 56;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(CC1)CCCNC(=O)C2=CC=C(C=C2)Cl
819;389383747;19;1804286;386051310;118282842;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 65;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(CC1)CCNC(=O)C2=CC=C(C=C2)Cl
820;389383748;76;1804286;386051339;118282811;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 104;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNS(=O)(=O)C1=CC=C(C=C1)Cl)CC2=CC=CC=C2
821;389383750;8;1804286;386051295;118282906;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 51;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)Cl)CCC2=CC=CC=C2
822;389383751;100;1804286;386051318;118282845;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;>;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 75;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(C1)CCCNC(=O)C2=CC=C(C=C2)Cl
823;389383752;58;1804286;386051276;118282976;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 31;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)Cl)CCC2=CC=CC=C2
824;389383754;22;1804286;386051292;118282882;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 48;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCN(CC)CCNC(=O)C1=CC(=C(C=C1)OC)[123I]
825;389383755;76;1804286;386051314;118282901;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 69;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=CC(=C1)CO[C@@H]2CCCN(C2)CC3=CC(=C(C=C3)OC)F)F
826;389383756;100;1804286;386051342;118282815;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 107;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
827;389383761;71;1804286;386051272;118282877;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 27;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C(C=C1)CC[C@H](C2=CC(=CC=C2)OCCN3CCOCC3)OC(=O)[C@@H]4CCCCN4C(=O)[C@@H](C5CCCCC5)C6=CC(=C(C(=C6)OC)OC)OC)OC
828;389383764;81;1804286;386051312;118282942;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 67;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1CC2=CC=CC=C2C3(O1)CCC(CC3)NCC4=CC=CC=C4
829;389383765;36;1804286;386051279;118282879;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 35;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CCCNC(=O)C3=CC=C(C=C3)CO[N+](=O)[O-]
830;389383769;21;1804286;386051283;118282961;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 39;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1CC2=CC3=C(C=C2)NC(=O)CO3)C4=CC=C(C=C4)Cl
831;389383770;13;1804286;386051330;118282855;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 88;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C=CCN1CCN(CC1)C2=CC3=C(CN(CC3)C(=O)OCC4=CC=CC=C4)C=C2
832;389383772;100;1804286;386051326;118283024;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 84;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC=CC=C1CO[C@H]2CCCN(C2)CC3=CC4=C(C=C3)N(N=C4)C
833;389383773;12;1804286;386051266;118282965;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 21;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CC3=CC=CC=C3CNC(=O)C4=CC(=CC=C4)Cl)O
834;389383774;100;1804286;386051324;118283000;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 82;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=CC(=C(C=C3C2)Cl)Cl
835;389383775;76;1804286;386051305;118282907;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 60B;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
836;389383776;100;1804286;386051335;118282847;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 100;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=CC(=C(C=C3C2)Cl)Cl
837;389383797;89;1804286;386051284;118282964;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 40;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
838;389383798;1;1804286;386051331;118283078;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 95;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=CC(=C(C=C3C2)Cl)Cl
839;389383799;26;1804286;386051319;118278079;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';Isoindoline derivative 1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
840;389383800;16;1804286;386051304;118282905;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 60A;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC(CCC1N2C=NC3=C(C2=N)C(=C(N3CC4=CC=CC=C4)C5=CC=CC=C5)C6=CC=CC=C6)O
841;389383801;16;1804286;386051290;118282904;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 46;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC=C(C=C1)CO[C@H]2CCCN(C2)CC3=CC=C(C=C3)C#N
842;389383802;100;1804286;386051333;118282860;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 98;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CC1NCC2=CC(=CC=C2)C(=O)N)C3=CC(=C(C=C3)F)Cl
843;389383803;36;1804286;386051327;118283004;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 85;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1C2=C(CC(CC2)NCCC3=CC=C(C=C3)O)C(=N1)C(=O)N4CCCCC4
844;389383804;11;1804286;386051336;118282849;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 101;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=C3CC(CCC3=NN2C4=CC=C(C=C4)F)NCCC5=CC=NC=C5
845;389383805;54;1804286;386051296;118282902;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 52;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=C3CC(CCC3=NN2C4=CC=C(C=C4)O)NCCC5=CC=CC=C5
846;389383806;9;1804286;386051315;118283052;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 70;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)N(C)C
847;389383807;44;1804286;386051128;118282969;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';Isoindoline derivative 2;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CCN4CCCC4)C)C=C(C=C3)O
848;389383810;18;1804286;386051337;118282800;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 102;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C=CCN1CCN(CC1)C2=CC3=C(CN(CCC3)C(=O)OCC4=CC=CC=C4)C=C2
849;389383873;31;1804286;386051344;118282805;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 109;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1NC(=O)C2=CC=C(C=C2)CO[N+](=O)[O-])CC3=CC=CC=C3
850;389383875;100;1804286;386051325;123982988;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 83;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CCCCNC(=O)C3=CC=C(C=C3)C#N)O
851;389383876;91;1804286;386051275;118282966;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 30;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CC3=CC=CC=C3CNC(=O)C4=CC(=CC=C4)Br)O
852;389383877;11;1804286;386051329;118282867;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 87;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=CC=C1Cl)NC(=O)CN2CCC(CC2)OCC3=CC(=C(C=C3)F)F
853;389383881;18;1804286;386051340;118282812;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 105;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CCN4CCOCC4)C)C=C(C=C3)O
854;389383882;32;1804286;386051302;118282837;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 58;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN[C@]1(CCCCC1NCCCN2CCCC2)C3=CC=CC=C3Cl
855;389383883;18;1804286;386051298;118282883;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 54;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=C(C(=CC=C1)Cl)Cl)CC2=CC=CC=C2
856;389383884;4;1804286;386051313;118282843;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 68;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C=CC(=C3C2)F)F
857;389383885;24;1804286;386051341;118282813;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 106;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C=CC(=C3C2)F)F
858;389383886;14;1804286;386051291;118283044;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 47;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C=CC(=C3C2)F)F
859;389383887;57;1804286;386051303;118282980;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 59;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=C(C(=CC=C1)Cl)Cl)CC2=CC=CC=C2
860;389383888;38;1804286;386051285;118282835;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 41;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=C(C=C(C=C1)Cl)Cl)CC2=CC=CC=C2
861;389383938;14;1804286;386051316;118282903;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 73;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC[C@H]1C2=C(C3=CC=CC=C3C=C2)OC[C@@]1(C)N
862;389383939;14;1804286;386051338;118282911;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 103;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC=C(C=C1)N2C[C@@]3([C@@H](CCN3)C4=C2C=CC(=C4)C)C
863;389383940;46;1804286;386051321;118283019;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 79;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC[C@H]1C2=C(C=CC(=C2)C3=CC=CC=C3)OC[C@@]1(C)N
864;389383941;14;1804286;386051287;118282968;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 43;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@]12COC3=C(C=CC=C3[C@@H]1CCN2C)C4=CC=CC=C4
865;389383942;66;1804286;386051332;118282857;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 96;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=C2[C@@H]3CCN[C@@]3(COC2=C1)C)C
866;389383943;86;1804286;386051309;118278087;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 64;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCCC4=CC5=C(C=C4)OCO5)C6=CC=CC=C6
867;389383946;100;1804286;386051328;118282913;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 86;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)CO[N+](=O)[O-])CC3=CC=CC=C3
868;389383948;74;1804286;386051346;118282806;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 111;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)C1=CC=CC(=C1)C(=O)NCCCN(C)CC2=CC=CC=C2
869;389383949;95;1804286;386051301;118282979;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 57;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CCNC(=O)C3=CC=CC(=C3)CO[N+](=O)[O-]
870;389383950;26;1804286;386051311;118283049;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 66;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC(=CC=C1)Cl)CC2=CC=CC=C2
871;389383972;12;1804286;386051334;118282848;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 99;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC(=CC=C1)Cl)CC2=CC=CC=C2
872;389383973;55;1804286;386051317;118282884;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 74;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC(C1)C(C2CCC2)NC3=C4C(=NC(=N3)Cl)N(C=N4)[C@@H]5[C@H]6C[C@]6([C@H]([C@H]5O)O)CCl
873;389383974;15;1804286;386051343;118282810;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 108;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1C2=CC=CC=C2CN1CCCNC(=O)C3=CC=C(C=C3)Cl
874;389383975;100;1804286;386051345;118282802;27346;;Confirmatory;20231017;0;0;Inactive;Q5BJF2;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 110;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC(=CC=C1)Br)CC2=CC=CC=C2
875;389477131;83;1805387;160849728;132060765;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';Benzyl 8-[4-(3-ethoxy-3-oxopropyl)piperazin-1-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC(=CC=C1)Br)CC2=CC=CC=C2
876;389477132;82;1805387;160849620;132060746;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';Benzyl 5-(4-cyclopentylpiperazin-1-yl)-1,3-dihydroisoindole-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)C(F)F
877;389477133;85;1805387;444858095;132060750;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A23;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)[N+](=O)[O-])CC2=CC=CC=C2
878;389477134;17;1805387;444858096;132060780;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example KTL-01-264;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CC3=CC=CC=C3CNC(=O)C4=CC=CC=C4Br)O
879;389477135;65;1805387;160849705;132060720;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';2-Benzyl-5-(3-methoxyphenyl)-1,3-dihydroisoindole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)CCO
880;389477136;95;1805387;444858081;132060742;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example KTL-01-253;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)CCO
881;389477137;25;1805387;160849727;132060763;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';benzyl 7-[4-(2-methylprop-2-enyl)piperazin-1-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)CCO
882;389477138;129;1805387;160849806;132060775;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';benzyl 7-(4-methylpiperazin-1-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)[N+](=O)[O-])CC2=CC=CC=C2
883;389477139;134;1805387;160849699;132060752;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';Benzyl 5-[4-(3-ethoxy-3-oxopropyl)piperazin-1-yl]-1,3-dihydroisoindole-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCCN(CC1)CCN2C3=C(C=C(C=C3)CCCF)SC2=O
884;389477140;27;1805387;160849725;132060776;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';benzyl 7-(4-cyclopentylpiperazin-1-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)(C)C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
885;389477141;553;1805387;160849619;132060743;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';Benzyl 5-(4-methylpiperazin-1-yl)-1,3-dihydroisoindole-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)(C)C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
886;389477142;57;1805387;160849673;132060812;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';2-benzyl-6-(3-methoxyphenyl)-3,4-dihydro-1H-isoquinoline;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)(C)C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
887;389477143;528;1805387;444858106;132060819;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A34;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)C(=O)COC(=O)C1=CC(=C2C=CC(=CC2=C1)C3=CC=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)[C@H]5C[C@H]6C[C@@H]5CN6
888;389477144;25;1805387;444858082;132060745;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example KTL-01-276;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC(=O)N[C@@H]1CC[C@@H](C1)C(=O)N(C)C2=CC=C(C=C2)C3=NC4=CC=CC=C4O3
889;389477181;268;1805387;444858110;132060772;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A38;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC(=O)N[C@@H]1CC[C@@H](C1)C(=O)N(C)C2=CC=C(C=C2)C3=NC4=CC=CC=C4O3
890;389477182;27;1805387;444858094;132060799;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example KTL-01-257;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1C2=C(CC(CC2)NCCC3=CC4=C(C=C3)OCO4)C(=N1)C(=O)N(C)C
891;389477183;166;1805387;160849764;132060733;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';4-(2-Benzylisoindolin-5-yl)morpholine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC(=O)N[C@@H]1CC[C@@H](C1)C(=O)N(C)C2=CC=C(C=C2)C3=NC4=CC=CC=C4O3
892;389477184;31;1805387;444858107;132060798;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A35;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=CC=C1)CC2=CC=CC=C2
893;389477185;235;1805387;444858091;132060755;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A19;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
894;389477186;81;1805387;160849763;132075203;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';4-(2-Benzyl-1,3,4,5-tetrahydro-2-benzazepin-7-yl)morpholine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
895;389477187;179;1805387;444858108;132060817;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A36;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
896;389477188;5;1805387;444858097;132060813;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A25;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C(C=C1)CC[C@H](C2=CC(=CC=C2)OCCN3CCOCC3)OC(=O)[C@H]4CCCCN4C(=O)[C@H](C5CCCCC5)C6=CC(=C(C(=C6)OC)OC)OC)OC
897;389477189;198;1805387;160849729;132060770;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';benzyl 7-[4-(3-ethoxy-3-oxopropyl)piperazin-1-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)C1=CC(=CC(=C1)C2=CN3C=C(N=C3C=C2)NC(=O)C4=CC=C(C=C4)C(C)(C)C(=O)N5CCN(CC5)C)C(C)(C)C
898;389477190;4;1805387;444858088;132060753;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A16;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C(C=C1)CC[C@H](C2=CC(=CC=C2)OCCN3CCOCC3)OC(=O)[C@H]4CCCCN4C(=O)[C@H](C5CCCCC5)C6=CC(=C(C(=C6)OC)OC)OC)OC
899;389477191;33;1805387;160849726;132075278;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';4-(2-benzyl-3,4-dihydro-1H-isoquinolin-6-yl)morpholine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)C1=CC(=CC(=C1)C2=CN3C=C(N=C3C=C2)NC(=O)C4=CC=C(C=C4)C(C)(C)C(=O)N5CCN(CC5)C)C(C)(C)C
900;389477192;77;1805387;444858077;132060712;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A5;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1CN2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=C(C=C(C=C5)Cl)Cl
901;389477193;14;1805387;444858109;132060814;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A37;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1N2C[C@H]3[C@H](C2)OCC4=C(N=NN34)C5=C(C=C(C=C5)C(F)(F)F)Cl
902;389477194;19;1805387;160849721;132060795;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';Benzyl 8-[4-(2-methylprop-2-enyl)piperazin-1-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN[C@]1(CCCC[C@@H]1NCCCC2=CC=CC=C2)C3=CC=CC=C3Cl
903;389477195;86;1805387;444858098;132060739;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example KTL-01-184;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1C[C@@H]2C[C@H]1C[C@@H]2NC3=C4C(=NC=N3)N(C=N4)[C@H]5[C@@H]([C@@H]([C@H](O5)CCl)O)O
904;389477196;159;1805387;444858114;132075286;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A42;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN[C@]1(CCCC[C@@H]1NCCCN2CCN(CC2)C)C3=CC=CC=C3Cl
905;389477197;614;1805387;444858087;132060756;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example KTL-01-Table 3.A15;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1=CC2=CC(=CC=C2)OC3=NC=C(C=C3)C(F)(F)F)C(=O)NC4=NN=CC=C4
906;389477198;153;1805387;160849711;132060734;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';Benzyl 5-[4-(2-methylprop-2-enyl)piperazin-1-yl]-1,3-dihydroisoindole-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1=CC2=CC(=CC=C2)OC3=NC=C(C=C3)C(F)(F)F)C(=O)NC4=NN=CC=C4
907;389477199;117;1805387;444858101;132060773;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A29;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1=CC2=CC(=CC=C2)OC3=NC=C(C=C3)C(F)(F)F)C(=O)NC4=NN=CC=C4
908;389477200;443;1805387;444858103;132075285;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A31;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1C(CN1C(=O)NC2=NN=CC=C2)C/C=C/C3=CN=CC(=N3)OC4=NC=C(C=C4)C(F)(F)F
909;389477201;89;1805387;444858075;132060722;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example KTL-01-121;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CC3=CC=CC=C3CNC(=O)C4=CC=CC=C4Cl)O
910;389477202;134;1805387;444858089;132060804;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A17;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=CC(=C1)C2=CC3=C(CN(CCC3)CC4=CC=CC=C4)C=C2
911;389477203;13;1805387;160849730;132060758;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';Benzyl 8-(4-cyclopentylpiperazin-1-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2=C(CN(C1)CC3=CC(=CC(=C3)Cl)Cl)C=C(C=C2)N4CCOCC4
912;389477204;39;1805387;444858084;132060803;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A12;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1N(CC2=CC(=CC=C2)F)C(=O)C3=CC=CO3)CCC4=CC=CC=C4
913;389477205;151;1805387;160849811;132060805;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';Benzyl 8-(4-methylpiperazin-1-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)NCCO
914;389477206;52;1805387;444858112;132075218;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A40;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)NCCO
915;389477266;44;1805387;160850029;132075295;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';2-Benzyl-7-(3-methoxyphenyl)-1,3,4,5-tetrahydro-2-benzazepine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)NCCO
916;389477267;17;1805387;444858100;132060792;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A28;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)F)CC2=CC=CC=C2
917;389477268;54;1805387;444858099;132060821;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A27;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)F)CC2=CC=CC=C2
918;389513897;39;1805407;447116407;142436853;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 12;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)[C@@H]1CCN(C1)C2=CC(=NC3=CC=NN32)C4=CC=CC=C4
919;389513898;11;1805407;447116402;135337952;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 7;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CC3=CC=CC=C3CNC(=O)C4=C(C(=CC=C4)Cl)Cl)O
920;389513943;68;1805407;447116411;135337924;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 16;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1[C@@H]2CC3=CC=CC=C3[C@@]1(CCN2CC4=CC=CC=C4)C
921;389513944;34;1805407;447116404;142436848;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 9;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)[C@@H]1CCN(C1)C2=CC(=NC3=CC=NN32)C4=CC=CC=C4
922;389513945;35;1805407;447116396;135338062;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)[C@@H]1CCN(C1)C2=CC(=NC3=CC=NN32)C4=CC=CC=C4
923;389513946;39;1805407;447116401;135338017;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 6;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)[C@@H]1CCN(C1)C2=CC(=NC3=CC=NN32)C4=CC=CC=C4
924;389513947;3;1805407;447116406;142436859;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 11;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1CCCO)C2=CC=CC(=C2)C3COCCN3C(=O)OCC4=CC=CC=C4
925;389513948;2;1805407;447116399;135337773;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 4;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1CCCO)C2=CC=CC(=C2)C3COCCN3C(=O)OCC4=CC=CC=C4
926;389513949;59;1805407;447116405;142436856;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 10;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl
927;389513950;29;1805407;447116397;135337909;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 2;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCC4=CC=CC=C4)C5=CC=CC=C5
928;389513951;24;1805407;447116400;135337739;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 5;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@]1(C(=O)N(C2=NC=C(N21)C(=O)NC3(CC3)C4=NC(=NO4)C5CCC5)C6=CC(=CC(=C6)Cl)Cl)CC7=CC=C(C=C7)C#N
929;389513952;53;1805407;447116410;135337481;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 15;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(CC1)C2=CC3=C(CN(CCC3)C(=O)OCC4=CC=CC=C4)C=C2
930;389513953;7;1805407;447116412;135337712;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 17;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CN(CCN3C(=O)OCC4=CC=CC=C4)C
931;389513954;24;1805407;447116403;135338546;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 8;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=CC4=C(C=C3C2)OCO4
932;389513955;15;1805407;447116409;142436850;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 14;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=CC4=C(C=C3C2)OCO4
933;389513956;39;1805407;447116398;135338382;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 3;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=CC4=C(C=C3C2)OCO4
934;389513957;96;1805407;447116413;135337871;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 18;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CN(CCN3C(=O)OCC4=CC=CC=C4)C
935;389513958;65;1805407;447116414;135337748;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 19;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(C(C1)C2=CC(=CC=C2)N3CCN(CC3)CCCO)C(=O)OCC4=CC=CC=C4
936;389513959;22;1805407;447116416;135337753;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 21;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C=CC(=C3C2)F)F)O
937;389513960;12;1805407;447116408;142436857;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 13;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C=CC(=C3C2)F)F)O
938;389513961;25;1805407;447116415;135337823;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;IC50;;BindingDB;Radiolabel Binding Assay from US Patent US10961249: 'Modulators of the sigma-2 receptor and their method of use';US10961249, Entry 20;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C=CC(=C3C2)F)F)O
939;389686473;598;1806763;459070364;118250113;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Pharmacological Activity from US Patent US11426411: 'Cycloalkyl-diamines for the treatment of inflammation';US11007200, Example 2a;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(CC1)C2=CC3=C(CN(C3)C(=O)OCC4=CC=CC=C4)C=C2
940;389686474;675;1806763;459070367;162369105;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Pharmacological Activity from US Patent US11426411: 'Cycloalkyl-diamines for the treatment of inflammation';US11007200, Example 3b;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(C(C1)C2=CC(=CC=C2)N3CCN(CC3)CCCO)C(=O)OCC4=CC=CC=C4
941;389686568;155;1806763;459070368;118250091;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Pharmacological Activity from US Patent US11426411: 'Cycloalkyl-diamines for the treatment of inflammation';US11007200, Example 4a;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@]1(C(=O)N(C2=NC=C(N21)C(=O)NC3(CC3)C4=NC(=NO4)C5CCC5)C6=CC(=CC(=C6)Cl)Cl)CC7=CC=C(C=C7)C#N
942;389686570;18;1806763;459070366;156086530;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Pharmacological Activity from US Patent US11426411: 'Cycloalkyl-diamines for the treatment of inflammation';US11007200, Example 3a;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@]1(C(=O)N(C2=NC=C(N21)C(=O)NC3(CC3)C4=NC(=NO4)C5CCC5)C6=CC(=CC(=C6)Cl)Cl)CC7=CC=C(C=C7)C#N
943;389686573;426;1806763;459070369;118250089;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Pharmacological Activity from US Patent US11426411: 'Cycloalkyl-diamines for the treatment of inflammation';US11007200, Example 4b;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CNCCN1CCC(CC1)OCC2=CC=CC=C2
944;389686574;435;1806763;459070372;118250135;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Pharmacological Activity from US Patent US11426411: 'Cycloalkyl-diamines for the treatment of inflammation';US11007200, Example 13b;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC=C(C=C1)CO[C@H]2CCCN(C2)CC3=CC(=CC=C3)F
945;389686576;98;1806763;459070370;118250102;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Pharmacological Activity from US Patent US11426411: 'Cycloalkyl-diamines for the treatment of inflammation';US11007200, Example 13a;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC(CCC=C1)C2=NC3=C(N2)C(=NC4=CC=CC=C43)NC5=CC(=C(C=C5)Cl)Cl
946;389686577;305;1806763;473129772;165436724;27346;;Confirmatory;20231017;0;0;Active;Q5BJF2;Ki;;BindingDB;Pharmacological Activity from US Patent US11426411: 'Cycloalkyl-diamines for the treatment of inflammation';US11426411, Example 2b;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC(C1)C(C2CCC2)NC3=C4C(=NC(=N3)Cl)N(C=N4)[C@@H]5[C@H]6C[C@]6([C@H]([C@H]5O)O)CSC7=CC=CC=C7F
947;402102369;11;1796671;384224373;118607454;27346;;Confirmatory;20240109;0;0;Active;Q5BJF2;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-(2-(benzyl(methyl)amino)ethyl)-2,4-dichlorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC2=C(C=C1)[C@@H](C[C@@H](O2)C3=CC(=C(C=C3)OC)OC)NC(=O)C4(CC4)C5=CC6=C(C=C5)OC(O6)(F)F
948;402102372;12;1796671;384224368;18118654;27346;;Confirmatory;20240109;0;0;Unspecified;Q5BJF2;Ki;>;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-3-methoxybenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC2=C(C=C1)[C@H](C[C@H](O2)C3=CC(=C(C=C3)OC)OC)NC(=O)C4(CC4)C5=CC6=C(C=C5)OC(O6)(F)F
949;402102395;14;1796671;384224375;118607309;27346;;Confirmatory;20240109;0;0;Active;Q5BJF2;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-(2-(benzyl(methyl)amino)ethyl)-4-nitrobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC2=C(C=C1)[C@H](C[C@H](O2)C3=CC(=C(C=C3)OC)OC)NC(=O)C4(CC4)C5=CC6=C(C=C5)OC(O6)(F)F
950;402102396;17;1796671;384224374;118607283;27346;;Confirmatory;20240109;0;0;Active;Q5BJF2;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-(2-(benzyl(methyl)amino)ethyl)-4-cyanobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)N1CCC(CC1)C2=CC=C(C=C2)C3=C4C=CC(=CC4=CC(=C3)C(=O)OCC(=O)N(C)C)C5=CC=C(C=C5)C(F)(F)F
951;402102398;16;1796671;384224348;52750322;27346;;Confirmatory;20240109;0;0;Active;Q5BJF2;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-4-propylbenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1CCCS(=O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)Cl
952;402102400;31;1796671;384224363;41306445;27346;;Confirmatory;20240109;0;0;Active;Q5BJF2;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-2,3-dichlorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)C1=C(C2=CC(=C(N=C2N(C1=O)C)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl)NC(=O)C
953;402102401;2;1796671;384224357;118607455;27346;;Confirmatory;20240109;0;0;Active;Q5BJF2;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[4-(benzylmethylamino)butyl]-4-chlorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)N1CCC(CC1)[C@](C2=CC=CC=C2)(C3=CC4=C(C=C3)N=C(C(=C4Cl)CC5=CC=C(C=C5)N6C=CC=N6)OC)O
954;402102402;47;1796671;384224352;51111240;27346;;Confirmatory;20240109;0;0;Active;Q5BJF2;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-4-fluorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)C1=C(C2=CC(=C(N=C2N(C1=O)C)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl)NC(=O)C
955;402102403;19;1796671;384224356;41306362;27346;;Confirmatory;20240109;0;0;Active;Q5BJF2;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';Benzamide derivative 11;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)C1=C(C2=CC(=C(N=C2N(C1=O)C)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl)NC(=O)C
956;402102405;2;1796671;384224358;118607351;27346;;Confirmatory;20240109;0;0;Active;Q5BJF2;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(N-methyl-2-phenylethylamino)propyl]-4-chlorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NC2=CC(=C(C=C2C(=N1)N[C@@H](C)C3=CC(=CS3)C4=CC=CC=C4CNC)OC)OC
957;402102406;85;1796671;384224355;138375187;27346;;Confirmatory;20240109;0;0;Active;Q5BJF2;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(2-(N-methylbenzyl)amino)ethyl]-4-chlorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=CC(=C1)C(=O)NCC2=CC=CC=C2CN3CCC4=CC(=C(C=C4C3)O)OC
958;402102407;31;1796671;384224364;41306378;27346;;Confirmatory;20240109;0;0;Active;Q5BJF2;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-2,4-dichlorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(CC1)C2=CC3=C(CN(CC3)C(=O)OCC4=CC=CC=C4)C=C2
959;402102469;36;1796671;384224372;27148262;27346;;Confirmatory;20240109;0;0;Active;Q5BJF2;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-4-nitrobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@]12COC3=C([C@@H]1CCN2)C=CC=C3Br
960;402102472;49;1796671;384224349;118607453;27346;;Confirmatory;20240109;0;0;Active;Q5BJF2;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-4-butylbenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC[C@H]1C2=CC=CC=C2N(C[C@@]1(C)N)C3=CC=CC=C3
961;402102474;12;1796671;384224353;41306333;27346;;Confirmatory;20240109;0;0;Unspecified;Q5BJF2;Ki;>;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-2-chlorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1CCCS(=O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)Cl
962;402102475;12;1796671;384224360;40624141;27346;;Confirmatory;20240109;0;0;Unspecified;Q5BJF2;Ki;>;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-2-bromobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1C2=C(CC(CC2)NCCC3=CC=C(C=C3)C(F)(F)F)C(=N1)C(=O)N(C)C
963;402102476;35;1796671;384224361;41306385;27346;;Confirmatory;20240109;0;0;Active;Q5BJF2;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-3-bromobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)N1CCC(CC1)[C@](C2=CC=CC=C2)(C3=CC4=C(C=C3)N=C(C(=C4Cl)CC5=CC=C(C=C5)N6C=CC=N6)OC)O
964;402102477;34;1796671;384224354;18118650;27346;;Confirmatory;20240109;0;0;Active;Q5BJF2;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-3-chlorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NC2=CC(=C(C=C2C(=N1)N[C@@H](C)C3=CC(=CS3)C4=CC=CC=C4CNC)OC)OC
965;402102478;98;1796671;384224351;110445832;27346;;Confirmatory;20240109;0;0;Active;Q5BJF2;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-4-trifluoromethylbenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NC2=CC(=C(C=C2C(=N1)N[C@@H](C)C3=CC(=CS3)C4=CC=CC=C4CNC)OC)OC
966;402102479;10;1796671;384224369;18118651;27346;;Confirmatory;20240109;0;0;Unspecified;Q5BJF2;Ki;>;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-4-methoxybenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCSC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)NC(C4CCC4)C5CCC5)O)O
967;402102483;16;1796671;384224362;9049339;27346;;Confirmatory;20240109;0;0;Active;Q5BJF2;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-[benzyl(methyl)amino]propyl]-4-bromobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2C[C@@H]([C@H]1CN2)C3=CC=C(C=C3)C4=C5C=CC(=CC5=CC(=C4)C(=O)O)C6=CC=C(C=C6)C(F)(F)F
968;402102520;12;1796671;384224371;41306434;27346;;Confirmatory;20240109;0;0;Unspecified;Q5BJF2;Ki;>;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-4-cyanobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCCN(CC1)CCN2C3=C(C=CC(=C3)Cl)OC2=O
969;402102521;48;1796671;384224366;118607347;27346;;Confirmatory;20240109;0;0;Active;Q5BJF2;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';Benzamide derivative 8;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=CC=C1NC2=NC(=NC=C2OC)C3=NN(C4=CC=CC=C43)CC5=C(C=C(C=C5F)OCCCO)F
970;402102523;59;1796671;384224365;118607364;27346;;Confirmatory;20240109;0;0;Active;Q5BJF2;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-3,4-dichlorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=CC=C1NC2=NC(=NC=C2OC)C3=NN(C4=CC=CC=C43)CC5=C(C=C(C=C5F)OCCCO)F
971;403018495;545;1920070;104162389;9795739;27346;;Confirmatory;20240403;0;0;Active;Q5BJF2;Ki;;BindingDB;In-Vitro Binding Assay from US Patent US20230390272: 'USE OF PRIDOPIDINE AND ANALOGS FOR THE TREATMENT OF ANXIETY AND DEPRESSION';Pridopidine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC(C1)C(C2CCC2)NC3=C4C(=NC=N3)N(C=N4)[C@H]5[C@@H]([C@@H]([C@H](O5)CCl)O)O
972;403018497;1000;1920070;488871656;57810440;27346;;Confirmatory;20240403;0;0;Inactive;Q5BJF2;Ki;>;BindingDB;In-Vitro Binding Assay from US Patent US20230390272: 'USE OF PRIDOPIDINE AND ANALOGS FOR THE TREATMENT OF ANXIETY AND DEPRESSION';4-(3-Methylsulfonylphenyl)-1-propylpiperidin-4-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1N2C[C@H]3[C@H](C2)OCC4=C(N=NN34)C5=CC=C(C=C5)C(F)(F)F
973;403018499;1000;1920070;488871657;118600037;27346;;Confirmatory;20240403;0;0;Inactive;Q5BJF2;Ki;>;BindingDB;In-Vitro Binding Assay from US Patent US20230390272: 'USE OF PRIDOPIDINE AND ANALOGS FOR THE TREATMENT OF ANXIETY AND DEPRESSION';(3R,4S)-4-(3-methylsulfonylphenyl)-1-propylpiperidin-3-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC(=O)N(CC1=CC=C(C=C1)F)C2CCN(CC2)CCC3=CC=CC=C3
974;407905631;86;1922006;494403003;171347530;27346;360891130;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);6-fluoro-3-nitro-2-(trifluoromethyl)-2H-chromene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN[C@]1(CCCC[C@@H]1NCCCC2=CC=C(C=C2)F)C3=CC=CC=C3Cl
975;407906199;206;1922171;494398713;15340337;27346;362020630;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);N-[2-(diethylamino)ethyl]-3-(123I)iodanyl-4-methoxybenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN([C@@H](C2=C1N=CC=C2)C3=CC=C(C=C3)F)C(=O)NC4=CC=C(C=C4)OC5=CC=C(C=C5)F
976;407906242;2;1922171;103520864;16737780;27346;362020630;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);Benzamide, N-(4-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)butyl)-2-(2-(fluoro-18F)ethoxy)-5-methyl-;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN([C@@H](C2=C1N=CC=C2)C3=CC=C(C=C3)F)C(=O)NC4=CC=C(C=C4)OC5=CC=C(C=C5)F
977;407906243;364;1922171;163339105;58511957;27346;362020630;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin);2(3H)-Benzothiazolone, 6-(3-fluoropropyl)-3-(2-(hexahydro-1H-azepin-1-yl)ethyl)-;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN([C@@H](C2=C1N=CC=C2)C3=CC=C(C=C3)F)C(=O)NC4=CC=C(C=C4)OC5=CC=C(C=C5)F
978;407906524;1542;1922167;494397724;171344250;27346;362020630;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to human sigma 2 receptor;(1R,9S,13S)-1,13-dimethyl-10-(2-methylprop-1-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)CC(=O)N1CCC2=C(C1)C(=NC(=N2)C3=CC=C(C=C3)Br)N(C)CC4=CC=CC=C4
979;407906525;17;1922167;103458141;9841596;27346;362020630;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to human sigma 2 receptor;N-(4-methoxy-3-phenethoxyphenethyl)-N-propylpropan-1-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)CC(=O)N1CCC2=C(C1)C(=NC(=N2)C3=CC=C(C=C3)Br)N(C)CC4=CC=CC=C4
980;407906526;10;1922167;163334751;44247568;27346;362020630;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;>;ChEMBL;Binding affinity to human sigma 2 receptor;4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)CC(=O)N1CCC2=C(C1)C(=NC(=N2)C3=CC=C(C=C3)Br)N(C)CC4=CC=CC=C4
981;407906527;252;1922167;103230778;132995;27346;362020630;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to human sigma 2 receptor;N-(1-benzylpiperidin-4-yl)-4-iodobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2C[C@@H]([C@H]1CN2)C3=CC=C(C=C3)C4=C5C=CC(=CC5=CC(=C4)C(=O)O)C6=CC=C(C=C6)C(F)(F)F
982;407906528;18;1922167;103167216;3559;27346;362020630;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to human sigma 2 receptor;Haloperidol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C=C(C=C3)N4CCNCC4
983;407906529;321;1922167;103272556;126402;27346;362020630;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;=;ChEMBL;Binding affinity to human sigma 2 receptor;2-(4-Morpholino)ethyl-1-phenylcyclohexane-1-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C=C(C=C3)N4CCNCC4
984;407906530;1377;1922167;381854209;9817231;27346;362020630;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to human sigma 2 receptor;3-(4-methylphenyl)-5-(1-propyl-3,6-dihydro-2H-pyridin-5-yl)-1,2-oxazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C=C(C=C3)N4CCNCC4
985;407906531;68;1922169;103237360;10474335;27346;362020630;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [H3]DTG from sigma 2 receptor (unknown origin) by competition binding assay;1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NN(C=C1)C2=C(C=C(C=C2)C3=CN(N=N3)C4CCC5=CC=CC=C5N(C4=O)CC(F)(F)F)OC
986;407906532;77;1922169;374357080;124197459;27346;362020630;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [H3]DTG from sigma 2 receptor (unknown origin) by competition binding assay;[9-(10-aminodecyl)-9-azabicyclo[3.3.1]nonan-3-yl] N-(2-methoxy-5-methylphenyl)carbamate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)C1=CC=C(C=C1)C2=NC(=NN2C3CC3)CN4CCCC4
987;407906533;37;1922169;494418697;154838222;27346;362020630;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [H3]DTG from sigma 2 receptor (unknown origin) by competition binding assay;3-[1-(3-phenylpropyl)-1,2,3,6-tetrahydropyridin-4-yl]-1H-pyrrolo[2,3-b]pyridine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC(C1)C(C2CCC2)NC3=C4C(=NC=N3)N(C=N4)[C@@H]5[C@H]6C[C@]6([C@H]([C@H]5O)O)CO
988;407906534;45;1922169;461554908;6913112;27346;362020630;Confirmatory;20240503;0;0;Active;Q5BJF2;IC50;=;ChEMBL;Displacement of [H3]DTG from sigma 2 receptor (unknown origin) by competition binding assay;SR-31747 free base;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=CC=C1)OC)N2C=C3C=CC(=CC3=C2)S(=O)(=O)C
989;407906535;819;1922169;404718077;9799284;27346;362020630;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [H3]DTG from sigma 2 receptor (unknown origin) by competition binding assay;Roluperidone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=CC=C1)OC)N2C=C3C=CC(=CC3=C2)S(=O)(=O)C
990;407906536;126;1922169;103252427;9829526;27346;362020630;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [H3]DTG from sigma 2 receptor (unknown origin) by competition binding assay;Siramesine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=CC=C1)OC)N2C=C3C=CC(=CC3=C2)S(=O)(=O)C
991;407906537;4;1922169;494405242;162368342;27346;362020630;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [H3]DTG from sigma 2 receptor (unknown origin) by competition binding assay;6-({[(1S)-1-hydroxy-2-methyl-1-phenylpropan-2-yl]amino}methyl)-1-methyl-3,4-dihydroquinolin-2(1H)-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=CC(=C1)N2C=CN3C2=CC(=N3)C4=CN=CC=C4)NC(=O)C5=CC(=CC=C5)S(F)(F)(F)(F)F
992;407906869;37;1922178;494410530;171352041;27346;362020630;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) expressed in human RT-4 cells;2-[(2R)-4-ethyl-1-(naphthalen-1-ylmethyl)piperazin-2-yl]ethanol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCC=C(C1)C2=CC(=NO2)C3=CC=C(C=C3)C
993;407906870;43;1922178;194180558;73056461;27346;362020630;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) expressed in human RT-4 cells;2-[(2S)-4-(cyclohexylmethyl)-1-[(4-phenylphenyl)methyl]piperazin-2-yl]ethanol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)C(=O)O)O)O)N
994;407906871;39;1922178;194166848;73056753;27346;362020630;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) expressed in human RT-4 cells;2-[(2R)-4-(cyclohexylmethyl)-1-[(4-phenylphenyl)methyl]piperazin-2-yl]ethanol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=CC(=C1)N2C=CN3C2=CC(=N3)C4=CN=CC=C4)NC(=O)C5=CC(=CC=C5)S(F)(F)(F)(F)F
995;407906872;16;1922178;494423740;171358352;27346;362020630;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) expressed in human RT-4 cells;2-[(2S)-4-ethyl-1-(naphthalen-1-ylmethyl)piperazin-2-yl]ethanol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=CC(=C1)N2C=CN3C2=CC(=N3)C4=CN=CC=C4)NC(=O)C5=CC(=CC=C5)S(F)(F)(F)(F)F
996;407918226;;1925769;494419988;169444309;27346;345698030;Literature-derived;20240503;0;0;Unspecified;Q5BJF2;;;ChEMBL;Inhibition of Sigma2 receptor (unknown origin) at 10 uM;[1-(4-Fluorophenyl)indol-5-yl]-[3-(4-pyrimidin-2-ylpiperazin-1-yl)azetidin-1-yl]methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C(=CC=C3)F
997;407996146;3;1946588;494423267;171358061;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;2-[(6-chloro-1H-indol-2-yl)methyl]-9-[(3,4-difluorophenyl)methyl]-2,9-diazaspiro[4.5]decane;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C(=CC=C3)F
998;407996147;7;1946588;482065857;168282745;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;6-[[4-[(4-chloro-3-fluorophenyl)methoxy]piperidin-1-yl]methyl]-1H-benzimidazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C(=CC=C3)F
999;407996148;574;1946588;482062057;168279962;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;(3S)-1-[(3-fluorophenyl)methyl]-3-[(4-methylphenyl)methoxy]piperidine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)CC#CC1=CC(=C(C=C1)OCCCC2=C(N=C(S2)N3CCC4=C(C3)C(=CC=C4)C(=O)NC5=NC6=CC=CC=C6S5)C(=O)O)F
1000;407996149;73;1946588;482060851;168279082;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;6-[[4-[[3-(trifluoromethyl)phenyl]methoxy]piperidin-1-yl]methyl]-1H-benzimidazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)CC#CC1=CC(=C(C=C1)OCCCC2=C(N=C(S2)N3CCC4=C(C3)C(=CC=C4)C(=O)NC5=NC6=CC=CC=C6S5)C(=O)O)F
1001;407996150;299;1946588;482083349;163322331;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;D4R antagonis-2;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)CC#CC1=CC(=C(C=C1)OCCCC2=C(N=C(S2)N3CCC4=C(C3)C(=CC=C4)C(=O)NC5=NC6=CC=CC=C6S5)C(=O)O)F
1002;407996151;239;1946588;494404913;171348668;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;1-methyl-5-[[(3S)-3-[(2-methylphenyl)methoxy]piperidin-1-yl]methyl]indazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C1=CC2=C(C[C@H]3[C@@H]4[C@]2(CCCC4)CCN3C)C=C1)(F)F
1003;407996152;121;1946588;494424520;171358804;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;N-(3-chloro-2-methylphenyl)-2-[1-[(3,4-difluorophenyl)methyl]-1,8-diazaspiro[4.5]decan-8-yl]acetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)N
1004;407996153;1;1946588;482085506;168296363;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;5-[[4-[(3,4-Difluorophenyl)methoxy]piperidin-1-yl]methyl]-1-methylindazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC(F)(F)F
1005;407996154;47;1946588;494409998;171351690;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;2-[1-[(3,4-difluorophenyl)methyl]-1,7-diazaspiro[4.4]nonan-7-yl]-N-(4-fluoro-3-methylphenyl)acetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NN(C=C1)C2=C(C=C(C=C2)C3=CN(N=N3)[C@H]4CCC5=CC=CC=C5N(C4=O)CC(F)(F)F)OC
1006;407996155;248;1946588;482056687;168276065;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;4-[[(3S)-3-[(4-methylphenyl)methoxy]piperidin-1-yl]methyl]benzonitrile;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NN(C=C1)C2=C(C=C(C=C2)C3=CN(N=N3)C4CCC5=CC=CC=C5N(C4=O)CC(F)(F)F)OC
1007;407996569;206;1946588;482063462;168280974;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;(3R)-1-[(3-fluoro-4-methoxyphenyl)methyl]-3-[(4-fluoro-3-methylphenyl)methoxy]piperidine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCNC(=O)C1=CC=C(C=C1)Cl)CC2=CC=CC=C2
1008;407996570;4;1946588;494402162;171347009;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;(3S)-3-[(3-fluoro-4-methoxyphenyl)methoxy]-1-[(4-methylphenyl)methyl]piperidine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CNC1=CC=CC=C1CNCCCNC(=O)C2=CC=C(C=C2)Cl
1009;407996571;76;1946588;482066608;168283295;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;(3S)-3-[(4-fluoro-3-methylphenyl)methoxy]-1-[(4-methylphenyl)methyl]piperidine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)C(=O)COC(=O)C1=CC(=C2C=CC(=CC2=C1)C3=CC=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)[C@@H]5C[C@@H]6C[C@H]5C(=O)N6
1010;407996572;45;1946588;494404670;171348511;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;2-[9-[(3,4-difluorophenyl)methyl]-2,9-diazaspiro[4.5]decan-2-yl]-N-(4-fluoro-3-methylphenyl)acetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CC[C@]23CCCC[C@@H]2[C@H]1CC4=C3C=C(C=C4)OC
1011;407996573;123;1946588;482056009;163322330;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;D4R antagonist-1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)C(F)(F)F
1012;407996574;123;1946588;482049371;168270809;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;2-[4-[(3,4-difluorophenyl)methoxy]piperidin-1-yl]-N-(4-fluoro-3-methylphenyl)acetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](C1=C(C=NC2=CC(=NN21)Cl)NC3=CC=C(C=C3)[C@H](C(F)(F)F)N(C)C(=O)C4CCS(=O)(=O)CC4)OC
1013;407996575;166;1946588;482049009;168270563;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;6-[[4-[(3,4-difluorophenyl)methoxy]piperidin-1-yl]methyl]-1H-benzimidazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](C1=C(C=NC2=CC(=NN21)Cl)NC3=CC=C(C=C3)[C@H](C(F)(F)F)N(C)C(=O)C4CCS(=O)(=O)CC4)OC
1014;407996576;43;1946588;494407734;171350337;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;N-(3-chloro-2-methylphenyl)-2-[1-[(3,4-difluorophenyl)methyl]-1,7-diazaspiro[4.4]nonan-7-yl]acetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CN(C=N1)C2=C(C=C(C=C2)C3=CN(N=N3)C4CCC5=C(C=CC=C5F)N(C4=O)CC(F)(F)F)OC
1015;407996577;23;1946588;494418671;171356469;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;7-[(6-chloro-1H-indol-2-yl)methyl]-1-[(3,4-difluorophenyl)methyl]-1,7-diazaspiro[4.4]nonane;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCC(CCC)C1=NC2=C(N1)C(=NC3=CC=CC=C32)NC4=CC=C(C=C4)I
1016;407996578;23;1946588;494395548;171342825;27346;362831800;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma-2 receptor in HEK293 cell membrane assessed as inhibition constant;2-[[1-[(3,4-Difluorophenyl)methyl]-1,7-diazaspiro[4.4]nonan-7-yl]methyl]imidazo[1,2-a]pyridine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CN(C=N1)C2=C(C=C(C=C2)C3=CN(N=N3)C4CCC5=C(C=CC=C5F)N(C4=O)CC(F)(F)F)OC
1017;408004007;;1948318;494424653;171358892;27346;369199560;Literature-derived;20240503;0;0;Unspecified;Q5BJF2;;;ChEMBL;Binding affinity to sigma 2 receptor in human MCF7 cells assessed as increase in fluorescent intensity pretreated with (+)-pentazocine for 60 mins followed by compound addition incubated for 45 mins by flow cytometric analysis;"6-[(2Z)-3,3-dimethyl-2-[(2E,4E)-5-(1,3,3-trimethylindol-1-ium-2-yl)penta-2,4-dienylidene]indol-1-yl]-N-[6-[3-(4-spiro[1H-2-benzofuran-3,4'-piperidine]-1'-ylbutyl)indol-1-yl]hexyl]hexanamide;iodide";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](C1=C(C=NC2=CC(=NN21)Cl)NC3=CC=C(C=C3)[C@H](C(F)(F)F)N(C)C(=O)C4CCS(=O)(=O)CC4)OC
1018;408004009;314;1948320;494424653;171358892;27346;369199560;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor in human MCF7 cells assessed as displacement of compound by measuring inhibition constant of DTG incubated for 120 mins by saturation binding assay;"6-[(2Z)-3,3-dimethyl-2-[(2E,4E)-5-(1,3,3-trimethylindol-1-ium-2-yl)penta-2,4-dienylidene]indol-1-yl]-N-[6-[3-(4-spiro[1H-2-benzofuran-3,4'-piperidine]-1'-ylbutyl)indol-1-yl]hexyl]hexanamide;iodide";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCCCC(CCC1)C2=NC3=C(N2)C(=NC4=CC=CC=C43)NC5=CC(=C(C=C5)Cl)Cl
1019;408004010;58;1948320;494413581;171353666;27346;369199560;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor in human MCF7 cells assessed as displacement of compound by measuring inhibition constant of DTG incubated for 120 mins by saturation binding assay;"6-[(2E)-3,3-dimethyl-2-[(2E,4E)-5-(1,3,3-trimethylindol-1-ium-2-yl)penta-2,4-dienylidene]indol-1-yl]-N-[1-(4-spiro[1H-2-benzofuran-3,4'-piperidine]-1'-ylbutyl)indol-6-yl]hexanamide;iodide";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C=C(C=C3)F
1020;408004011;504;1948321;494413581;171353666;27346;369199560;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor in human MCF7 cells assessed as displacement of compound by measuring inhibition constant of 2-(3-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)propyl)-5-methoxy-3,4-dihydroisoquinolin-1(2H)-one incubated for 120 mins;"6-[(2E)-3,3-dimethyl-2-[(2E,4E)-5-(1,3,3-trimethylindol-1-ium-2-yl)penta-2,4-dienylidene]indol-1-yl]-N-[1-(4-spiro[1H-2-benzofuran-3,4'-piperidine]-1'-ylbutyl)indol-6-yl]hexanamide;iodide";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C=C(C=C3)F
1021;408004012;407;1948321;494424653;171358892;27346;369199560;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor in human MCF7 cells assessed as displacement of compound by measuring inhibition constant of 2-(3-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)propyl)-5-methoxy-3,4-dihydroisoquinolin-1(2H)-one incubated for 120 mins;"6-[(2Z)-3,3-dimethyl-2-[(2E,4E)-5-(1,3,3-trimethylindol-1-ium-2-yl)penta-2,4-dienylidene]indol-1-yl]-N-[6-[3-(4-spiro[1H-2-benzofuran-3,4'-piperidine]-1'-ylbutyl)indol-1-yl]hexyl]hexanamide;iodide";TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C=C(C=C3)F
1022;408004321;69;1948306;494398235;171344553;27346;369199560;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant;2-[[5-[3-(4-Cyclohexylpiperazin-1-yl)propyl]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy]-5-(dimethylamino)isoindole-1,3-dione;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC(=CC=C1CC(=O)N)C2=CC(=CC(=C2)N3C=C(N=N3)C4=CC=C(C=C4)C(F)(F)F)C(=O)O
1023;408004322;179;1948306;336888945;127039559;27346;369199560;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant;5-(Dimethylamino)-2-[6-[5-[4-(4-methylpiperidin-1-yl)butyl]naphthalen-2-yl]oxyhexyl]isoindole-1,3-dione;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CN(C1)C(=S)NC2=CC(=CC(=C2)F)F)CC3=CC=C(C=C3)F
1024;408004323;126;1948306;103252427;9829526;27346;369199560;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant;Siramesine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC(=O)N1CCCC1CNC2CCC(CC2)(C3=C(C=CC(=C3)F)F)S(=O)(=O)C4=CC=C(C=C4)Cl
1025;408004324;68;1948306;103237360;10474335;27346;369199560;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Binding affinity to sigma 2 receptor (unknown origin) assessed as inhibition constant;1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=C(C=C1NC(=O)C2=CC(=CC(=C2)C#N)S(F)(F)(F)(F)F)N3C=CN4C3=CC(=N4)C5=CN=CC=C5)C
1026;408048910;114;1959978;103218326;10336644;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma 2 receptor (unknown origin) assessed as inhibition constant incubated for 120 mins in presence of (+)-SKF10047 by radioligand binding assay;(1R,9S,13S)-1,13-dimethyl-10-(2-piperidin-1-ylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC(=O)N1CCCC1CNC2CCC(CC2)(C3=C(C=CC(=C3)F)F)S(=O)(=O)C4=CC=C(C=C4)Cl
1027;408048911;144;1959978;494406320;25234108;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma 2 receptor (unknown origin) assessed as inhibition constant incubated for 120 mins in presence of (+)-SKF10047 by radioligand binding assay;(1R,9S,13S)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC(=O)N1CCCC1CNC2CCC(CC2)(C3=C(C=CC(=C3)F)F)S(=O)(=O)C4=CC=C(C=C4)Cl
1028;408048912;111;1959978;103217947;10664642;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma 2 receptor (unknown origin) assessed as inhibition constant incubated for 120 mins in presence of (+)-SKF10047 by radioligand binding assay;(1R,9S,13S)-10-(2-anilinoethyl)-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)[C@H]1CCN(C1)C2=CC(=NC3=CC=NN32)C4=CC=CC=C4
1029;408048913;3;1959978;103218288;10404406;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma 2 receptor (unknown origin) assessed as inhibition constant incubated for 120 mins in presence of (+)-SKF10047 by radioligand binding assay;(1R,9S,13S)-1,13-dimethyl-10-(2-morpholin-4-ylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)[C@H]1CCN(C1)C2=CC(=NC3=CC=NN32)C4=CC=CC=C4
1030;408048914;151;1959978;103218467;10807270;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma 2 receptor (unknown origin) assessed as inhibition constant incubated for 120 mins in presence of (+)-SKF10047 by radioligand binding assay;(1R,9S,13S)-10-[2-(azepan-1-yl)ethyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)[C@H]1CCN(C1)C2=CC(=NC3=CC=NN32)C4=CC=CC=C4
1031;408048915;26;1959978;103218327;10852782;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma 2 receptor (unknown origin) assessed as inhibition constant incubated for 120 mins in presence of (+)-SKF10047 by radioligand binding assay;(1R,9S,13S)-1,13-dimethyl-10-(2-pyrrolidin-1-ylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=C(C=C1NC(=O)C2=CC(=CC(=C2)C#N)S(F)(F)(F)(F)F)N3C=CN4C3=CC(=N4)C5=CN=CC=C5)C
1032;408048916;124;1959978;103217894;10784078;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma 2 receptor (unknown origin) assessed as inhibition constant incubated for 120 mins in presence of (+)-SKF10047 by radioligand binding assay;(1R,9S,13S)-1,13-dimethyl-10-[2-(N-methylanilino)ethyl]-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=C(C=C1NC(=O)C2=CC(=CC(=C2)C#N)S(F)(F)(F)(F)F)N3C=CN4C3=CC(=N4)C5=CN=CC=C5)C
1033;408049026;832;1959992;494418108;51008973;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma 2 receptor (unknown origin) assessed as inhibition constant in presence of haloperidol measured for 120 mins by scintillation counting analysis;(1R,9S,13S)-10-benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NN(C(=C1CNCC2=CC(=CC(=C2)F)F)Cl)C3=CC=CC=C3Cl
1034;408049027;487;1959992;494400306;50909171;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma 2 receptor (unknown origin) assessed as inhibition constant in presence of haloperidol measured for 120 mins by scintillation counting analysis;(1R,9S,13S)-10-benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
1035;408049028;154;1959992;494419282;51011612;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma 2 receptor (unknown origin) assessed as inhibition constant in presence of haloperidol measured for 120 mins by scintillation counting analysis;(1R,9S,13S)-4-fluoro-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@]12CN(C3=CC=CC=C3[C@@H]1CCN2)C4=CC=CC=C4
1036;408049068;42;1959990;494415206;171354558;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma 2 receptor (unknown origin) assessed as inhibition constant in presence of (+)-SKF10047 by radioligand binding assay;(1R,9S,13S)-1,13-dimethyl-10-(2-pyrrolidin-1-ylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@]12COC3=C([C@@H]1CCN2)C=CC(=C3)O
1037;408049069;13;1959990;494417519;171355855;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma 2 receptor (unknown origin) assessed as inhibition constant in presence of (+)-SKF10047 by radioligand binding assay;(1R,9S,13S)-1,13-dimethyl-10-(2-piperidin-1-ylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCCN(CC1)CCSC2=NC3=C(S2)C=CC(=C3)Cl
1038;408049070;144;1959990;494423682;171358320;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma 2 receptor (unknown origin) assessed as inhibition constant in presence of (+)-SKF10047 by radioligand binding assay;N-[2-[(1R,9S,13S)-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl]ethyl]aniline;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(NC1/N=C/C2=CC=C(C=C2)Br)C3=CC=CC(=C3)C(F)(F)F
1039;408049071;157;1959990;494406990;171349916;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma 2 receptor (unknown origin) assessed as inhibition constant in presence of (+)-SKF10047 by radioligand binding assay;N-[2-[(1R,9S,13S)-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl]ethyl]-N-methylaniline;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CC1N2CCC3=CC=CC=C3C2)C(=O)C4=CNC5=CC=CC=C54
1040;408049090;34;1960001;494397570;171344145;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin);benzyl (1S,8R)-5-(4-prop-2-enylpiperazin-1-yl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=NN1C2=CC=C(C=C2)F)C(=O)NC(CN(C)C)C3=CC=CC=C3
1041;408049091;23;1960001;494397431;171344061;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin);benzyl (1S,8R)-5-[4-(3-methylbut-2-enyl)piperazin-1-yl]-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCN1C2=NN3C=CN=C3C=C2)C(=O)C(CC4=CC=CC=C4)N
1042;408049092;27;1960001;494417219;171355732;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin);(1S,8R)-9-(3,5-dichlorophenyl)sulfonyl-5-(4-methylpiperazin-1-yl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)C(=O)N1CCC(CC1)NC(C)CCC2=CNC3=CC=CC=C32
1043;408049093;71;1960001;404686954;145973361;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin);benzyl (1S,8R)-5-(4-methylpiperazin-1-yl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCC2=C(C1=O)C=C(C=C2)OCCCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
1044;408049094;162;1960001;404665434;138464885;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin);benzyl (1S,8R)-5-[4-(3-ethoxy-3-oxopropyl)piperazin-1-yl]-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CNC(=O)C2=C3CC(CCC3=NN2C1)NCCC4=CC=C(C=C4)C#N
1045;408049095;16;1960001;494418802;171356542;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Inhibition of sigma 2 receptor (unknown origin);benzyl (1S,8R)-5-[4-[(E)-but-2-enyl]piperazin-1-yl]-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1C2=C(CC(CC2)NCCC3=CC=NC=C3)C(=N1)C(=O)NC4=CC(=CC=C4)OC
1046;408049203;171;1959983;242578828;73349939;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma 2 receptor (unknown origin) assessed as inhibition constant;(1R,9S,13S)-10-benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1C2=C(CN(CC2)CCC3=CC=C(C=C3)F)C(=N1)C(=O)N4CCCCC4
1047;408049699;258;1959992;494423890;171358448;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma 2 receptor (unknown origin) assessed as inhibition constant in presence of haloperidol measured for 120 mins by scintillation counting analysis;(1R,9S,13S)-10-benzyl-N,N,1,13-tetramethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCCC4=CC=C(C=C4)C#N)C5=CC=CC=C5
1048;408049700;831;1959992;494406320;25234108;27346;299084420;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma 2 receptor (unknown origin) assessed as inhibition constant in presence of haloperidol measured for 120 mins by scintillation counting analysis;(1R,9S,13S)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCCC4=NC=CN4)C5=CC=CC=C5
1049;408152414;434;1915189;440162092;124125214;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000309b TMEM97;N-[4-(3-chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1C2=C(CN(CC2)CCC3=CC(=CC=C3)C(F)(F)F)C(=N1)C(=O)N4CCCCC4
1050;409044089;;1794446;103745040;11577204;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2=NN3CCNC(=O)C3=C2CC1NCCC4=CC5=C(C=C4)OCO5
1051;409044090;;1794446;163325400;71455782;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Msd-M1pam-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)N4CCC5=CC=CC=C5C4)C6=CC=CC=C6
1052;409044091;;1794446;318376732;118430456;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Dhodh-IN-1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCC4CCOCC4)C5=CC=CC=C5
1053;409044092;;1794446;318444609;53251189;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Syk-IN-3;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN2C(=C3CC(CCC3=N2)NCC4=CC=C(C=C4)F)C1=O
1054;409044093;;1794446;336898978;127046693;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;5-chloro-1-[(1S)-1-(3-cyanophenyl)ethyl]-2-iminopyridine-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=NC(=N1)CN2CCCC2)C3=CC=C(C=C3)C(F)(F)F
1055;409044094;;1794446;440131550;91885570;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Mgat2-IN-1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=NC(=N1)CN2CCCC2)C3=CC4=C(CCCC4)C=C3
1056;409044095;100;1794446;440131550;91885570;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Mgat2-IN-1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=NC(=N1)CN2CCCC2)C3=CC(=CC=C3)C4(CC4)C(F)(F)F
1057;409044096;;1794446;136938862;56850410;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-[[[5-(1H-indol-5-yl)-1-methylpyrazole-3-carbonyl]amino]methyl]benzoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=NC(=N1)CN2CCCC2)C3=CC4=C(C=C3)C=CS4
1058;409044097;;1794446;312359684;59652086;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;5-[[benzyl(methyl)amino]methyl]-N-[(3-methoxyphenyl)methyl]-4-oxo-3H-thieno[2,3-d]pyrimidine-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=NC(=N1)CN2CCCC2)C3=CC=CC(=C3)C4=CC=CC=C4
1059;409044098;;1794446;440159052;155541355;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Thpp-1-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC=C(C=C1)C2=NC(=NN2C)CN3CCCC3
1060;409044099;70778;1794446;440159052;155541355;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Thpp-1-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=NC(=N1)CN2CCCC2)C3=CC4=C(CCC4)C=C3
1061;409044586;70795;1794446;440159052;155541355;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Thpp-1-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
1062;409044587;;1794446;440165545;155544007;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[3-methyl-5-(6-pyridin-3-ylimidazo[1,2-b]pyrazol-1-yl)phenyl]-3-(pentafluoro-lambda6-sulfanyl)benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=NC(=N1)CN2CCCC2)C3=CC(=CC=C3)OC4=CC=CC=C4
1063;409044588;79612;1794446;440165545;155544007;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[3-methyl-5-(6-pyridin-3-ylimidazo[1,2-b]pyrazol-1-yl)phenyl]-3-(pentafluoro-lambda6-sulfanyl)benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=C(C=C1)C2=NC(=NN2C)CN3CCCC3)C
1064;409044589;78886;1794446;440165545;155544007;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[3-methyl-5-(6-pyridin-3-ylimidazo[1,2-b]pyrazol-1-yl)phenyl]-3-(pentafluoro-lambda6-sulfanyl)benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=NC(=N1)CN2CCCC2)C3=CC=C(C=C3)C4CC4
1065;409044590;;1794446;103683319;45268455;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Pyrido(1,2-a)indole-10-acetic acid, 7-(((4-fluorophenyl)sulfonyl)methylamino)-6,7,8,9-tetrahydro-, (7R)-;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=NC(=N1)CN2CCCC2)C3=CC=C(C=C3)C4(CC4)C(F)(F)F
1066;409044591;;1794446;134457814;56678756;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(1S,3R)-N-[4-(1,3-benzoxazol-2-yl)phenyl]-N-methyl-3-propanamidocyclopentane-1-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)C1=CC=C(C=C1)C2=NC(=NN2C)CN3CCCC3
1067;409044592;396;1794446;134457814;56678756;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(1S,3R)-N-[4-(1,3-benzoxazol-2-yl)phenyl]-N-methyl-3-propanamidocyclopentane-1-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=NC(=N1)CN2CCCC2)C3=CC(=C(C=C3)Cl)Cl
1068;409044593;39811;1794446;134457814;56678756;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(1S,3R)-N-[4-(1,3-benzoxazol-2-yl)phenyl]-N-methyl-3-propanamidocyclopentane-1-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=NC(=N1)CN2CCCC2)C3=CC=C(C=C3)Cl
1069;409044594;;1794446;318393143;86277887;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;SAFit2;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)C1=CC=CC(=C1)C2=NC(=NN2C)CN3CCCC3
1070;409044595;226;1794446;318393143;86277887;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;SAFit2;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)C1=CC=C(C=C1)C2=NC(=NN2C)CN3CCCC3
1071;409044596;10000000;1794446;318393143;86277887;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;SAFit2;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=NC(=N1)CN2CCCC2)C3=CC4=C(C=C3)C=C(S4)Cl
1072;409044597;;1794446;381872584;121301295;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CFTR corrector 4;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=CC(=C1)C2=NC(=NN2C)CN3CCCC3)C(F)(F)F
1073;409044598;119234;1794446;381872584;121301295;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CFTR corrector 4;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CS(=O)(=O)C1C[C@H]2C[C@@H]1C[C@@H]2C3=CC=C(C=C3)C4=C5C=CC(=CC5=CC(=C4)C(=O)O)C6=CC=C(C=C6)C(F)(F)F
1074;409044599;120226;1794446;381872584;121301295;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CFTR corrector 4;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2C[C@H]([C@@H]1C3=CC=C(C=C3)C4=C5C=CC(=CC5=CC(=C4)C(=O)O)C6=CC=C(C=C6)C(F)(F)F)NC2
1075;409044600;;1794446;440124631;118191391;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N4-[1-[(4-cyanophenyl)methyl]-5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-fluoro-2,4-Quinolinedicarboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@H](C[C@@H]([C@H]1CO)C2=CC=C(C=C2)C3=C4C=CC(=CC4=CC(=C3)C(=O)O)C5=CC=C(C=C5)C(F)(F)F)N
1076;409044601;;1794446;440171575;132585205;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Clk-IN-T3;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1N2C[C@H]3[C@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
1077;409044602;;1794446;440190963;155554081;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(5R)-5-[(4-cyanophenyl)methyl]-N-[1-(3-cyclobutyl-1,2,4-oxadiazol-5-yl)cyclopropyl]-7-(3,5-dichlorophenyl)-5-methyl-6-oxoimidazo[1,2-a]imidazole-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=C(C=NC=C5)F
1078;409044603;55765;1794446;440190963;155554081;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(5R)-5-[(4-cyanophenyl)methyl]-N-[1-(3-cyclobutyl-1,2,4-oxadiazol-5-yl)cyclopropyl]-7-(3,5-dichlorophenyl)-5-methyl-6-oxoimidazo[1,2-a]imidazole-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1CN2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
1079;409044604;50699;1794446;440190963;155554081;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(5R)-5-[(4-cyanophenyl)methyl]-N-[1-(3-cyclobutyl-1,2,4-oxadiazol-5-yl)cyclopropyl]-7-(3,5-dichlorophenyl)-5-methyl-6-oxoimidazo[1,2-a]imidazole-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@H]2[C@H](CN1CC3=CC=CC=C3)OCC4=C(N=NN24)C5=CC=CC=C5F
1080;409044605;;1794446;440202897;155558842;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-Pyridin-2-yl-2,3-dihydro-1,3-benzothiazin-4-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=CC=C3)OCC4=C(N=NN24)C5=CC=CC=C5F
1081;409044606;;1794446;461563592;155884467;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(2~{R})-2-[[3-cyano-2-[4-(2-fluoranyl-3-methyl-phenyl)phenyl]-1,7-naphthyridin-4-yl]amino]butanoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCC(CC1)C2=C3CO[C@@H]4CN(C[C@H]4N3N=N2)CC5=CC=C(C=C5)F
1082;409044607;;1794446;494417403;171355807;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;1-(1-cyanocyclopropyl)-N-[(2S)-1-[[4-[3-(1-methylpyrazol-3-yl)phenyl]-1,3-thiazol-2-yl]amino]-1-oxopropan-2-yl]imidazole-4-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=C(C=CC=N5)F
1083;409044608;;1794446;312361687;59447577;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-[8-(1,3-Benzothiazol-2-Ylcarbamoyl)-3,4-Dihydroisoquinolin-2(1h)-Yl]-5-(3-{4-[3-(Dimethylamino)prop-1-Yn-1-Yl]-2-Fluorophenoxy}propyl)-1,3-Thiazole-4-Carboxylic Acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@H]2[C@H](CN1CC3=CC=CC=C3)OCC4=C(N=NN24)C5=CC(=CC=C5)F
1084;409044609;80612;1794446;312361687;59447577;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-[8-(1,3-Benzothiazol-2-Ylcarbamoyl)-3,4-Dihydroisoquinolin-2(1h)-Yl]-5-(3-{4-[3-(Dimethylamino)prop-1-Yn-1-Yl]-2-Fluorophenoxy}propyl)-1,3-Thiazole-4-Carboxylic Acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=CC=C3)OCC4=C(N=NN24)C5=CC(=CC=C5)F
1085;409044610;;1794446;381885815;78319901;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;MLi-2-Bio-X;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1C2=C3CO[C@@H]4CN(C[C@H]4N3N=N2)CC5=CC=C(C=C5)F
1086;409044611;460045;1794446;381885815;78319901;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;MLi-2-Bio-X;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)OC)CC2=CC=CC=C2
1087;409044612;457088;1794446;381885815;78319901;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;MLi-2-Bio-X;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
1088;409044613;;1794446;440134679;139600336;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CID 139600336;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=CO1)CC2=CC=CC=C2
1089;409044614;205116;1794446;440134679;139600336;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CID 139600336;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1CN(C[C@@H](O1)C)C2=NC=NC(=C2)C3=NN(C4=C3C=C(C=C4)OC5(CC5)C)C
1090;409045073;204174;1794446;440134679;139600336;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CID 139600336;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1CN(C[C@@H](O1)C)C2=NC=NC(=C2)C3=NN(C4=C3C=C(C=C4)OC5(CC5)C)C
1091;409045074;;1794446;440180707;155550034;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-(1-acetylpiperidin-4-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)-3-(trifluoromethyl)benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1CN(C[C@@H](O1)C)C2=NC=NC(=C2)C3=NN(C4=C3C=C(C=C4)OC5(CC5)C)C
1092;409045075;;1794446;440205039;118877194;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CID 118877194;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCNCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl
1093;409045076;200124;1794446;440205039;118877194;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CID 118877194;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1C2=NC(=CS2)C3=CC4=CC=CC=C4O3)CC5=NC6C(N5)C=CC=N6
1094;409045077;199526;1794446;440205039;118877194;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CID 118877194;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1[C@H]2C3(CCS(=O)(=O)CC3)C4=C(N2S(=O)(=O)C5=CC=C(C=C5)F)C=CC(=C4)C(=O)NCC6=C(C=C(C=N6)C(F)(F)F)Cl
1095;409045078;109922;1794446;442055944;156016206;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(4R)-5-[(6-bromo-3-methyl-2-piperazin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCNCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl
1096;409045079;109648;1794446;442055944;156016206;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(4R)-5-[(6-bromo-3-methyl-2-piperazin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H](C[C@H]([C@@H]1CO)C2=CC=C(C=C2)C3=C4C=CC(=CC4=CC(=C3)C(=O)O)C5=CC=C(C=C5)C(F)(F)F)N
1097;409045080;;1794446;442055944;156016206;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(4R)-5-[(6-bromo-3-methyl-2-piperazin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1[C@H]2C3(CCS(=O)(=O)CC3)C4=C(N2S(=O)(=O)C5=CC=C(C=C5)F)C=CC(=C4)C(=O)NCC6=C(C=C(C=N6)C(F)(F)F)Cl
1098;409045081;;1794446;442057934;146368333;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CID 146368333;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1[C@H]2C3(CCS(=O)(=O)CC3)C4=C(N2S(=O)(=O)C5=CC=C(C=C5)F)C=CC(=C4)C(=O)NCC6=C(C=C(C=N6)C(F)(F)F)Cl
1099;409045082;;1794446;461558359;122668091;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Borussertib;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1C2=NC(=CS2)C3=CC4=CC=CC=C4O3)CC5=NC6=C(N5)C=CC=N6
1100;409045083;335803;1794446;163327014;45279963;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Skepinone-L;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1C2=NC(=CS2)C3=CC4=CC=CC=C4O3)CC5=NC6C(N5)C=CC=N6
1101;409045084;323594;1794446;163327014;45279963;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Skepinone-L;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CNCCC1C2=CC=C(C=C2)C3=C4C=CC(=CC4=CC(=C3)C(=O)O)C5=CC=C(C=C5)C(F)(F)F
1102;409045085;;1794446;163327014;45279963;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Skepinone-L;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](C1=CC(=NC=C1)NC2=NC3=C(N2)C=C(C=C3)C4=CC(=NC=N4)N(C)C)N5CCN(CC5)C(=O)CC(F)(F)F
1103;409045086;;1794446;163339280;49821991;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[2-(6-chloropyridin-3-yl)-4-(2-methoxyethoxy)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl]-imidazo[1,5-a]pyridin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CNCCC1C2=CC=C(C=C2)C3=C4C=CC(=CC4=CC(=C3)C(=O)O)C5=CC=C(C=C5)C(F)(F)F
1104;409045087;335043;1794446;163339280;49821991;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[2-(6-chloropyridin-3-yl)-4-(2-methoxyethoxy)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl]-imidazo[1,5-a]pyridin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1C2=NOC(=N2)[C@H]3C[C@H](CN(C3)C(=O)N4CCS(=O)(=O)CC4)C5=CC=C(C=C5)OC(F)(F)F
1105;409045088;338844;1794446;163339280;49821991;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[2-(6-chloropyridin-3-yl)-4-(2-methoxyethoxy)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl]-imidazo[1,5-a]pyridin-1-ylmethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](C1=CC(=NC=C1)NC2=NC3=C(N2)C=C(C=C3)C4=CC(=NC=N4)N(C)C)N5CCN(CC5)C(=O)CC(F)(F)F
1106;409045089;;1794446;381887626;137662140;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;5-[4-Methyl-2-[[3-(trifluoromethyl)phenyl]methyl]-1,3-thiazol-5-yl]pyridine-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](C1=CC(=NC=C1)NC2=NC3=C(N2)C=C(C=C3)C4=CC(=NC=N4)N(C)C)N5CCN(CC5)C(=O)CC(F)(F)F
1107;409045090;;1794446;404679711;49846946;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Bcl2-IN-1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC(C1)C(C2CCC2)NC3=C4C(=NC=N3)N(C=N4)[C@@H]5[C@H]6C[C@]6([C@H]([C@H]5O)O)CCl
1108;409045091;;1794446;103478702;11386747;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CB1 inverse agonist 1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC2=C(C=C1)[C@H](C[C@H](O2)C3=CC(=C(C=C3)OC)OC)NC(=O)C4(CC4)C5=CC6=C(C=C5)OC(O6)(F)F
1109;409045092;605;1794446;103478702;11386747;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CB1 inverse agonist 1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC2=C(C=C1)[C@@H](C[C@@H](O2)C3=CC(=C(C=C3)OC)OC)NC(=O)C4(CC4)C5=CC6=C(C=C5)OC(O6)(F)F
1110;409045093;60256;1794446;103478702;11386747;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CB1 inverse agonist 1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1C2=CC=C(C=C2)C3=C4C=CC(=CC4=CC(=C3)C(=O)O)C5=CC=C(C=C5)C(F)(F)F)CCCCC6=CN(N=N6)CCCCCCN
1111;409045094;;1794446;381855577;135308996;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(3S)-3-(2-benzyl-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridin-6-yl)-5-methyl-2,3-dihydro-1,5-benzoxazepin-4-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)C#N)CC2=CC=CC=C2
1112;409045095;;1794446;440131106;133080719;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-Fluoro-N'-(3-fluoro-5-(pyridin-2-yl)benzoyl)benzenesulfonohydrazide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=CC=C1Cl)CC2=CC=CC=C2
1113;409045096;;1794446;440162092;124125214;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[4-(3-chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)OC)CC2=CC=CC=C2
1114;409045097;434421;1794446;440162092;124125214;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[4-(3-chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC(=CC=C1)OC)CC2=CC=CC=C2
1115;409045098;416869;1794446;440162092;124125214;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[4-(3-chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=CC=C1Br)CC2=CC=CC=C2
1116;409045099;;1794446;440177709;155548816;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-[1-(3a,7a-dihydro-1H-imidazo[4,5-b]pyridin-2-ylmethyl)piperidin-4-yl]-4-(1-benzofuran-2-yl)-1,3-thiazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@H]2C[C@H]([C@@H]1CN2)C3=CC=C(C=C3)C4=C5C=CC(=CC5=CC(=C4)C(=O)O)C6=CC=C(C=C6)C(F)(F)F
1117;409045100;111832;1794446;440177709;155548816;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-[1-(3a,7a-dihydro-1H-imidazo[4,5-b]pyridin-2-ylmethyl)piperidin-4-yl]-4-(1-benzofuran-2-yl)-1,3-thiazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CNCC1C2=CC=C(C=C2)C3=C4C=CC(=CC4=CC(=C3)C(=O)O)C5=CC=C(C=C5)C(F)(F)F
1118;409045101;109648;1794446;440177709;155548816;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-[1-(3a,7a-dihydro-1H-imidazo[4,5-b]pyridin-2-ylmethyl)piperidin-4-yl]-4-(1-benzofuran-2-yl)-1,3-thiazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
1119;409045558;;1794446;440196822;59842446;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;3-[(4-Bromophenoxy)methyl]-1-(4-fluorobenzoyl)azetidine-3-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
1120;409045559;100;1794446;440131550;91885570;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Mgat2-IN-1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC=C(C=C1)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
1121;409045560;;1794446;440153796;91827581;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(2R,3S,4R)-1-[2-(dibutylamino)-2-oxoethyl]-2-(2,2-dimethylpentyl)-4-(7-methoxy-1,3-benzodioxol-5-yl)pyrrolidine-3-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC(=CC=C1)OC)CC2=CC=CC=C2
1122;409045561;;1794446;440164983;23652660;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;3-Amino-4-(1,1-difluoropropyl)-6-(4-methylsulfonylpiperidin-1-yl)thieno[2,3-b]pyridine-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=CC=C1Cl)CC2=CC=CC=C2
1123;409045562;;1794446;440175420;95882508;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(S)-ZINC-3573;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=CC=C1Br)CC2=CC=CC=C2
1124;409045563;97286;1794446;440175420;95882508;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(S)-ZINC-3573;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)C#N)CC2=CC=CC=C2
1125;409045564;97724;1794446;440175420;95882508;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(S)-ZINC-3573;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC2=C(C=C1)[C@@H](C[C@@H](O2)C3=CC(=C(C=C3)OC)OC)NC(=O)C4(CC4)C5=CC6=C(C=C5)OC(O6)(F)F
1126;409045565;;1794446;440186718;155552436;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-[3-[2-(5-Chloro-2-fluorophenyl)-5-methylpyridin-4-yl]-2-oxobenzimidazol-1-yl]acetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1C2=NOC(=N2)[C@@]3(C[C@@](CN(C3)C(=O)N4CCS(=O)(=O)CC4)(C5=CC=C(C=C5)OC(F)(F)F)S)S
1127;409045566;;1794446;440186768;155552454;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;6-chloro-4-N-[4-(3-chloro-1-methylpyrrolo[2,3-b]pyridin-4-yl)oxy-3,5-difluorophenyl]pyrimidine-2,4-diamine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1C2=NOC(=N2)[C@H]3C[C@H](CN(C3)C(=O)N4CCS(=O)(=O)CC4)C5=CC=C(C=C5)OC(F)(F)F
1128;409045567;;1794446;440201576;155558331;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;MLi-2-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)N1CC[C@@H]2[C@]1(CN(C3=CC=CC=C23)C4=CC=CC=C4)C
1129;409045568;107498;1794446;440201576;155558331;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;MLi-2-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)N1CC[C@@H]2[C@]1(COC3=C(C=CC=C23)C4=CC=CC=C4)C
1130;409045569;107152;1794446;440201576;155558331;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;MLi-2-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC(F)F
1131;409045570;;1794446;440223918;140309892;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;1-(5-aminopyrimidin-2-yl)-N-(4-chloro-2,6-difluorophenyl)-7-(2-oxopyrrolidin-1-yl)-2,3-dihydroindole-5-sulfonamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@]12C[C@@H]1[C@H]([C@@H]([C@@H]2O)O)N3C=NC4=C(N=C(N=C43)C#CC5=CC=CC=C5)NCCC6=CC=CC=C6
1132;409045571;;1794446;442048931;156011311;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[9-(4-chloro-3-ethoxyphenyl)-3-oxa-7,9-diazabicyclo[3.3.1]nonan-7-yl]-[(2R,4S)-1-(4-chlorophenyl)-4-hydroxypyrrolidin-2-yl]methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2CCCC(C1)(C2)C3=NC4=C(N3)C(=NC5=CC=CC=C54)NC6=CC(=C(C=C6)Cl)Cl
1133;409045572;147605;1794446;442048931;156011311;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[9-(4-chloro-3-ethoxyphenyl)-3-oxa-7,9-diazabicyclo[3.3.1]nonan-7-yl]-[(2R,4S)-1-(4-chlorophenyl)-4-hydroxypyrrolidin-2-yl]methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=CC(=N1)C)C[C@H]2CCCN(C2)CC3=CSC(=N3)NC(=O)C
1134;409045573;147911;1794446;442048931;156011311;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[9-(4-chloro-3-ethoxyphenyl)-3-oxa-7,9-diazabicyclo[3.3.1]nonan-7-yl]-[(2R,4S)-1-(4-chlorophenyl)-4-hydroxypyrrolidin-2-yl]methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCC(CCC)C1=NC2=C(N1)C(=NC3=CC=CC=C32)NC4=CC(=C(C=C4)Cl)Cl
1135;409045574;;1794446;442049681;132004022;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(2~{S},3~{S})-2-(fluoranylmethyl)-~{N}7-methyl-~{N}5-[(1~{R},5~{S})-3-oxabicyclo[3.1.0]hexan-6-yl]-3-phenyl-2,3-dihydro-1-benzofuran-5,7-dicarboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCC=C(C1)C2=CC(=NO2)C3=CC=C(C=C3)C
1136;409045575;730771;1794446;461563584;162677475;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;3-amino-N,N-dimethyl-6-(4-methylsulfonylpiperidin-1-yl)-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=CC(=N1)C)C[C@H]2CCCN(C2)CC3=CSC(=N3)NC(=O)C
1137;409045576;724436;1794446;461563584;162677475;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;3-amino-N,N-dimethyl-6-(4-methylsulfonylpiperidin-1-yl)-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCNC(=O)C1=CC=C(C=C1)[N+](=O)[O-])CC2=CC=CC=C2
1138;409045577;;1794446;461563584;162677475;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;3-amino-N,N-dimethyl-6-(4-methylsulfonylpiperidin-1-yl)-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=C(C=C1)C(=O)NCC2=CC=CC=C2CN3CCC4=CC(=C(C=C4C3)O)OC
1139;409045578;;1794446;194175385;25117126;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Defactinib;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@H]2C[C@@H]([C@H]1C3=CC=C(C=C3)C4=C5C=CC(=CC5=CC(=C4)C(=O)O)C6=CC=C(C=C6)C(F)(F)F)NC2=O
1140;409045579;;1794446;381840647;121301422;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CFTR corrector 8;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCOC(=O)N1C[C@H]2C[C@@H]1C[C@@H]2C3=CC=C(C=C3)C4=C5C=CC(=CC5=CC(=C4)C(=O)OCC(=O)N(C)C)C6=CC=C(C=C6)C(F)(F)F
1141;409045580;58398;1794446;381840647;121301422;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CFTR corrector 8;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCOCC4
1142;409045581;58884;1794446;381840647;121301422;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CFTR corrector 8;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCOCC4
1143;409045582;;1794446;404661187;131953432;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[3,5-bis(trifluoromethyl)phenyl]methyl (1~{S},5~{R})-6-[(1~{H}-benzotriazol-5-ylcarbonylamino)methyl]-3-azabicyclo[3.1.0]hexane-3-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCOCC4
1144;409045583;;1794446;440157481;155540682;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[4-(3-chlorophenoxy)-3-sulfamoylphenyl]-1-(2-chlorophenyl)cyclopropane-1-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCNC(=O)C1=CC=C(C=C1)[N+](=O)[O-])CC2=CC=CC=C2
1145;409045584;194133;1794446;440157481;155540682;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[4-(3-chlorophenoxy)-3-sulfamoylphenyl]-1-(2-chlorophenyl)cyclopropane-1-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)C(C(F)(F)F)(F)F
1146;409045585;194984;1794446;440157481;155540682;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[4-(3-chlorophenoxy)-3-sulfamoylphenyl]-1-(2-chlorophenyl)cyclopropane-1-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
1147;409045586;;1794446;440165585;10278851;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-[(2R)-2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-[4-(trifluoromethoxy)phenyl]benzonitrile;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(CC1)C2=NC(=NC=C2)NCCC3=CC=CC=C3
1148;409045587;;1794446;440199577;155557564;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Gsi-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)N1C(=NC(=N1)CN2CCCC2)C3=CC=C(C=C3)C(C)(C)C
1149;409046004;959;1794446;440199577;155557564;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Gsi-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CCN(CC1)C2=NC(=NC=C2)NCCC3=CC=CC=C3
1150;409046005;95499;1794446;440199577;155557564;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Gsi-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
1151;409046006;;1794446;440202169;56849304;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-[4-[3-[1-[4-(2-aminopyrimidin-5-yl)phenyl]cyclopropyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
1152;409046007;;1794446;461563593;151094027;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;5-[2-[2-[[4-(Dimethylamino)quinolin-8-yl]sulfonylamino]phenyl]ethynyl]-4-methoxypyridine-2-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCOC1=C(C=CC(=C1)N2C3CN(CC2COC3)C(=O)[C@H]4C[C@@H](CN4C5=CC=C(C=C5)Cl)O)Cl
1153;409046008;;1794446;440224957;6451154;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-[(2S)-2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-[4-(trifluoromethoxy)phenyl]benzonitrile;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCOC1=C(C=CC(=C1)N2C3CN(CC2COC3)C(=O)[C@H]4C[C@@H](CN4C5=CC=C(C=C5)Cl)O)Cl
1154;409046009;;1794446;442049255;146018690;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;iBET-BD2;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCC(CC6)OC)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C
1155;409046010;;1794446;442063095;156021282;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[(2R,4S)-1-(4-chlorophenyl)-4-hydroxypyrrolidin-2-yl]-[9-[(4-chlorophenyl)methyl]-3-oxa-7,9-diazabicyclo[3.3.1]nonan-7-yl]methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCC(CC6)OC)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C
1156;409046011;21697;1794446;442063095;156021282;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[(2R,4S)-1-(4-chlorophenyl)-4-hydroxypyrrolidin-2-yl]-[9-[(4-chlorophenyl)methyl]-3-oxa-7,9-diazabicyclo[3.3.1]nonan-7-yl]methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCC(CC6)OC)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C
1157;409046012;218776;1794446;442063095;156021282;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[(2R,4S)-1-(4-chlorophenyl)-4-hydroxypyrrolidin-2-yl]-[9-[(4-chlorophenyl)methyl]-3-oxa-7,9-diazabicyclo[3.3.1]nonan-7-yl]methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2C=C(C)C)C)C=C(C=C3)O
1158;409046013;;1794446;461563585;162677476;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-phenyl-N-[5-[(1R,4R)-5-pyridazin-3-yl-2,5-diazabicyclo[2.2.1]heptan-2-yl]-1,3,4-thiadiazol-2-yl]acetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CNC(=O)C12C[C@@H]1[C@H]([C@@H]([C@@H]2O)O)N3C=NC4=C(N=C(N=C43)Cl)NC5CCCC5
1159;409046014;67608;1794446;440228548;155568985;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(5R)-N-[4-(4-fluorophenoxy)phenyl]-5-(4-fluorophenyl)-7,8-dihydro-5H-1,6-naphthyridine-6-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)(C)C)N2CC3=C(C=CC(=C3C2)F)F
1160;409046015;;1794446;440230063;24959105;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2,6-Dimethyl-4-(3-methyl-1H-indazol-5-yl)-1,4-dihydropyridine-3,5-dicarbonitrile;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)(C)C)N2CC3=C(C=CC(=C3C2)F)F
1161;409046016;;1794446;461563586;135135317;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[5-[[(3R)-3-[(2,6-dimethylpyridin-4-yl)methyl]piperidin-1-yl]methyl]-1,3-thiazol-2-yl]acetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)(C)C)N2CC3=C(C=CC(=C3C2)F)F
1162;409046017;;1794446;103349868;5310991;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)-;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCCN(CC1)CCN2C3=C(C=CC(=C3)Cl)SC2=O
1163;409046018;;1794446;134461578;51346964;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;S2JB42Bbp5;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=C(C2=C1C=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)C5CCNCC5)C(=O)O
1164;409046019;;1794446;160701240;11203294;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CID 11203294;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)N1C[C@@H]2C[C@H]1C[C@H]2C3=CC=C(C=C3)C4=C5C=CC(=CC5=CC(=C4)C(=O)O)C6=CC=C(C=C6)C(F)(F)F
1165;409046020;;1794446;318374355;122179556;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;MSD-CYP11B2-Negative-control;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1C[C@H]2CNC[C@H]1C2(C3=CC=C(C=C3)C4=C5C=CC(=CC5=CC(=C4)C(=O)O)C6=CC=C(C=C6)C(F)(F)F)O
1166;409046021;;1794446;318377030;118430525;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Ipp/cnrs-A019;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=C(C2=C1C=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)C5CCNCC5)C(=O)O
1167;409046022;525278;1794446;318377030;118430525;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Ipp/cnrs-A019;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=C(C2=C1C=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)C5CCNCC5)C(=O)O.Cl
1168;409046023;446684;1794446;318377030;118430525;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Ipp/cnrs-A019;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCN1C(=NC(=N1)CN2CCCC2)C3=CC=C(C=C3)C(C)(C)C
1169;409046024;;1794446;336900042;89794927;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(R)-1-(4-Methyl-5-(6-(trifluoromethyl)-1H-indazol-4-yl)pyrimidin-2-yl)pyrrolidin-3-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)O
1170;409046025;;1794446;440195453;155555842;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;3-(4-Chloro-3-(o-tolyloxy)naphthalen-1-yl)-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC(=O)C1=NN(C=N1)[C@@H]2[C@H]3C[C@]3([C@H]([C@H]2O)O)CO
1171;409046026;;1794446;440225117;59126962;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(1S,4R,7Z,14S,18R)-14-(cyclopentyloxycarbonylamino)-18-[7-methoxy-8-methyl-2-[2-(2-methylpropanoylamino)-1,3-thiazol-4-yl]quinolin-4-yl]oxy-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
1172;409046027;;1794446;461563595;162677480;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(2S)-2-[[3-cyano-2-[4-(2-fluoro-3-methylphenyl)phenyl]-1,7-naphthyridin-4-yl]amino]butanoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC2=C(C=C1)NC(=CC2=O)CNCCCOC3=CC=CC=C3
1173;409046028;;1794446;494422364;168310320;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[(2S)-3-methoxy-1-[[4-[3-(1-methylpyrazol-3-yl)phenyl]-1,3-thiazol-2-yl]amino]-1-oxopropan-2-yl]-1-methylsulfonylpyrrole-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2C[C@H]([C@@H]1C3=CC=C(C=C3)C4=C5C=CC(=CC5=CC(=C4)C(=O)O)C6=CC=C(C=C6)C(F)(F)F)C(=O)N2
1174;409046029;;1794446;318390136;23728722;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;5-[(6r)-5-Ethanoyl-4-Methyl-2-Oxidanylidene-3-[3-(Trifluoromethyl)phenyl]-1,6-Dihydropyrimidin-6-Yl]pyridine-2-Carbonitrile;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC=C(C=C1)C2=CC(=NC3=CC(=NN23)C(=O)NCCCN4C=CN=C4)C5=CC=CC=C5
1175;409046030;;1794446;381857418;137645416;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-ethyl-1-methyl-4-[(3S)-3-methylmorpholin-4-yl]pyrrolo[2,3-b]pyridine-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC2=C(C=C1)NC(=CC2=O)CNCCCOC3=CC=CC=C3
1176;409046031;;1794446;440112062;139030333;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;5-amino-N-[[4-(3-cyclohexylpropylcarbamoyl)phenyl]methyl]-1-phenylpyrazole-4-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC=C(C=C1)C2=CC(=NC3=CC(=NN23)C(=O)NCCCN4C=CN=C4)C5=CC=CC=C5
1177;409046032;;1794446;440122181;131750228;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Moz-IN-2;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1(C2=CC=CC=C2Cl)C(=O)NC3=CC(=C(C=C3)OC4=CC(=CC=C4)Cl)S(=O)(=O)N
1178;409046033;;1794446;440154412;155539293;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(1R,2R)-2-(4-fluoroanilino)-1-(trifluoromethyl)cyclohexan-1-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1(C2=CC=CC=C2Cl)C(=O)NC3=CC(=C(C=C3)OC4=CC(=CC=C4)Cl)S(=O)(=O)N
1179;409046464;;1794446;440156611;155540255;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(1S,4R,7Z,14S,18R)-14-(cyclopentyloxycarbonylamino)-2,15-dioxo-18-pyridin-4-yloxy-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1(C2=CC=CC=C2Cl)C(=O)NC3=CC(=C(C=C3)OC4=CC(=CC=C4)Cl)S(=O)(=O)N
1180;409046465;;1794446;440160912;95882507;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(R)-ZINC-3573;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCN(CC)CCOCCOC(=O)C1(CCCC1)C2=CC=CC=C2
1181;409046466;48944;1794446;440160912;95882507;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(R)-ZINC-3573;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=CC(=C1)CCNC2=C3C(=NC(=N2)C#CC4=CC=CC=C4)N(C=N3)[C@@H]5[C@H]6C[C@H]6[C@H]([C@H]5O)O)O
1182;409046467;47863;1794446;440160912;95882507;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(R)-ZINC-3573;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC[C@H]1C2=C(C=CC3=CC=CC=C32)OC[C@@]1(C)N
1183;409046468;;1794446;440175888;85469632;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Unii-66vrx9TN9T;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1C2=C(CC(CC2)NCC3=CC=C(C=C3)F)C(=N1)C(=O)N(C)C
1184;409046469;11079;1794446;440175888;85469632;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Unii-66vrx9TN9T;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1[C@@H]2C3(CCS(=O)(=O)CC3)C4=C(N2S(=O)(=O)C5=CC=C(C=C5)F)C=CC(=C4)C(=O)NCC6=C(C=C(C=N6)C(F)(F)F)Cl
1185;409046470;109648;1794446;440175888;85469632;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Unii-66vrx9TN9T;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C=C(C=C1)N2CCN(CC2)CC3=NC4=CC=CC=C4N3)C
1186;409046471;;1794446;440179305;137479135;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;1-[4-[[2-[[6-[5-chloro-6-(dimethylamino)pyrimidin-4-yl]-1H-benzimidazol-2-yl]amino]pyridin-4-yl]methyl]piperazin-1-yl]-3,3,3-trifluoropropan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H](C[C@@H]([C@H]1C2=CC=C(C=C2)C3=C4C=CC(=CC4=CC(=C3)C(=O)O)C5=CC=C(C=C5)C(F)(F)F)C(=O)O)N
1187;409046472;219458;1794446;440179305;137479135;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;1-[4-[[2-[[6-[5-chloro-6-(dimethylamino)pyrimidin-4-yl]-1H-benzimidazol-2-yl]amino]pyridin-4-yl]methyl]piperazin-1-yl]-3,3,3-trifluoropropan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1[C@@H]2C3(CCS(=O)(=O)CC3)C4=C(N2S(=O)(=O)C5=CC=C(C=C5)F)C=CC(=C4)C(=O)NCC6=C(C=C(C=N6)C(F)(F)F)Cl
1188;409046473;218776;1794446;440179305;137479135;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;1-[4-[[2-[[6-[5-chloro-6-(dimethylamino)pyrimidin-4-yl]-1H-benzimidazol-2-yl]amino]pyridin-4-yl]methyl]piperazin-1-yl]-3,3,3-trifluoropropan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1[C@@H]2C3(CCS(=O)(=O)CC3)C4=C(N2S(=O)(=O)C5=CC=C(C=C5)F)C=CC(=C4)C(=O)NCC6=C(C=C(C=N6)C(F)(F)F)Cl
1189;409046474;;1794446;440204884;145925651;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-[1-[2-(5-Chloro-2-fluorophenyl)-5-methylpyridin-4-yl]-2-oxoimidazo[4,5-c]pyridin-3-yl]acetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(C1)C(C2CCCC2)NC3=C4C(=NC(=N3)Cl)N(C=N4)[C@@H]5[C@H]6C[C@H]6[C@H]([C@H]5O)O
1190;409046475;;1794446;440208510;155561056;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Pptn-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCOC(=O)[C@@]12C[C@@H]1[C@H]([C@@H]([C@@H]2O)O)N3C=NC4=C(N=C(N=C43)Cl)NC(C5CCC5)C6CCC6
1191;409046476;170451;1794446;440208510;155561056;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Pptn-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN([C@H](C2=C1N=CC=C2)C3=CC=C(C=C3)F)C(=O)NC4=CN=C(N=C4)OC5=CC=C(C=C5)F
1192;409046477;169824;1794446;440208510;155561056;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Pptn-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN([C@H](C2=C1N=CC=C2)C3=CC=C(C=C3)F)C(=O)NC4=CN=C(N=C4)OC5=CC=C(C=C5)F
1193;409046478;;1794446;440217259;11364870;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-(3-Acetyl-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-1-methyl-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)methanesulfonamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN([C@H](C2=C1N=CC=C2)C3=CC=C(C=C3)F)C(=O)NC4=CN=C(N=C4)OC5=CC=C(C=C5)F
1194;409046479;;1794446;442046237;156009445;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(1,1-dioxo-1,3-thiazolidin-3-yl)-[(3S,5S)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@H]2[C@@]1([C@H]([C@H]([C@@H]2N3C=NC(=N3)C(=O)N)O)O)CO
1195;409046480;139916;1794446;461563591;162677479;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;1-(4-((3-((2,6-Dimethyl-pyridin-4-yl)-methyl)-piperidin-1-yl)-methyl)-thiazol-2-ylamino)-ethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2C[C@H]([C@@H]1C3=CC=C(C=C3)C4=C5C=CC(=CC5=CC(=C4)C(=O)O)C6=CC=C(C=C6)C(F)(F)F)NC2=O
1196;409046481;134896;1794446;461563591;162677479;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;1-(4-((3-((2,6-Dimethyl-pyridin-4-yl)-methyl)-piperidin-1-yl)-methyl)-thiazol-2-ylamino)-ethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C1=NC(=NC=C1)CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)C4)S(=O)(=O)C
1197;409046482;;1794446;461563591;162677479;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;1-(4-((3-((2,6-Dimethyl-pyridin-4-yl)-methyl)-piperidin-1-yl)-methyl)-thiazol-2-ylamino)-ethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C1=NC(=NC=C1)CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)C4)S(=O)(=O)C
1198;409046483;149108;1794446;404679711;49846946;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Bcl2-IN-1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C1=NC(=NC=C1)CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)C4)S(=O)(=O)C
1199;409046484;147911;1794446;404679711;49846946;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Bcl2-IN-1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H](CN([C@H]1C(=O)N2CC3COCC(C2)N3CC4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl)O
1200;409046485;;1794446;440159327;11996298;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-methyl-N-[2-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]methyl]pyrimidin-4-yl]methanesulfonamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H](CN([C@H]1C(=O)N2CC3COCC(C2)N3CC4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl)O
1201;409046486;212324;1794446;440159327;11996298;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-methyl-N-[2-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]methyl]pyrimidin-4-yl]methanesulfonamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)C1=NC=NC(=C1Cl)C2=CC3=C(C=C2)N=C(N3)NC4=NC=CC(=C4)CN5CCN(CC5)C(=O)CC(F)(F)F
1202;409046487;213796;1794446;440159327;11996298;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-methyl-N-[2-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]methyl]pyrimidin-4-yl]methanesulfonamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)C1=NC=NC(=C1Cl)C2=CC3=C(C=C2)N=C(N3)NC4=NC=CC(=C4)CN5CCN(CC5)C(=O)CC(F)(F)F
1203;409046488;;1794446;440198624;155557179;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;ERKi-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)C1=NC=NC(=C1Cl)C2=CC3=C(C=C2)N=C(N3)NC4=NC=CC(=C4)CN5CCN(CC5)C(=O)CC(F)(F)F
1204;409046489;;1794446;440226684;155568238;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[[4-[[(2S)-4-cyclohexyl-1-[(1-methylsulfonylpiperidin-3-yl)amino]-1-oxobutan-2-yl]carbamoyl]phenyl]methyl]imidazo[1,2-a]pyridine-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC(=CC=C1C2=CC(=CC(=C2)N3C=C(N=N3)C4=CC=C(C=C4)C(F)(F)F)C(=O)O)C5=NNN=N5
1205;409046490;;1794446;442061337;146681130;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(3~{R},4~{R})-~{N}-cyclohexyl-4-[[5-(furan-2-yl)-3-methyl-2-oxidanylidene-1~{H}-1,7-naphthyridin-8-yl]amino]-1-methyl-piperidine-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC(=C(C=C1C2C3=C(CCN2)C4=C(N3)C=CC(=C4)F)OC)OC.Cl
1206;409046491;146321;1794446;461523307;44548528;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-(4-methylpiperazin-1-yl)-N-(2-phenylethyl)pyrimidin-2-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NN(C=C1CN(C)CC2=CSC(=N2)C3=CC=CC=C3)CCO
1207;409046492;144544;1794446;461523307;44548528;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-(4-methylpiperazin-1-yl)-N-(2-phenylethyl)pyrimidin-2-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1CN(C[C@@H](C1(F)F)C)C2=NC=C(C(=N2)NC3=CC4=C(C=C3)N(C(=O)N4CCC(C)(C)O)C)Cl
1208;409046783;;1794446;461523307;44548528;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-(4-methylpiperazin-1-yl)-N-(2-phenylethyl)pyrimidin-2-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1CN(C[C@@H](C1(F)F)C)C2=NC=C(C(=N2)NC3=CC4=C(C=C3)N(C(=O)N4CCC(C)(C)O)C)Cl
1209;409046784;65524;1794446;475988474;166630510;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;3-[3,5-Difluoro-4-[[3-[5-methoxy-4-(2-methoxyanilino)pyrimidin-2-yl]indazol-1-yl]methyl]phenoxy]propan-1-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=C(C=C2)O[N+](=O)[O-])CC3=CC=CC=C3
1210;409046785;66069;1794446;475988474;166630510;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;3-[3,5-Difluoro-4-[[3-[5-methoxy-4-(2-methoxyanilino)pyrimidin-2-yl]indazol-1-yl]methyl]phenoxy]propan-1-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@H]2[C@@]1([C@H]([C@H]([C@@H]2N3C=NC4=C(N=C(N=C43)Cl)N)O)O)CCl
1211;409046786;;1794446;475988474;166630510;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;3-[3,5-Difluoro-4-[[3-[5-methoxy-4-(2-methoxyanilino)pyrimidin-2-yl]indazol-1-yl]methyl]phenoxy]propan-1-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CCCCNC(=O)C3=CC=C(C=C3)CO
1212;409046787;;1794446;124963756;24771824;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-pyridazin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methylidene]piperidine-1-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CCNC(=O)C3=CC=C(C=C3)CO[N+](=O)[O-]
1213;409046788;43672;1794446;124963756;24771824;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-pyridazin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methylidene]piperidine-1-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=C(C=C1)OCCN2CCN(CC2)C(=O)C3=CC4=CC=CC=C4N3
1214;409046789;43652;1794446;124963756;24771824;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-pyridazin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methylidene]piperidine-1-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC1=CC=CC=C1C(=O)NC2=NNC3=C(C(=C(C=C32)C4C(=C(N(C(=C4C#N)C)C)C)C#N)F)C
1215;409046790;;1794446;194172536;11622248;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(2S)-2-[[(2R)-2-[[(2R)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-pyridin-4-ylpropanoyl]amino]-N-[(2S)-1-[[(2S)-1-[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-[(N'-methylcarbamimidoyl)amino]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]hydrazinyl]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]butanediamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(CC1)CCCNC(=O)C2=CC=C(C=C2)CNC(=O)C3=C(N(N=C3)C4=CC=CC=C4)C(F)(F)F
1216;409046791;;1794446;312359683;11525848;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-(((2-((3-Methoxybenzyl)carbamoyl)-4-oxo-1,4-dihydrothieno[2,3-d]pyrimidin-5-yl)methoxy)methyl)benzoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCCCCC(CCCCC1)C2=NC3=C(N2)C(=NC4=CC=CC=C43)NC5=CC(=C(C=C5)Cl)Cl
1217;409046792;4553;1794446;312359683;11525848;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-(((2-((3-Methoxybenzyl)carbamoyl)-4-oxo-1,4-dihydrothieno[2,3-d]pyrimidin-5-yl)methoxy)methyl)benzoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCC1=CC=CC=C1C(=O)NC2=NNC3=C(C(=C(C=C32)C4C(=C(N(C(=C4C#N)C)C)C)C#N)F)C
1218;409046793;398107;1794446;312359683;11525848;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-(((2-((3-Methoxybenzyl)carbamoyl)-4-oxo-1,4-dihydrothieno[2,3-d]pyrimidin-5-yl)methoxy)methyl)benzoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(CC1)CCCNC(=O)C2=CC=C(C=C2)CNC(=O)C3=C(N(N=C3)C4=CC=CC=C4)C(F)(F)F
1219;409046794;;1794446;381842065;137635074;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;3-Chloro-4-((2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)amino)benzonitrile;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C(=O)C2=C(N1)C=C(C=C2)C(F)(F)F)CN(C)CC3=CC=CC=C3
1220;409046795;;1794446;440162068;138973681;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;BAY 293 Negative Control;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(CC1)C2=NC3=C(N2)C(=NC4=CC=CC=C43)NC5=CC=C(C=C5)I
1221;409046796;63788;1794446;440162068;138973681;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;BAY 293 Negative Control;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@]12COC3=C([C@@H]1CCN2)C=C(C=C3)OC
1222;409046797;60954;1794446;440162068;138973681;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;BAY 293 Negative Control;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](C(F)(F)F)N(CC1=CC=C(C=C1)F)C(=O)CN2C(=O)[C@]3(CCC4=C3C=C(C=C4)NC(=O)NC)OC2=O
1223;409046798;;1794446;440188647;57861719;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;3-fluoro-4-phenyl-N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridin-2-yl]benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)C(=O)COC(=O)C1=CC(=C2C=CC(=CC2=C1)C3=CC=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)[C@@H]5C[C@@H]6C[C@H]5NC6=O
1224;409046799;;1794446;440228548;155568985;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(5R)-N-[4-(4-fluorophenoxy)phenyl]-5-(4-fluorophenyl)-7,8-dihydro-5H-1,6-naphthyridine-6-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1C(CN(C1=O)CC2=CC=CO2)C(=O)NC3=CC=C(C=C3)C4=NC(=NO4)C5=CC=C(C=C5)Cl
1225;409046800;67562;1794446;440228548;155568985;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(5R)-N-[4-(4-fluorophenoxy)phenyl]-5-(4-fluorophenyl)-7,8-dihydro-5H-1,6-naphthyridine-6-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2=C(C=CC(=C2)NC3=C(C=C(C=C3)F)F)C(=O)C4=C1C=CC(=C4)OC[C@@H](CO)O
1226;409046801;81283;1794446;312361687;59447577;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-[8-(1,3-Benzothiazol-2-Ylcarbamoyl)-3,4-Dihydroisoquinolin-2(1h)-Yl]-5-(3-{4-[3-(Dimethylamino)prop-1-Yn-1-Yl]-2-Fluorophenoxy}propyl)-1,3-Thiazole-4-Carboxylic Acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C2=CC=CC=C2OC[C@@H](C1=O)N3CCC4=C(N(N=C4C3=O)CC5=CC=CC=C5)Br
1227;409046802;;1794446;318459881;87522699;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(NE)-N-[(E)-1-(4-fluoro-3-methylphenyl)-2-methylpent-1-en-3-ylidene]hydroxylamine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](C(F)(F)F)N(CC1=CC=C(C=C1)F)C(=O)CN2C(=O)[C@]3(CCC4=C3C=C(C=C4)NC(=O)NC)OC2=O
1228;409046803;;1794446;404696611;118958122;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-(4-Fluorobenzyl)-2-((R)-5-(3-methylureido)-2',4'-dioxo-2,3-dihydrospiro[indene-1,5'-oxazolidin]-3'-yl)-N-((S)-1,1,1-trifluoropropan-2-yl)acetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](C(F)(F)F)N(CC1=CC=C(C=C1)F)C(=O)CN2C(=O)[C@@]3(CCC4=C3C=C(C=C4)NC(=O)NC)OC2=O
1229;409046804;552539;1794446;404696611;118958122;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-(4-Fluorobenzyl)-2-((R)-5-(3-methylureido)-2',4'-dioxo-2,3-dihydrospiro[indene-1,5'-oxazolidin]-3'-yl)-N-((S)-1,1,1-trifluoropropan-2-yl)acetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COCCOC1=NC(=NC2=C1CN(CC2)C(=O)C3=C4C=CC=CN4C=N3)C5=CN=C(C=C5)Cl
1230;409046805;512861;1794446;404696611;118958122;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-(4-Fluorobenzyl)-2-((R)-5-(3-methylureido)-2',4'-dioxo-2,3-dihydrospiro[indene-1,5'-oxazolidin]-3'-yl)-N-((S)-1,1,1-trifluoropropan-2-yl)acetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COCCOC1=NC(=NC2=C1CN(CC2)C(=O)C3=C4C=CC=CN4C=N3)C5=CN=C(C=C5)Cl
1231;409046806;;1794446;440132040;154701643;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[2-Amino-4-(trifluoromethoxy)phenyl]-[4-[2-methyl-7-(4-methylpiperazin-1-yl)pyrido[3,2-d]pyrimidin-4-yl]piperidin-1-yl]methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2=C(C=CC(=C2)NC3=C(C=C(C=C3)F)F)C(=O)C4=C1C=CC(=C4)OC[C@@H](CO)O
1232;409046807;490343;1794446;440132040;154701643;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[2-Amino-4-(trifluoromethoxy)phenyl]-[4-[2-methyl-7-(4-methylpiperazin-1-yl)pyrido[3,2-d]pyrimidin-4-yl]piperidin-1-yl]methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC2=C(C=CC(=C2)NC3=C(C=C(C=C3)F)F)C(=O)C4=C1C=CC(=C4)OC[C@@H](CO)O
1233;409046808;489779;1794446;440132040;154701643;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[2-Amino-4-(trifluoromethoxy)phenyl]-[4-[2-methyl-7-(4-methylpiperazin-1-yl)pyrido[3,2-d]pyrimidin-4-yl]piperidin-1-yl]methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COCCOC1=NC(=NC2=C1CN(CC2)C(=O)C3=C4C=CC=CN4C=N3)C5=CN=C(C=C5)Cl
1234;409046809;;1794446;440151760;129284334;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-{2-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]-6-(morpholin-4-yl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl}pyrazolo[1,5-a]pyrimidine-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCCCC1=CC(=C(C(=C1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O
1235;409046810;;1794446;440161803;68944900;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;5-[(4S)-5-Acetyl-1,2,3,4-tetrahydro-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-4-pyrimidinyl]-2-pyridinecarbonitrile;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1C[C@@H]2C[C@H](C1)CC(C2)C3=NC4=C(N3)C(=NC5=CC=CC=C54)NC6=CC(=C(C=C6)Cl)Cl
1236;409046811;;1794446;442051800;138618774;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(2R,3R)-2-(fluoromethyl)-7-N-methyl-5-N-[(1S,5R)-3-oxabicyclo[3.1.0]hexan-6-yl]-3-phenyl-2,3-dihydro-1-benzofuran-5,7-dicarboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C2=CC=CC=C2OC[C@@H](C1=O)N3CCC4=C(N(N=C4C3=O)CC5=CC=CC=C5)Br
1237;409047189;;1794446;475992648;162760334;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-(5-Fluoropyridin-2-yl)-6,6-dimethyl-3-(2-methylpyrazolo[3,4-b]pyridin-4-yl)-4,7-dihydropyrazolo[5,1-c][1,4]oxazine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCCCC(CCCC1)C2=NC3=C(N2)C(=NC4=CC=CC=C43)NC5=CC(=C(C=C5)Cl)Cl
1238;409047190;;1794446;163338225;51031001;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-(1-Acetylpiperidin-4-yl)-N-carbamimidoyl-3-(trifluoromethyl)benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC(=CC(=C1)I)C2=C(SC(=N2)NC(=O)C3=CN=CC=C3)C4=CC=NC=C4
1239;409047191;;1794446;318386330;59472574;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;gamma-Secretase modulator 2;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@]12COC3=C([C@@H]1CCN2C)C=CC(=C3)O
1240;409047192;89;1794446;318386330;59472574;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;gamma-Secretase modulator 2;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=CC(=C1)CNC(=O)C2=NC3=C(C(=CS3)COCC4=CC=C(C=C4)C(=O)O)C(=O)N2
1241;409047193;89125;1794446;318386330;59472574;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;gamma-Secretase modulator 2;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC=C(C=C1)CC(=O)NC2=CC(=C(C=C2)OC3=CC(=CC=C3)Cl)S(=O)(=O)N
1242;409047194;;1794446;381861468;56649300;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Ftbmt;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC=C(C=C1)CC(=O)NC2=CC(=C(C=C2)OC3=CC(=CC=C3)Cl)S(=O)(=O)N
1243;409047195;;1794446;440156172;9837640;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-(pyridin-2-yl)-4H-benzo[e][1,3]thiazin-4-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC=C(C=C1)CC(=O)NC2=CC(=C(C=C2)OC3=CC(=CC=C3)Cl)S(=O)(=O)N
1244;409047196;;1794446;440179852;155549686;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(1R,2R,5S)-2-[4-[2-(oxan-4-yl)ethoxy]benzoyl]-5-[(4-oxo-1,2,3-benzotriazin-3-yl)methyl]cyclopentane-1-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CC1NC(=O)[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O
1245;409047197;;1794446;440180856;155550101;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;1-(4-fluorophenyl)-N-[(1S)-3-(methanesulfonamido)-1-(2-methylsulfonylpyridin-4-yl)propyl]pyrazolo[3,4-c]pyridine-4-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C(=NN1C2=NC=C(C=C2)C3CC3)OC(C)C)OC4=CC=C(C=C4)F
1246;409047198;;1794446;440217121;118425786;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(1S,2S,5R)-2-[4-[2-(oxan-4-yl)ethoxy]benzoyl]-5-[(4-oxo-1,2,3-benzotriazin-3-yl)methyl]cyclopentane-1-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC=CC=C1C(=O)NC2=NN(C3=C2C=C(C=C3)C4C(=C(NC(=C4C#N)C)C)C#N)C
1247;409047199;;1794446;442046236;156009444;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[5-(3,5-dicyano-2,6-dimethyl-1,4-dihydropyridin-4-yl)-1-methylindazol-3-yl]-2-methylbenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC=CC=C1C(=O)NC2=NN(C3=C2C=C(C=C3)C4C(=C(NC(=C4C#N)C)C)C#N)C
1248;409047200;447095;1794446;442046236;156009444;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[5-(3,5-dicyano-2,6-dimethyl-1,4-dihydropyridin-4-yl)-1-methylindazol-3-yl]-2-methylbenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC=CC=C1C(=O)NC2=NN(C3=C2C=C(C=C3)C4C(=C(NC(=C4C#N)C)C)C#N)C
1249;409047201;446684;1794446;442046236;156009444;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[5-(3,5-dicyano-2,6-dimethyl-1,4-dihydropyridin-4-yl)-1-methylindazol-3-yl]-2-methylbenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC=CC=C1C(=O)NC2=NN(C3=C2C=C(C=C3)C4C(=C(NC(=C4C#N)C)C)C#N)C
1250;409047202;;1794446;461540474;162640825;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;O-GlcNAcase-IN-1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=CC(=C1)CNC(=O)C2=NC3=C(C(=CS3)COCC4=CC=C(C=C4)C(=O)O)C(=O)N2
1251;409047203;;1794446;461563590;150189198;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Mct4-IN-1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=CC=CC(=C1)CNC(=O)C2=NC3=C(C(=CS3)COCC4=CC=C(C=C4)C(=O)O)C(=O)N2
1252;409047204;;1794446;475992981;166632756;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;7-(4-acetamidophenyl)-N-(3-imidazol-1-ylpropyl)-5-phenylpyrazolo[1,5-a]pyrimidine-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1CN(C[C@@H](O1)C)C2=NC=NC(=C2)C3=NNC4=C3C=C(C=C4)OC5(CC5)C
1253;409047205;;1794446;312372725;44543970;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Unii-KQ33evh4KU;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1CN(C[C@@H](O1)C)C2=NC=NC(=C2)C3=NNC4=C3C=C(C=C4)OC5(CC5)C
1254;409047206;;1794446;440172743;155546818;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Gsm-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H]1CN(C[C@@H](O1)C)C2=NC=NC(=C2)C3=NNC4=C3C=C(C=C4)OC5(CC5)C
1255;409047207;83475;1794446;440172743;155546818;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Gsm-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC(=CC=C1C2=C3C=CC(=CC3=CC(=C2)C(=O)O)C4=CC=C(C=C4)C(F)(F)F)C5=NOC(=C5)CO
1256;409047208;74131;1794446;440172743;155546818;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Gsm-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NC2=C(C(=N1)C3CCN(CC3)C(=O)C4=C(C=C(C=C4)OC(F)(F)F)N)N=CC(=C2)N5CCN(CC5)C
1257;409047209;;1794446;440193399;155555047;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-[4-[[2-(4-Chlorophenyl)-4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-N-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NC2=C(C(=N1)C3CCN(CC3)C(=O)C4=C(C=C(C=C4)OC(F)(F)F)N)N=CC(=C2)N5CCN(CC5)C
1258;409047210;837144;1794446;440193399;155555047;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-[4-[[2-(4-Chlorophenyl)-4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-N-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NC2=C(C(=N1)C3CCN(CC3)C(=O)C4=C(C=C(C=C4)OC(F)(F)F)N)N=CC(=C2)N5CCN(CC5)C
1259;409047211;831764;1794446;440193399;155555047;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-[4-[[2-(4-Chlorophenyl)-4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-N-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(CCCNC(=O)C1=CC=CO1)CC2=CC(=C(C=C2)OC)OC
1260;409047212;;1794446;440194870;124203924;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-N-[1-[(4-tert-butylphenyl)methyl]-5-methyl-3-(trifluoromethyl)pyrazol-4-yl]-7-fluoroquinoline-2,4-dicarboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](C(F)(F)F)N(CC1=CC=C(C=C1)F)C(=O)CN2C(=O)[C@]3(CCC4=C3C=CC(=C4)NC(=O)NC)OC2=O
1261;409047213;;1794446;475982193;166627367;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-[[3-[4-(1,1-Dioxothian-4-yl)oxy-2,6-dimethylphenyl]phenyl]methoxy]-2-fluorobenzoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C(=NN1C2=NC=C(C=C2)C3CC3)OC(C)C)OC4=CC=C(C=C4)F
1262;409047214;;1794446;242645573;25114442;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;1-(4-Fluorobenzoyl)-3-[(6-methoxynaphthalen-2-yl)oxymethyl]azetidine-3-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=C(C(=NN1C2=NC=C(C=C2)C3CC3)OC(C)C)OC4=CC=C(C=C4)F
1263;409047215;;1794446;318374372;56645363;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Cyp11B2-IN-1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCC(CC1)C2=CC(=CC=C2)S(=O)(=O)C
1264;409047216;;1794446;440135457;39791182;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(3-(4-Amino-6-(benzylamino)-1,3,5-triazin-2-yl)phenyl)methanol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@H](C(F)(F)F)N(CC1=CC=C(C=C1)F)C(=O)CN2C(=O)[C@]3(CCC4=C3C=CC(=C4)NC(=O)NC)OC2=O
1265;409047217;;1794446;440170635;58026161;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-[(4S)-4-[(5-ethylsulfonyl-1H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5,5,5-trifluoro-4-hydroxy-2-methylpentan-2-yl]-5-fluorobenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CNCCC1=CC=C(C=C1)O
1266;409047218;;1794446;440175882;145925685;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(R)-1-(4-(1-(2-((6-(6-(Dimethylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-yl)amino)pyridin-4-yl)ethyl)piperazin-1-yl)-3,3,3-trifluoropropan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)C(=O)C1=C(C2=C(S1)N=C(C=C2C(F)(F)F)N3CCC(CC3)S(=O)(=O)C)N
1267;409047587;115557;1794446;440175882;145925685;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(R)-1-(4-(1-(2-((6-(6-(Dimethylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-yl)amino)pyridin-4-yl)ethyl)piperazin-1-yl)-3,3,3-trifluoropropan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN(C)C(=O)C1=C(C2=C(S1)N=C(C=C2C(F)(F)F)N3CCC(CC3)S(=O)(=O)C)N
1268;409047588;112202;1794446;440175882;145925685;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(R)-1-(4-(1-(2-((6-(6-(Dimethylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-yl)amino)pyridin-4-yl)ethyl)piperazin-1-yl)-3,3,3-trifluoropropan-1-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1C(CN1C(=O)C2=NC3=C(N2C4=CC(=C(C=C4)Cl)Cl)N=CC=C3)(F)F
1269;409047589;;1794446;440210612;155561913;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Nvs-malt1-C;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1CNC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=C(C=C(C=C3)N4CCN(CC4)CC5=C(C=C(C=C5)C(F)(F)F)C6=CC=C(C=C6)Cl)OC7=CN=C8C(=C7)C=CN8)[N+](=O)[O-]
1270;409047590;88982;1794446;440210612;155561913;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Nvs-malt1-C;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1C(CN1C(=O)NC2=NN=CC=C2)C/C=C/C3=CN=CC(=N3)OC4=NC=C(C=C4)C(F)(F)F
1271;409047591;89125;1794446;440210612;155561913;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Nvs-malt1-C;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1CNC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=C(C=C(C=C3)N4CCN(CC4)CC5=C(C=C(C=C5)C(F)(F)F)C6=CC=C(C=C6)Cl)OC7=CN=C8C(=C7)C=CN8)[N+](=O)[O-]
1272;409047592;;1794446;442051944;146018691;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-[2-(methoxymethyl)-1-[(1~{R})-1-phenylethyl]-8-[[(3~{S})-pyrrolidin-3-yl]methoxy]imidazo[4,5-c]quinolin-7-yl]-3,5-dimethyl-1,2-oxazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1CNC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=C(C=C(C=C3)N4CCN(CC4)CC5=C(C=C(C=C5)C(F)(F)F)C6=CC=C(C=C6)Cl)OC7=CN=C8C(=C7)C=CN8)[N+](=O)[O-]
1273;409047593;;1794446;461563597;162677482;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(3S)-N-[5-(2-azidoacetyl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-1-cyanopyrrolidine-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1C(CN1C(=O)NC2=NN=CC=C2)C/C=C/C3=CN=CC(=N3)OC4=NC=C(C=C4)C(F)(F)F
1274;409047594;192486;1794446;475994378;3113005;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[3-(1H-imidazol-1-yl)propyl]-5,7-diphenylpyrazolo[1,5-a]pyrimidine-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC2=C(C=C1F)C=C(C(O2)C(F)(F)F)[N+](=O)[O-]
1275;409047595;190546;1794446;475994378;3113005;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[3-(1H-imidazol-1-yl)propyl]-5,7-diphenylpyrazolo[1,5-a]pyrimidine-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC[C@H]1C2=C(C=CC(=C2)OC)OC[C@@]1(C)N
1276;409047596;;1794446;475994378;3113005;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[3-(1H-imidazol-1-yl)propyl]-5,7-diphenylpyrazolo[1,5-a]pyrimidine-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC[C@H]1C2=C(CC[C@@]1(C)N)C=CC(=C2)OC
1277;409047597;;1794446;134451810;42611190;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-((Piperindin-4-yl)-phenyl)-(7-(4-(trifluoromethyl)-phenyl)-2-naphthoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)N1CC[C@@H]2[C@]1(COC3=C2C=CC(=C3)O)C
1278;409047598;112099;1794446;134451810;42611190;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-((Piperindin-4-yl)-phenyl)-(7-(4-(trifluoromethyl)-phenyl)-2-naphthoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC[C@H]1C2=C(C=CC(=C2)C)OC[C@@]1(C)N
1279;409047599;112202;1794446;134451810;42611190;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-((Piperindin-4-yl)-phenyl)-(7-(4-(trifluoromethyl)-phenyl)-2-naphthoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C[C@@]12COC3=C([C@@H]1CCN2)C(=CC(=C3)OC)OC
1280;409047600;;1794446;242510763;11524200;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;6-Chloro-N4-[3,5-difluoro-4-[(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl]-2,4-pyrimidinediamine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC[C@H]1C2=C(C=C(C=C2)O)OC[C@@]1(C)N
1281;409047601;;1794446;381863071;131801156;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;BCL6-IN-8c;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=C3CC(CCC3=NN2C4=CC=CC=C4)NCCC5=CC=C(C=C5)C(F)(F)F
1282;409047602;;1794446;440164595;155543618;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(4R)-2-(4-chlorophenyl)-6-methyl-4-(3-methyl-2H-indazol-5-yl)-1,4-dihydropyridine-3,5-dicarbonitrile;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=C3CC(CCC3=NN2C4=CC=C(C=C4)F)NCC5=CC=C(C=C5)F
1283;409047603;;1794446;440207296;155560620;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Nvs-malt1;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=C3CC(CCC3=NN2C4=CC=C(C=C4)F)NCC5=CC=C(C=C5)F
1284;409047604;63666;1794446;461563589;162677478;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;1-[4-[(S)-[4-chloro-2-methoxy-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-hydroxy-phenylmethyl]piperidin-1-yl]ethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=C3CC(CCC3=NN2C4=CC=C(C=C4)C(=O)N)NCCC5=CC=CC=C5
1285;409047605;60256;1794446;461563589;162677478;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;1-[4-[(S)-[4-chloro-2-methoxy-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-hydroxy-phenylmethyl]piperidin-1-yl]ethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCCC4=CC(=CC=C4)O)C5=CC=CC=C5
1286;409047606;;1794446;461563589;162677478;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;1-[4-[(S)-[4-chloro-2-methoxy-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-hydroxy-phenylmethyl]piperidin-1-yl]ethanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCCC4=CC=NC=C4)CC5=CC=CC=C5
1287;409047607;;1794446;124976534;53326879;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CRTH2-negative-control;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCCC4=CC=C(C=C4)C(F)(F)F)C5=CC=CC=C5
1288;409047608;;1794446;134447941;25229646;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;1-((4-cyano-4-(pyridin-2-yl)piperidin-1-yl)methyl)-4-oxo-4H-quinolizine-3-carboxylic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1C2=C(CC(CC2)SCC3=CC=C(C=C3)F)C(=N1)C(=O)N(C)C
1289;409047609;;1794446;318372032;60195662;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(R)-3-((N-(1-(4-fluorophenyl)ethyl)quinoline-3-carboxamido)methyl)benzoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCC4=CC=C(C=C4)F)C5=CC=CC=C5
1290;409047610;;1794446;440120698;134128280;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(2-Amino-4-(trifluoromethoxy)phenyl)(4-(7-(4-methylpiperazin-1-yl)pyrido[3,2-d]pyrimidin-4-yl)piperidin-1-yl)methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1C2=C(CC(CC2)NC(=O)C3=CC=C(C=C3)F)C(=N1)C(=O)N(C)C
1291;409047611;;1794446;440170404;155545891;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;MRL-SYKi-NC;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCC4=CC=C(C=C4)F)CC5=CC=CC=C5
1292;409047612;;1794446;440174729;137322663;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(R)-6,7-Dimethoxy-2-methyl-N-(1-(4-(2-((methylamino)methyl)phenyl)thiophen-2-yl)ethyl)quinazolin-4-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1C2=C(CC(CC2)NS(=O)(=O)C3=CC=C(C=C3)F)C(=N1)C(=O)N(C)C
1293;409047613;17981;1794446;440174729;137322663;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(R)-6,7-Dimethoxy-2-methyl-N-(1-(4-(2-((methylamino)methyl)phenyl)thiophen-2-yl)ethyl)quinazolin-4-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1C2=C(CC(CC2)OCC3=CC=C(C=C3)F)C(=N1)C(=O)N(C)C
1294;409047614;17783;1794446;440174729;137322663;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(R)-6,7-Dimethoxy-2-methyl-N-(1-(4-(2-((methylamino)methyl)phenyl)thiophen-2-yl)ethyl)quinazolin-4-amine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=NC=CC2=C1C(NC3=C2C=CC(=C3)Br)(C)C
1295;409047615;;1794446;440189837;155553652;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-[1-(3a,7a-dihydro-1H-imidazo[4,5-b]pyridin-2-ylmethyl)piperidin-4-yl]-4-(1-methylbenzimidazol-2-yl)-1,3-thiazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC(=CC=C1CO)C(=O)O
1296;409047616;15189;1794446;440189837;155553652;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-[1-(3a,7a-dihydro-1H-imidazo[4,5-b]pyridin-2-ylmethyl)piperidin-4-yl]-4-(1-methylbenzimidazol-2-yl)-1,3-thiazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC1=CC=C(C=C1)C(=O)O
1297;409047938;15136;1794446;440189837;155553652;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-[1-(3a,7a-dihydro-1H-imidazo[4,5-b]pyridin-2-ylmethyl)piperidin-4-yl]-4-(1-methylbenzimidazol-2-yl)-1,3-thiazole;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1=CC(=CC=C1CO[N+](=O)[O-])C(=O)O
1298;409047939;;1794446;440192898;155554839;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(2-methylpyrimidin-4-yl)methyl (1R,5S)-6-[(2H-benzotriazole-5-carbonylamino)methyl]-3-azabicyclo[3.1.0]hexane-3-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CC3=CC=CC=C3CNC(=O)C4=CC=CC(=C4)C#N)O
1299;409047940;;1794446;440197846;155556859;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(1R,2R)-2-(4-fluoro-3-methoxyanilino)-1-(trifluoromethyl)cyclohexan-1-ol;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1CC[C@]23CCCC[C@@H]2[C@H]1CC4=C3C=C(C=C4)O
1300;409047941;;1794446;440218803;134817183;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[5-(3,5-dicyano-1,2,6-trimethyl-4H-pyridin-4-yl)-6-fluoro-7-methyl-1H-indazol-3-yl]-2-ethylbenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=NC=C(C=C1)CN2C[C@H]3[C@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
1301;409047942;284381;1794446;440218803;134817183;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[5-(3,5-dicyano-1,2,6-trimethyl-4H-pyridin-4-yl)-6-fluoro-7-methyl-1H-indazol-3-yl]-2-ethylbenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=NC=C(C=C1)CN2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=CC(=CC=C5)F
1302;409047943;281838;1794446;440218803;134817183;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[5-(3,5-dicyano-1,2,6-trimethyl-4H-pyridin-4-yl)-6-fluoro-7-methyl-1H-indazol-3-yl]-2-ethylbenzamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1N2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=NC=C(C=C5)F
1303;409047944;;1794446;440224265;155567293;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(2S)-2-[[(2R)-2-[[(2R)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-N-[(2S)-1-[[(2S)-1-[2-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-5-[(N'-methylcarbamimidoyl)amino]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]hydrazinyl]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]butanediamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CN=C(C=C3)C(F)(F)F)OCC4=C(N=NN24)C5=CC=CC=C5F
1304;409047945;;1794446;475994610;166633549;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[(1R)-3-(3,4-dimethoxyphenyl)-1-[3-(2-morpholin-4-ylethoxy)phenyl]propyl] (2R)-1-[(2R)-2-cyclohexyl-2-(3,4,5-trimethoxyphenyl)acetyl]piperidine-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=CN=CC=C5
1305;409047946;40935;1794446;475994610;166633549;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[(1R)-3-(3,4-dimethoxyphenyl)-1-[3-(2-morpholin-4-ylethoxy)phenyl]propyl] (2R)-1-[(2R)-2-cyclohexyl-2-(3,4,5-trimethoxyphenyl)acetyl]piperidine-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=NC=CC=N5
1306;409047947;40738;1794446;475994610;166633549;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[(1R)-3-(3,4-dimethoxyphenyl)-1-[3-(2-morpholin-4-ylethoxy)phenyl]propyl] (2R)-1-[(2R)-2-cyclohexyl-2-(3,4,5-trimethoxyphenyl)acetyl]piperidine-2-carboxylate;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=NC=C(C=C1)CN2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
1307;409047948;;1794446;475995198;118958833;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CID 118958833;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=NC=C(C=C5)F
1308;409047949;;1794446;136929043;45376872;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-[[[5-(2-ethoxycarbonyl-1H-indol-5-yl)-1-methylpyrazole-3-carbonyl]amino]methyl]benzoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C=CN=C1CN2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
1309;409047950;;1794446;440121033;135386938;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;5-[[2-[(3~{S},5~{R})-4,4-bis(fluoranyl)-3,5-dimethyl-piperidin-1-yl]-5-chloranyl-pyrimidin-4-yl]amino]-1-methyl-3-(3-methyl-3-oxidanyl-butyl)benzimidazol-2-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=CC=CC=N5
1310;409047951;250346;1794446;440121033;135386938;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;5-[[2-[(3~{S},5~{R})-4,4-bis(fluoranyl)-3,5-dimethyl-piperidin-1-yl]-5-chloranyl-pyrimidin-4-yl]amino]-1-methyl-3-(3-methyl-3-oxidanyl-butyl)benzimidazol-2-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@H]2[C@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=CC=CC=N5
1311;409047952;251189;1794446;440121033;135386938;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;5-[[2-[(3~{S},5~{R})-4,4-bis(fluoranyl)-3,5-dimethyl-piperidin-1-yl]-5-chloranyl-pyrimidin-4-yl]amino]-1-methyl-3-(3-methyl-3-oxidanyl-butyl)benzimidazol-2-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1N2C[C@H]3[C@H](C2)OCC4=C(N=NN34)C5=NC=C(C=C5)F
1312;409047953;;1794446;440164301;135309104;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(3S)-3-(2-benzyl-3-bromo-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridin-6-yl)-5-methyl-2,3-dihydro-1,5-benzoxazepin-4-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CN=CC=C3)OCC4=C(N=NN24)C5=CC=CC=C5F
1313;409047954;348343;1794446;440164301;135309104;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(3S)-3-(2-benzyl-3-bromo-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridin-6-yl)-5-methyl-2,3-dihydro-1,5-benzoxazepin-4-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1N2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
1314;409047955;323594;1794446;440164301;135309104;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(3S)-3-(2-benzyl-3-bromo-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridin-6-yl)-5-methyl-2,3-dihydro-1,5-benzoxazepin-4-one;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1COCCC1CN2C[C@H]3[C@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
1315;409047956;;1794446;440222829;68287831;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-chloro-5-[[[(1R)-1-(4-fluorophenyl)ethyl]-(quinoline-3-carbonyl)amino]methyl]benzoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)NCCN(C)C
1316;409047957;;1794446;461542924;162662928;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-pyridazin-3-yl-3-[(E)-3-[6-[5-(trifluoromethyl)pyridin-2-yl]oxypyrazin-2-yl]prop-2-enyl]azetidine-1-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)CCN(C)C
1317;409047958;841201;1794446;461542924;162662928;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-pyridazin-3-yl-3-[(E)-3-[6-[5-(trifluoromethyl)pyridin-2-yl]oxypyrazin-2-yl]prop-2-enyl]azetidine-1-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)C(=O)O)O
1318;409047959;831764;1794446;461542924;162662928;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-pyridazin-3-yl-3-[(E)-3-[6-[5-(trifluoromethyl)pyridin-2-yl]oxypyrazin-2-yl]prop-2-enyl]azetidine-1-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)C(=O)O
1319;409047960;;1794446;312390293;66764813;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-[4-[3-[(1R)-1-[4-(2-aminopyrimidin-5-yl)phenyl]-1-cyclopropylethyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)N4CCNCC4
1320;409047961;;1794446;318398468;46853762;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(R)-3-[2,4-dioxo-1-(1,4,6-trimethyl-1H-indol-3-ylmethyl)-1,4-dihydro-2H-pyrido[3,2-d]pyrimidin-3-yl]-pentanoic acid;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)NCCOC
1321;409047962;;1794446;336898977;44470113;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;ADRA1D receptor antagonist 1 (free base);TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OC)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
1322;409047963;;1794446;442046238;154701640;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[(3S,5S)-3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-5-[4-(trifluoromethoxy)phenyl]piperidin-1-yl]-(1,1-dioxo-1,4-thiazinan-4-yl)methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCN(CC4)C
1323;409047964;120322;1794446;442046238;154701640;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[(3S,5S)-3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-5-[4-(trifluoromethoxy)phenyl]piperidin-1-yl]-(1,1-dioxo-1,4-thiazinan-4-yl)methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=CC=C1)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
1324;409047965;114815;1794446;442046238;154701640;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[(3S,5S)-3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-5-[4-(trifluoromethoxy)phenyl]piperidin-1-yl]-(1,1-dioxo-1,4-thiazinan-4-yl)methanone;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)N1CCN(CC1)C(=O)C2=CC=CC3=C2CN(C3)C(C)(C)CCC4=CC(=C(C=C4)O)OC
1325;409047966;;1794446;442052558;126648559;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;1-Benzyl-N5-cyclopropyl-N3-methyl-2-oxo-1,2-dihydropyridine-3,5-dicarboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)CCOC
1326;409047967;;1794446;442064588;156022246;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(3S,4S)-N-cyclohexyl-4-[[5-(furan-2-yl)-3-methyl-2-oxo-1H-1,7-naphthyridin-8-yl]amino]-1-methylpiperidine-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C#CC1=CC2=C(C=C1)NN=C2)N3CC4=C(C3)C=C(C=C4)S(=O)(=O)C
1327;409048224;;1794446;103333158;9915028;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;A-216546 free base;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)NCCN(C)C
1328;409048225;;1794446;163314754;51352628;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Imidazo(1,2-b)pyridazine, 3-(6-(2-methoxyethyl)-3-pyridinyl)-2-methyl-8-(4-morpholinyl)-;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)CCN(C)C
1329;409048226;;1794446;318456509;42641861;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;1-Penten-3-one, 1-(4-fluorophenyl)-2-methyl-, oxime, (1E,3E)-;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)C(=O)O)O
1330;409048227;;1794446;374280463;71623052;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[3-Cyano-5-[[[2,4-dimethyl-5-[6-(3-pyridinyl)-1H-imidazo[1,2-b]pyrazol-1-yl]phenyl]amino]carbonyl]phenyl]pentafluorosulfur;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)C(=O)O
1331;409048228;98368;1794446;374280463;71623052;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[3-Cyano-5-[[[2,4-dimethyl-5-[6-(3-pyridinyl)-1H-imidazo[1,2-b]pyrazol-1-yl]phenyl]amino]carbonyl]phenyl]pentafluorosulfur;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)N4CCNCC4
1332;409048229;95499;1794446;374280463;71623052;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;[3-Cyano-5-[[[2,4-dimethyl-5-[6-(3-pyridinyl)-1H-imidazo[1,2-b]pyrazol-1-yl]phenyl]amino]carbonyl]phenyl]pentafluorosulfur;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)NCCOC
1333;409048230;;1794446;381873421;129012086;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-Ethyl-4-[(3S)-3-methylmorpholin-4-yl]-1H-pyrrolo[2,3-b]pyridine-2-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OC)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
1334;409048231;;1794446;440170924;58431184;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(5R)-5-[(4-cyanophenyl)methyl]-7-(3,5-dichloro-4-fluorophenyl)-5-methyl-6-oxo-N-[(2S)-1-oxo-1-[(1-pyridin-2-ylcyclopropyl)amino]propan-2-yl]imidazo[1,2-a]imidazole-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCN(CC4)C
1335;409048232;288753;1794446;440171401;155546287;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[[4-(3-cyclohexylpropylcarbamoyl)phenyl]methyl]-1-phenyl-5-(trifluoromethyl)pyrazole-4-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=CC=C1)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
1336;409048233;281838;1794446;440171401;155546287;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[[4-(3-cyclohexylpropylcarbamoyl)phenyl]methyl]-1-phenyl-5-(trifluoromethyl)pyrazole-4-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)N1CCN(CC1)C(=O)C2=CC=CC3=C2CN(C3)C(C)(C)CCC4=CC(=C(C=C4)O)OC
1337;409048234;;1794446;440171401;155546287;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[[4-(3-cyclohexylpropylcarbamoyl)phenyl]methyl]-1-phenyl-5-(trifluoromethyl)pyrazole-4-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)CCOC
1338;409048235;;1794446;440178405;145925680;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;ERK-IN-2 (free base);TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C#CC1=CC2=C(C=C1)NN=C2)N3CC4=C(C3)C=C(C=C4)S(=O)(=O)C
1339;409048236;;1794446;440178544;56707820;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Ogerin;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)NCCN(C)C
1340;409048237;;1794446;440191048;146673143;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Clk-IN-T3N;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)CCN(C)C
1341;409048238;4119;1794446;440191048;146673143;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Clk-IN-T3N;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)C(=O)O
1342;409048239;40738;1794446;440191048;146673143;27346;;Confirmatory;20240503;0;0;Active;Q5BJF2;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;Clk-IN-T3N;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)C(=O)O)O
1343;409048240;;1794446;461525873;70817911;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-(4-(1-Aminocyclobutyl)phenyl)-3-phenylimidazo[1,2-b]pyridazine-6-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)N4CCNCC4
1344;409048241;;1794446;461563600;162677485;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(3R)-N-[5-(2-azidoacetyl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-1-cyanopyrrolidine-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)NCCOC
1345;409048242;;1794446;475979315;166625943;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(3S)-3-[2-[[5-chloro-3-(difluoromethyl)pyrazol-1-yl]methyl]-7-methyl-4-oxopyrazolo[1,5-a]pyrazin-5-yl]butanenitrile;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCN(CC4)C
1346;409048243;;1794446;475988416;162760083;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;2-(5-fluoropyridin-2-yl)-3-(1H-pyrazolo[3,4-b]pyridin-4-yl)-6,6-bis(trideuteriomethyl)-4,7-dihydropyrazolo[5,1-c][1,4]oxazine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OC)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
1347;409048244;;1794446;312441821;72901200;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;6-Methyl-2-{[(3-phenoxypropyl)amino]methyl}quinolin-4-OL;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=CC=C1)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
1348;409048245;189191;1794446;312441821;72901200;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;6-Methyl-2-{[(3-phenoxypropyl)amino]methyl}quinolin-4-OL;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(=O)N1CCN(CC1)C(=O)C2=CC=CC3=C2CN(C3)C(C)(C)CCC4=CC(=C(C=C4)O)OC
1349;409048246;190546;1794446;312441821;72901200;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;6-Methyl-2-{[(3-phenoxypropyl)amino]methyl}quinolin-4-OL;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)CCOC
1350;409048247;;1794446;440132255;52916803;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;CCR1 antagonist 8;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CC(C)(C#CC1=CC2=C(C=C1)NN=C2)N3CC4=C(C3)C=C(C=C4)S(=O)(=O)C
1351;409048248;;1794446;440157493;57861407;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;1-(2-ethoxyethyl)-6-oxo-N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridin-2-yl]pyridine-3-carboxamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=CC(=N1)C(F)(F)F)C2=CN=C(N=C2)N3CCC4=C3C(=CC(=C4)S(=O)(=O)NC5=C(C=C(C=C5F)Cl)F)N6CCCC6=O
1352;409048249;;1794446;440177378;137332060;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[(4-fluorophenyl)methyl]-2-[(3R)-5-(methylcarbamoylamino)-2',4'-dioxospiro[1,2-dihydroindene-3,5'-1,3-oxazolidine]-3'-yl]-N-[(2S)-1,1,1-trifluoropropan-2-yl]acetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CN1C(=CC(=N1)C(F)(F)F)C2=CN=C(N=C2)N3CCC4=C3C(=CC(=C4)S(=O)(=O)NC5=C(C=C(C=C5F)Cl)F)N6CCCC6=O
1353;409048250;327255;1794446;440177378;137332060;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[(4-fluorophenyl)methyl]-2-[(3R)-5-(methylcarbamoylamino)-2',4'-dioxospiro[1,2-dihydroindene-3,5'-1,3-oxazolidine]-3'-yl]-N-[(2S)-1,1,1-trifluoropropan-2-yl]acetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;C1CCC(CC1)(C2=CC=CC=C2)C(=O)OCCN3CCOCC3
1354;409048251;316228;1794446;440177378;137332060;27346;;Confirmatory;20240503;0;0;Unspecified;Q5BJF2;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 2;N-[(4-fluorophenyl)methyl]-2-[(3R)-5-(methylcarbamoylamino)-2',4'-dioxospiro[1,2-dihydroindene-3,5'-1,3-oxazolidine]-3'-yl]-N-[(2S)-1,1,1-trifluoropropan-2-yl]acetamide;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CCC(CC1)(C2=CC(=CC=C2)S(=O)(=O)C)O
1355;409048252;;1794446;469851451;164631600;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;4-[3-(4-Phenylpiperidin-1-yl)imidazo[1,2-a]pyrazin-8-yl]morpholine;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;CCCN1CC[C@H]([C@H](C1)O)C2=CC(=CC=C2)S(=O)(=O)C
1356;409048253;;1794446;475996307;165413047;27346;;Confirmatory;20240503;0;0;Inactive;Q5BJF2;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 2;(3R)-3-[2-[[5-chloro-3-(difluoromethyl)pyrazol-1-yl]methyl]-7-methyl-4-oxopyrazolo[1,5-a]pyrazin-5-yl]butanenitrile;TMEM97 - transmembrane protein 97 (human);/gene/27346;;Q5BJF2;9606;;;;;COC1=C(C=C(C=C1)CC[C@H](C2=CC(=CC=C2)OCCN3CCOCC3)OC(=O)[C@@H]4CCCCN4C(=O)[C@@H](C5CCCCC5)C6=CC(=C(C(=C6)OC)OC)OC)OC
